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     Abstract 
Gram negative bacteria such as Stenotrophomonas maltophilia, Pseudomonas aeruginosa 
and Citrobacter freundii are often associated with multiple drug resistance and the generation of 
nosocomial infections. In the current study several clinical strains of theses bacteria (Ps 1, Ps 3, Ps 
5, St 18, St 51, St 53 and C. freundii) and two culture collection strains Ps 10421 and St 9203 were 
evaluated for their ability to generate biofilms and the characteristics of the associated extracellular 
polysaccharides they produced.  
The ability of these strains to develop biofilms on a range of media and with a number of 
carbon sources was investigated. A range of mineral media employing glucose, ethanol and 
glycerol were developed in such a way as to ensure they did not contain compounds that interfere 
with extracellular polysaccharide analysis allowing a more in depth analysis of the extracellular 
polysaccharide generated by the bacteria under investigation.  
Following an assessment of the biofilm forming potential of all the strains under 
consideration, three were singled out for particular attention, i.e.  Ps 3, St 53 and C. freundii strain 
isolated during this investigation. Two of strains were chosen for the strength of their biofilm 
forming potential (Ps 3 and St 53), on the other hand C. freundii was chosen because the scientific 
literature contains very little published information regarding its extracellular polysaccharide and 
its biofilm forming characteristics. These bacteria were able to produce biofilm on both 
hydrophobic (plastic) and hydrophilic (glass) surfaces. In order to get a broader understanding of 
the biofilm forming capabilities of these bacteria their whole genomes were sequenced and 
subsequently published. These genomes demonstrated that St 53 and C. freundii both contained the 
pgaABCD which is known to be associated with biofilm formation.  Whilst Ps 3 contains a full 
complement of pel (PA3058-PA3064), psl (PA2231-2245) and alginate biosynthesis operons 
(PA3540-3548) related to biofilm formation. In addition all three species contained genes 
associated with virulence, pathogenicity and antibiotic resistance.  
The generation and extraction of extracellular polymeric substance generated by these 
three bacteria underwent a period of optimisations which included an optimisation of both the 
media and the growth conditions and the extraction process. In particular the use of trichloroacetic 
acid (TCA) was found to be critical with 0-5% TCA considered optimum for the removal of 
proteins prior to polysaccharide extraction. This is far less than has been previously employed in 
studies on lactic acid bacteria, however when used with the Gram negative bacteria investigated 
here, high levels of TCA degraded the polysaccharide that was being generated preventing its 
extraction in the quantities required for analysis.  
Analysis of the polysaccharides produced by St 53, Ps 3, and C. freundii, all demonstrated 
typical NMR spectra associated with bacterial extracellular polysaccharide. However, the NMR 
spectra from these polysaccharides also contained peaks typical of the presence of dextran. The use 
of a fungal dextranase confirmed the presence of a dextran like polymer in the polysaccharide 
generated by these bacteria. This indicated that all three of these bacteria generated complex 
polysaccharides with at least two components one mannose rich and the second a dextran like 
glucose rich polymer. This is the first report of a dextran being associated with the EPS of these 
bacteria and suggests that the Pel polysaccharide of P. aeruginosa is a dextran.  
Investigation of bacterial pathogenicity focussed on Ps 3 since P. aeruginosa is the most 
pathogenic of the three species investigated. The culture collection strain Ps 10421 failed to produce 
outer membrane vesicles (OMV) without antibiotic treatment, however Ps 3 generated OMV under 
normal growth conditions generating more when grown on ethanol rather than glucose. In order to 
investigate the impact of ethanol vs glucose grown culture a wax worm pathogenicity model was 
employed. This model revealed that ethanol grown cells were more pathogenic than glucose grown 
cells. This difference could be attributed to the effects of type of carbon sources that induce 
virulence genes to generate more toxins. Transcriptomic analysis of Ps 3 grown with ethanol vs 
growth on glucose revealed large differences in gene expression but no definitive evidence of which 
cellular processes were responsible for this enhanced pathogenicity associated with grown on 
ethanol. 
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1. Introduction  
Mortality and morbidity rates are high in intensive care units worldwide  
due to infections caused by multidrug resistant organisms (MDRO), in recent 
years there has been a significant increase in multidrug resistance amongst Gram 
negative bacteria (De Angelis et al., 2014). Gram negative bacterial species such 
as Stenotrophomonas maltophilia, Pseudomonas aeruginosa and Citrobacter 
freundii are opportunistic pathogens which are often multidrug resistant and have 
been shown to be problematic in clinical settings (Chaudhry et al., 2014, Kim et 
al., 2003, Brooke, 2012, Lister et al., 2009).  
Treatment of the infections caused by these bacteria is complicated by 
biofilm formation which increase their antibiotic resistance, prevalence and 
survival (de Abreu et al., 2014). The Extracellular Polymeric Substance (EPS) 
generated by  bacteria when they form a biofilm acts as a diffusion barrier against 
antimicrobial agents e.g. antibiotics, reducing the effective concentration that the 
bacteria is exposed to (Kokare et al., 2009). 
The persistence and survival of Gram negative bacteria on surfaces is 
longer than that see in in Gram positive bacteria (Kramer et al., 2006), Gram-
negative bacteria such as Pseudomonas aeruginosa and Stenotrophomonas 
maltophilia can survive for months on biotic (living) and abiotic (non-living) 
surfaces such as epithelial cells, glass and plastic surfaces (Kramer et al., 2006, 
Brooke, 2007) and this is due to biofilm formation and  the outer membrane 
structure of Gram negative bacteria (Martinez, 2011).   
The research reported in this thesis is focussed on the biofilm formation, 
EPS generation and associated pathogenicity of several Gram negative bacteria 
associated with human infections.  
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2. Literature Review  
2.1. Bacteria  
Bacteria can be defined as small, unicellular prokaryotic organisms with 
simplest life form. Prokaryotes are living cells without nucleus and other 
membrane-bound structures. Generally microorganisms are classified in to two 
major groups as eukaryotes and prokaryotes based on cellular structure and 
function. The prokaryotes are also classified in to eubacteria and archaebacteria. 
Eubacteria and archaebacteria are commonly referred to as bacteria (Gerardi, 
2006). Based on morphology and cell wall response to chemical stain (Gram 
stains), bacteria are commonly divided into several groups, one of them is Gram 
negative bacilli (Schleifer and Kandler, 1972).   
2.2. Gram negative bacilli bacteria 
This group of bacteria are considered a significant cause of infection in 
the community and nosocomial settings (Wong et al., 2014). Several studies have 
shown an increasing in incidence and resistance to antibiotics among Gram 
negative bacilli including Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Acinetobacter spp., Escherichia coli, Stenotrophomonas maltophilia, Citrobacter 
freundii with multidrug resistance being common (McGowan, 2006, Lockhart et 
al., 2007). In the USA, an analysis by the National Nosocomial Infection 
Surveillance System for diseases such as pneumonia and UTI acquired during 
stays in intensive care units between 1986 and 2003 showed that Gram negative 
bacilli were the most frequently isolated bacteria. The review also highlighted the 
difficulty of treating these intensive care units infections due to the increased 
incidence antimicrobial resistance in this group of bacteria (Rahal, 2009). 
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2.2.1. Stenotrophomonas maltophilia  
Stenotrophomonas maltophilia (S. maltophilia)  is a bacterium that was 
first isolated in 1943 and identified as Bacterium booker and then classified in 
1961 by (Hugh and Ryschenkow, 1961) as a member of the genus Pseudomonas 
(Pseudomonas maltophilia). It was then renamed as Xanthomonas maltophilia 
(Swings et al., 1983) and then transferred in 1993 (Palleroni and Bradbury, 1993) 
into the new Stenotrophomonas genus. Another 3 species, Pseudomonas 
geniculata, Pseudomonas betle and Pseudomonas hibiscicola were also 
reclassified as Stenotrophomonas maltophilia (Singer et al., 1994, Van den 
Mooter and Swings, 1990, Anzai et al., 2000). S. maltophilia is an obligate aerobic 
non-fermentative, Gram-negative, bacilli or curved rods, 0.5 to 1.5 µm, catalase 
positive and mostly oxidase negative, belonging to the Gammaproteobacteria 
class, Xanthomonadaceae family (Denton and Kerr, 1998, Brooke, 2012). S. 
maltophilia  has a broad distribution and can be found in various environments 
and geographical regions, It has been isolated from a wide range of both 
institutional and environmental habitats e.g. hospitals, water (rivers, wells, and 
bottled water), sewage, soil, plant and food (Youenou et al., 2015, Denton and 
Kerr, 1998, Hoefel et al., 2005).  
According to Svensson-Stadler et al. (2012) of the 12 identified species 
within the genus Stenotrophomonas only S. maltophilia is isolated from human 
and can cause disease, while the others are isolated from the environment and are 
non-pathogenic. One of the most important features of S. maltophilia is its ability 
to form biofilms on biotic and abiotic surfaces such the epithelial cells of the lung, 
implanted medical devices (catheters and respiratory therapy equipment), glass 
and plastic (Brooke, 2014, Denton and Kerr, 1998). 
S. maltophilia is listed by the World Health Organization (WHO) as one 
of the most important multidrug resistant bacteria in hospitals worldwide being 
resistant to β-lactam drugs, chloramphenicol, tetracyclines and cephalosporins. It 
is considered an opportunistic pathogen causing nosocomial infections especially 
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in intensive care units amongst the immunocompromised, cancer patients and 
those with central venous catheters (Brooke, 2014). Stenotrophomonas 
maltophilia can cause various serious infections in humans.  S. maltophilia is 
usually associated with respiratory tract infection in persons with cystic fibrosis 
(CF) (Waters et al., 2013) but recently the prevalence of infection even  in normal 
patients  (non-cystic  fibrosis) has increased, such infections include bloodstream 
infections (Garazi et al., 2012), meningitis (Papadakis et al., 1997), endocarditis 
(Rodero et al., 1996), bacteraemia (Friedman et al., 2002), pneumonia (Hanes et 
al., 2002, Irifune et al., 1994), septicaemia and urinary tract infection (Brooke, 
2012). 
2.2.2. Pseudomonas aeruginosa 
In 1882, Gessard isolated Pseudomonas aeruginosa from a cutaneous 
wound (Wilson and Dowling, 1998) to later described by Migula (1894), as such 
this species was part of the early history of bacteriology (Peix et al., 2009). 
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative aerobic or 
(facultative anaerobic), non-spore forming bacteria, bacilli or slightly curved 
shape, 0.5–1.0  to 1.5– 5.0 µm,  motile with polar flagella or rarely non-motile 
and belonging to the Gamma proteobacteria class, family Pseudomonadaceae  
(Frangipani et al., 2008, Brenner et al., 2005). The species grows well in moist 
environments but can grow in a wide variety of environments including soil, 
waters, plants and hospitals (Wilson and Dowling, 1998). The ability of P. 
aeruginosa to; grow with minimal nutritional requirements on a wide variety of 
carbon source, it’s tolerance and resistance  to a variety of physical and 
environmental condition, resistance to a wide range of antimicrobial agents and 
its ability to produces many virulence factors such as (exotoxin A, exoenzyme S, 
phospholipase C, rhamnolipid and alkaline protease) make it a highly successful 
species (Van Delden and Iglewski, 1998). These characteristics also enable its 
long-term persistence and transmission in a variety of environmental niches 
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including hospitals where it has become one of the most common opportunistic 
pathogenic bacteria (Persson, 2010, Lanini et al., 2011).   
P. aeruginosa is responsible for both community-acquired and hospital 
acquired infections. In the community it is associated with eye infections, 
ulcerative keratitis, skin infections (Fujitani et al., 2011, LaBauve and Wargo, 
2012) and diabetic wounds infections (Edmonds et al., 1986).  It is also 
responsible for many hospital-acquired infections (Fujitani et al., 2011, LaBauve 
and Wargo, 2012) especially in immunocompromised patients being responsible 
for cystic fibrosis lung infections (Oliver et al., 2000), acute pneumonias 
(Arancibia et al., 2002) burn and open wounds infection (Rumbaugh et al., 1999), 
acute and chronic urinary tract infection especially in patients with catheter device 
(Nicolle and Committee, 2005), bacteraemia and septicaemia (Kang et al., 2003).  
P. aeruginosa is considered one of major causes of nosocomial infections 
accounting for 10–15% of nosocomial infections worldwide (Strateva and 
Yordanov, 2009).  This is not surprising since it is one of the most frequently 
isolated bacteria in hospitals (Kramer et al., 2006).  Hospital environmental 
transmission is considered the major source of most Pseudomonas outbreaks, 
rather than cross transmission between patients. Hospital environmental isolates 
of P. aeruginosa have been shown to possesses higher levels of resistance to anti-
pseudomonal antibiotics when compared to Pseudomonas isolates from patients 
(Fujitani et al., 2011).  
Infections caused by P. aeruginosa  are very  difficult to treat, which is due to the 
natural resistance of P. aeruginosa  to a wide range of antimicrobial agents 
(Strateva and Yordanov, 2009). This is partially due to the fact that P. aeruginosa 
forms extensive biofilms on a variety of surfaces (O'Toole and Kolter, 1998, 
Tielker et al., 2005, Soto, 2014). 
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2.2.3. Enterobacteriaceae 
Enterobacteriaceae are a large heterogeneous family of bacteria in the 
Gammaproteobacteria class.  The Enterobacteriaceae members are Gram-
negative rods, which range between 1.0–6.0 µm in length, grow well at 22–35°C, 
and live in environments such as soil, water, fruits, meats, eggs, vegetables, and 
as a commensal in the intestines of humans and animals. Many members of the 
family Enterobacteriaceae have the ability to cause disease in human and animal 
such as Citrobacter spp., Enterobacter spp., Escherichia spp., Klebsiella spp 
(Brenner et al., 2005). Among the wide range of Gram-negative bacteria that are 
responsible for nosocomial infections, member of the family Enterobacteriaceae 
is considered the most commonly identified group (Peleg and Hooper, 2010). 
Increasing multidrug resistance among the Enterobacteriaceae is considered a 
significant risk to public health. Enterobacteriaceae that excrete Extended 
Spectrum β-lactamases (ESBL) and those producing carbapenemases have spread 
worldwide and have significantly reduced the usefulness of cephalosporins and 
carbapenems as treatment options (Delgado-Valverde et al., 2013, Gupta et al., 
2011a). 
2.2.3.1. Citrobacter freundii 
The genus Citrobacter was described for the first time by Braak and 
nominated as Bacterium freundii in 1928, and then later in 1932, the bacterium 
was re named as Citrobacter freundii by Werkman and Gillen. Citrobacter spp. 
are Gram negative rod shape, 2-6µm,  facultative anaerobes, with peritrichous 
flagella, they are oxidase negative and catalase positive (Borenshtein and Schauer, 
2006, Brenner et al., 2005). Citrobacter freundii (C. freundii) is a member of the 
family Enterobacteriaceae that can be found in environments such as soil, water 
and food (Samonis et al., 2009) it is also a commensal of the intestinal tracts of 
both humans and animals (Bai et al., 2012). It is also considered an opportunistic 
pathogen that can cause several infection especially in high-risk groups (Zhang et 
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al., 2008). It is typically associated with diarrhoea (Bai et al., 2012), wound 
infections (Rao et al., 2013), bacteremia (Shih et al., 1996), neonatal meningitis 
and brain abscess (Doran, 1999) (Badger et al., 1999), necrotizing pancreatitis 
(Lozano-Leon et al., 2011) and UTI and blood stream infections (Ranjan and 
Ranjan, 2013, Pepperell et al., 2002). C. freundii is resistant to several antibiotics 
such as ceftriaxone, ceftazidime, piperacillin cephalosporins and penicillins 
(Lavigne et al., 2007, Kim et al., 2003), ampicillin (Doran, 1999). There is also 
evidence of resistance to carbapenems which were considered to be one of the 
few remaining treatments for infections caused by multidrug resistant isolates 
(Zhang et al., 2008).  C. freundii produces several virulence factors such as Shiga-
like toxins and heat stable toxin type III and has the ability to produce biofilms to 
colonize and attach to surfaces and devices such as catheter  (Shirtliff and Leid, 
2009, Bai et al., 2012). 
2.3. Bacterial Pathogenicity 
Pathogenicity is the ability of an agent to cause disease (Beceiro et al., 2013) and 
a number of mechanisms are used by the pathogenic bacteria to cause disease in 
humans. Common mechanisms amongst pathogens include; adherence, invasion, 
toxin and enzymatic damage to host cells and tissues, avoidance and disruption of 
host defences (Wilson et al., 2002), all of which contribute to the establishment 
and propagation of an infection. Most pathogenic bacteria use of a combination 
of toxin generation and tissue/cell invasion to cause disease (Beceiro et al., 2013), 
these processes are summarised in (Figure 2.1). 
As mentioned previously, Gram-negative pathogens have received considerable 
attention in recent years due to the emergence of (MDRO). Key mechanisms 
driving this multi-drug resistance include the presence of bacteria efflux pumps 
and the generation of antibiotic degrading enzymes such as β-lactamases, the 
genes associated with these capabilities can be either genomic or plasmid 
associated and transferred by various gene transfer mechanisms.  Recently, the 
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reported cases of MDR associated infections due to P. aeruginosa S. maltophilia 
and C. freundii   have increased (Kumar et al., 2013, Brooke, 2012). 
In the case of S. maltophilia, pathogenicity is associated with their ability to: 
 Form biofilm on different surfaces including (Teflon, glass, and plastics 
and on host tissues). Biofilm formation is considered a significant feature 
of S. maltophilia pathogenesis with 65% of hospital-acquired infections 
being associated with biofilms. 
 Antibiotic resistance. 
 The production of hydrolytic enzymes. 
 Adherence to and invasion of host cells. 
 Lipopolysaccharide endotoxins (Brooke, 2012).  
In the case of C. freundii common virulence factors include: 
 Biofilm formation (Pereira et al., 2010). 
 Toxin generation including a Shiga-like enterotoxins. 
 A type III secretion system (T3SS) (Bai et al., 2012). 
 Hydrolytic enzyme (Gunasekaran et al., 2006). 
 Resistance to a wide range of antimicrobial agents (Lavigne et al., 2007).  
The pathogenicity of P. aeruginosa depends on a wide range of virulence factors 
which all combine to produce a highly effective pathogen (Figure 2.2) (Gellatly 
and Hancock, 2013) these include: 
 Ability to form biofilms on biotic or abiotic surfaces. 
 Extracellular factors including lipases and phospholipase. 
 Outer membrane vesicles. 
 Type III secretory systems.  
 Toxins such as pyocyanin, pyoverdine, hydrogen cyanide and Exotoxin 
A. 
 Enzymes such as neutral and alkaline proteases, elastase, rhamnolipid and 
haemolysin. 
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 Siderophores for iron sequestration. 
 Cellular factors including lipopolysaccharide (LPS), flagella and pili.  
 The control of virulence and associated pathogenicity through cell-to-cell 
communication mechanism (Quorum Sensing) (Li et al., 2007, Davies et 
al., 1998, Wagner and Iglewski, 2008, Lyczak et al., 2000, Ballok and 
O'Toole, 2013, Ledizet et al., 2012, Gellatly and Hancock, 2013).  
 Antimicrobial resistance associated with the expression of efflux pumps, 
the low permeability of the outer-membrane and the acquisition of β-
lactamases.  
The pathogenicity of P. aeruginosa and its ability to resist antibiotics and 
disinfectants has been attributed to the large size and the versatility of its genome 
(Mesaros et al., 2007). 
 
 
 
Figure 2.1 An overview of bacterial mechanisms for pathogenicity (Wilson et al., 2002). 
(A) The bacterial components that interact with the host include: (i) Capsules (protection) (ii) 
Lipopolysaccharide and cell wall (septic shock), (iii) Toxins (damage and invasion) and (iv) 
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Adhesions (attachment). (B) Once adhered to a host surface, a bacterial pathogen may further 
invade host tissues. (i) Proteases and glycanases (digest host and invasion), (ii) natural 
phagocytosis mechanisms of macrophages and neutrophils (invasion) or type III secretion 
system (T3SS) by induced uptake (adhesion). Within the host cell, the pathogen may reside 
within a phagolysosomal vacuole (a phagosome which has fused with a lysosome), a 
phagosome which has not fused with a lysosome, or within the host cell cytosol. 
 
 
 
Figure 2.2 A summary of Pseudomonas aeruginosa virulence factors (Gellatly and 
Hancock, 2013). Attachment and adhesion through flagella, pili and lipopolysaccharide that 
cause highly inflammatory. Activation of T3SS which is able to insert cytotoxins into the host 
cell. Secretion of several virulence factors such as proteases (degrade host complement factors, 
mucins, and disrupt tight junctions between epithelial cell), Exotoxin A (host elongation factor 
EF2 inhibitor), Lipases and phospholipases (lipids), pyocyanin (interfere with host cell electron 
transport pathways) and pyoverdine (chelating agent). 
 
2.4. Biofilms  
2.4.1. Bacterial biofilm formation 
Generally, bacteria exist in nature in two form, either planktonic where 
the bacteria are free living and growing in suspension or in a biofilm. In biofilms 
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bacteria are attached to each other and/or a surface as a community where they 
form a network of cells surrounded by a self-produced matrix of EPS (Lear and 
Lewis, 2012, Hall-Stoodley et al., 2004). It is estimated that more than 99% of 
microorganisms on the earth live as a biofilm (Vu et al., 2009, Garrett et al., 2008).  
Biofilm formation occurs as a sequential process and one key aspect of 
biofilm formation is (QS). In the case of Pseudomonas spp. biofilms, five stages 
of development have been identified (Figure 2.3) (Marić and Vraneš, 2007, 
Renner and Weibel, 2011).;  
1. Reversible attachment: Interaction between planktonic bacteria and substrate 
surface is considered the initial event in biofilm development. This phase is 
called reversible adsorption because some bacteria attach to the substrate 
surface only for a brief period and then detach from it (Figure 2.3). The contact 
between planktonic bacteria and the surface may be either random or 
controlled due to (chemotaxis and motility) (Dunne, 2002). 
2. Irreversible attachment: After binding to the surface, bacterial cells start the 
process of irreversible adhesion by the formation of multi-layered cell clusters 
and the production of EPS which provide the developing biofilm with 
structural support. Production of the EPS also secures the adhered bacterial 
biofilm more firmly to the surface. In this phase bacteria lose their mobility 
and bacterial cells attach to each other on the substrate surface and start to 
form microcolonies (Stoodley et al., 2002, Cegelski et al., 2008). 
3. Maturation I (microcolonies formation): After irreversibly attaching to a 
surface, bacterial cells undergo phenotypic changes, and the process of 
biofilm maturation I begins. In this phase, a matrix of EPS is produced and 
microcolonies become multi-layered (Figure 2.3). This matrix is an essential 
part of the biofilm, which contributes to its antibiotic resistance (Cegelski et 
al., 2008).  
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4. Maturation II: In this stage, microcolonies of bacteria grow to their maximum 
size and thickness. Once the biofilm has matured to this stage, it becomes 
more resistant and very difficult to treat or eradicate with antimicrobial agents 
and this is due to the failure of the agents to penetrate the full depth of this 
matured biofilm (Cegelski et al., 2008, Aslam, 2008). 
5. Detachment and dispersion: Microcolony structure changes to a shell-like 
structure having an inner empty cavity. In this stage, bacterial cells recover 
their mobility, start to detach, migrate and adhere to other surfaces where they 
form another biofilm. In this manner biofilm formation becomes a cyclical 
process (Stoodley et al., 2002). 
Biofilms are composed of microcolonies that consist of distinct communities of 
bacterial cells surrounded by EPS. Depending on the type of bacteria, 
microcolonies are composed of 10-25% of cells and 79-90% of EPS (Kokare et 
al., 2009, Marić and Vraneš, 2007, Garrett et al., 2008).  
Life in a biofilm has several advantages for the microbial communities 
involved, including: 
a) Protection from environmental factors such as desiccation, radiation and toxic 
compounds. 
b) The provision of ideal environmental conditions and nutrients. 
c) Opportunities for the transfer of genetic material between the individual cells 
within the bacterial communities. 
d) Protection from antimicrobial agents such as antibiotic, biofilms can increase 
resistance by more than a hundred fold in some species (Kokare et al., 2009, 
Garrett et al., 2008).  
Bacterial biofilms cause problems across a wide range of economic sectors such 
as food, dairy, water systems and oil industry. In hospitals, biofilms are associated 
with a wide range of nosocomial infections, since both commensal and pathogenic 
microorganisms form biofilm on a wide range of surfaces and medical devices 
especially implanted medical device including prosthetic heart valves, orthopedic 
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implants, intravascular catheters, artificial hearts, urinary catheters and contact 
lenses (Bryers, 2008). Currently, biofilms formation are estimated to be 
responsible for over 65% of nosocomial infections and 80% of all microbial 
infections (Soto, 2014). Biofilms are also associated with  several conditions such 
as otitis media, cystic fibrosis pneumonia, intensive care unit pneumonia, contact 
lens related infections, urinary catheter cystitis, central venous catheter infections 
and dental caries (Costerton et al., 1999). 
 
 
  
Figure 2.3 P. aeruginosa biofilm formation stages on glass slide under continuous flow 
medium starts with 1: initial attachment or reversible attachment of bacteria to the surface. 2: 
irreversible attachment and EPS production 3: early biofilm architecture I. 4: maturation of 
biofilm architecture II, and finally 5: biofilm dispersion  and  single cells spreading  (Stoodley 
et al., 2002).      
    
2.4.2. Biofilm analysis 
A wide range of quantitative and qualitative techniques have developed 
for the investigation of biofilms (Pantanella et al., 2013, Taj et al., 2011). The 
simplest of these approaches are staining methodologies such as crystal violet or 
safranin staining for biofilm biomass quantification tissue culture plate (TCP)  
(Christensen et al., 1985, Stepanović et al., 2000, Pantanella et al., 2007), tube 
methods (TM) or tube adherence (TA) (Freeman et al., 1989, Christensen et al., 
1982) Congo red agar method (CRA) (Freeman et al., 1989), bioluminescent 
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assays (Donlan et al., 2001, Angell et al., 1993), air-liquid interface coverslip 
assay (Ludwicka et al., 1985, Merritt et al., 2005), molecular techniques (PCR) 
(Melo et al., 2013). A wide range of microscopy approaches have been used to 
visualize biofilms from such as light or fluorescent microscopic examination 
(Juan C et al., 2012), confocal laser scanning microcopy, scanning electron 
microscope (SEM) and transmission electron microscopy (TEM) (Zahller and 
Stewart, 2002, Wallace et al., 2011).  
Due to complexity of biofilm, an extensive study of biofilm requires a 
combination of different experimental methods (Pantanella et al., 2013). 
Currently, several qualitative methods (TA, CRA) or quantitative method (TCP) 
are used as routine test in medical areas for the detection of biofilm production, 
as well as molecular techniques (PCR), which amplify the genes involved in 
biofilm production as a complement these methods (Oliveira and Maria de 
Lourdes, 2010).   
2.4.3. Quorum sensing (QS) 
Cell to cell communication in bacterial communities is called Quorum 
sensing (QS). Both Gram-positive and Gram-negative bacteria are capable of QS 
through the production and release of chemical signalling molecules which are 
called autoinducers (AIs).  The mechanism of QS starts by producing AI 
molecules inside the bacterial cells and their distribution throughout the inner and 
outer membranes, As the bacterial population density builds the AIs bind to  
transcription factors or activators (cytoplasmic receptors) forming AI-bound 
receptors that stimulate the bacteria to alter the expression of target genes e.g. 
genes that regulate various physiological activities include virulence factor 
secretion, antibiotic production, motility, sporulation, and biofilm formation (De 
Kievit and Iglewski, 2000, Miller and Bassler, 2001, Rutherford and Bassler, 
2012).  
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In general, the process or types of QS are different between Gram-negative and 
Gram-positive bacteria. Gram-negative bacteria use small molecules N-acyl or 
acylated homoserine lactones (AHL) as autoinducers, while Gram-positive 
bacteria use peptides or autoinducing peptides (AIP), as  signalling molecules to 
communicate (Miller and Bassler, 2001, Rutherford and Bassler, 2012).  QS 
systems are considered key to the regulation of virulence in both Gram-negative 
and Gram-positive pathogens and its function is different in Gram negative and 
Gram-positive bacteria. In P. aeruginosa for example QS is considered essential 
for the development of biofilm-associated infections, while in Staphylococcus 
species, biofilm formation is not promoted by QS (Sifri, 2008).  
In P. aeruginosa, beside the two major autoinducers (Las and Rhl), A third 
autoinducer molecule was identified and designated as Pseudomonas quinolone 
signal (PQS) which is structurally very different from the former autoinducers 
(Las and Rhl). While the AI in S. maltophilia are called diffusible signal factor 
(DSF) that regulate antibiotic resistance and virulence (Fouhy et al., 2007). A 
wide range of pathogens use QS to regulate the production of virulence factors 
(Rutherford and Bassler, 2012). For example, pathogenicity of P. aeruginosa 
usually depend on its ability to produce several extracellular virulence factors 
such as proteases, exotoxin A, haemolysins, pyocyanin, rhamnolipid and 
biosurfactants.  Regulation of the genes that encode these exoproducts is primarily 
under the control of the bacteria’s signalling system (Whitehead et al., 2001),  The 
AI’s of P. aeruginosa also have iron chelating properties (Antunes et al., 2010) 
and regulate gene expression during biofilm formation (De Kievit, 2009). In some 
other bacteria AI are used as signalling inhibitors during competition between 
species or strains. For example different strains of Staphylococcus aureus are able 
to generate peptides that are able to inhibit gene expression of other strains 
(Antunes et al., 2010). 
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2.5. Extracellular polymeric substance (EPS) 
The ‘‘EPS’’ abbreviation has been used to identify a range of biofilm 
associated materials such as Exopolymers (Omoike et al., 2004), Extra cellular 
polysaccharides (Kiraly et al., 1997), Exopolysaccharides (Roca et al., 2015b) 
(McSwain et al., 2005) and extracellular polymeric substances (Dogsa et al., 
2005) (McSwain et al., 2005).  The term extracellular polymeric substances (EPS) 
covers a much wider range of materials, including, polysaccharides, proteins, 
phospholipid and nucleic acids (Czaczyk and Myszka, 2007, Hall-Stoodley et al., 
2004, Vu et al., 2009) as such this use of the term covers the full range of 
extracellular polymers produced by bacteria during biofilm formation. EPS 
production has a wide variety of roles includes adhesion to surfaces, bacterial cell 
aggregation, protection from engulfment by predatory protozoa and (phagocytes), 
protection from desiccation and antimicrobial agents (Nwodo et al., 2012). 
Carbohydrates are generally classified as monosaccharaides, 
disaccharides, oligosaccharides and polysaccharides (Harvey and Ferrier, 2011). 
Polysaccharides are defined as compounds that are composed of a high number 
of monosaccharides (more than ten) linked together by glycosidic bonds 
(McNaught and McNaught, 1997) and include compounds such as cellulose and 
chitin which are very common in nature (Karunaratne, 2012). A wide range of 
Extracellular polysaccharides (EPS) are produced by bacteria (Staudt, 2009). 
Generally polysaccharide excreted by bacteria can be divided to two groups on 
the basis of their chemical composition:  
a) Homopolysaccharides are defined as a polymer that are composed of one type 
of sugar e.g. dextrans and cellulose which are composed  of series of D-
glucose units and produced by Streptococcus bovis (Bailey and Oxford, 1958)  
and Acetobacter xylinum (Matsuoka et al., 1996), respectively. 
b) Heteropolysaccharides which are composed of two or more different sugars, 
examples include the polysaccharides that formed by lactic acid bacteria 
(Sutherland, 1990, Hutkins, 2008). 
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2.5.1. Extraction and characterisation of Extracellular Polymeric 
Substances (EPS) 
In order to understand the role played by EPS in biofilm formation and 
persistence it is necessary to extract, purify and characterise individual EPS 
components. The selection of an appropriate extraction method is very important 
for studying the physical and chemical properties of EPS (Comte et al., 2006, 
Flemming et al., 2000) since different extraction methods often lead to very 
different results (Sun et al., 2014). There are three common approaches for the 
extraction of EPS: physical, chemical, and a combination of the two (Nguyen et 
al., 2012). Physical methods generally include centrifugation, ultra sonication and 
heating, while chemical methods employ chemical substance such as EDTA, 
formaldehyde, NaCl, ethanol, NaOH and NaOH-formamide for the extraction of 
EPS (Flemming et al., 2000, Liu and Fang, 2002, More et al., 2014). 
Combinations of physical and chemical methods have been  used in the study of 
sludge sample such as (centrifugation with chemical substance), (heating 
+centrifugation + chemical substance)  (Liu and Fang, 2002, Bales et al., 2013), 
lactic acid bacteria (Chadha, 2009, Laws et al., 2001) and Bifidobacteria spp. 
(Leivers, 2011). 
 Quantity, quality, composition, physical and chemical properties of the  
extracted EPS depends on both the interaction between the EPS and the cells 
surfaces and the extraction method employed (Flemming et al., 2000, Pan et al., 
2010). A study by Liu and Fang (2002), indicated that EPS yield depends on the 
method of extraction, for example using (formaldehyde + NaOH) yields more  
EPS than (formaldehyde + cation exchange resin +  EDTA) and the composition 
of the extracted EPS was the same regardless of the methods used i.e. 
carbohydrate, protein, humic substance,  and small quantities of uronic acid and 
DNA. Other studies by Comte et al. (2006) and Pan et al. (2010), indicated that 
generally the quantity of EPS extracted by chemical methods is greater than that 
extracted by physical methods. However with chemical approaches the extracted 
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EPS is often contaminated by the chemical reagents employed, especially in the 
case of EDTA. The presence of chemical contaminants may alter the 
characteristic of the extracted EPS (Comte et al., 2006). Comte et al. (2006) also 
indicated that heating (80˚C) may induce the hydrolysis of EPS. Centrifugation is 
often used as a control for EPS extraction against which other physical and 
chemical methods are compared (Pan et al., 2010, Liu and Fang, 2002, Comte et 
al., 2006). Overall a combination of physical and chemical methods is now 
considered to be more effective in terms of yield and purity than either approach 
as can be seen in most recent studies (Nguyen et al., 2012).  
The isolation and characterisation of the EPS produced by bacteria is 
important, since it allows the understanding of the roles played by this class of 
molecules in a wide range of functional applications. In order to find the primary 
structure of the crude EPS, it is necessary to identify or determine the monomer 
composition (repeat unit) and their relative ratio in the repeating unit as well as 
determine how each monosaccharide is arranged (linked) in the repeating unit. 
Beside these, Nuclear Magnetic Resonance (NMR) spectroscopy, vibration 
spectroscopic methods (FTIR) and Multi angle Laser Light Scattering (MALLS) 
have a great value for the study and characterisation of the structure of EPS 
(Synytsya and Novak, 2014, Judd, 2010). In addition to polysaccharide content 
EPS is also characterized for its protein and DNA content (Judd, 2010).  
2.5.1.1. Total carbohydrate and protein content  
Initial analysis of bacterial EPS generally involves an estimation of the 
total carbohydrate and/or protein content. The phenol sulphuric acid method by 
(Dubois et al., 1956) is often used for total carbohydrate content and the Bradford 
assay (Bradford, 1976) provides a good estimate for the total protein content.   
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2.5.1.2. Nuclear Magnetic Resonance (NMR) Analysis 
NMR spectroscopy is used for the elucidation of glycosidic linkages. It is 
an important non-destructive standard technique for the investigation of 
polysaccharides (Wingender et al., 2012). NMR spectroscopy determines the 
structure of the EPS by providing information on ring protons which are 
frequently crowded and are present in a narrow region (3.0 to 4.0 ppm) 
(pyranose/furanose) and the anomeric protons (alpha and beta) 4 to 6 (4.5-5.5) 
ppm are usually distinct from this region. Integration of the anomeric signals gives 
a preliminary indication of the number and relative orientations of sugars in the 
repeating unit. The popularity of the structural investigation of carbohydrates by 
NMR spectroscopy is highlighted by the large number of reviews published in 
recent years (Bush et al., 1999, Leeflang et al., 2000, Synytsya and Novak, 2014, 
Sadiq, 2015). 
Several type of NMR analysis are combined to analyse EPS such as one-
dimensional (1D) proton NMR analysis (1HNMR) and Two-dimensional NMR 
Analysis (2D). Combination of 1D-NMR with 2D-NMR analysis can be used to 
determine the structure of the oligosaccharide unit by establishing how the 
monosaccharide units are linked together and how each carbon and hydrogen are 
positioned. Combinations of the following 2D- experiments are often required for 
unequivocal structural determination of the repeating unit structure 
polysaccharide units:  
 COSY - Correlation Spectroscopy. 
 TOCSY - Total Correlation Spectroscopy. 
 HSQC - Heteronuclear Single Quantum Coherence. 
 HMBC - Heteronuclear Multiple Bond Correlation. 
NMR (1D and 2D) analysis of EPS is often combined with other analysis 
including mass spectrometry or chemical analysis (monosaccharide composition 
or methylation analysis) to determine the complete structure (Gruter et al., 1993).  
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2.5.1.3. Fourier transform infrared spectroscopy (FTIR)  
Fourier transform-infrared spectroscopy (FTIR) spectroscopy is a 
powerful tool for the structural analysis of polysaccharides. FTIR is a non-
destructive technique for the structural analysis of polysaccharides which works 
by determining of certain chemical groups on the surface of an internal reflection 
element.  FTIR enables the simultaneous collection of information on the 
chemical and structural features of adherent bacteria within a minute (Wingender 
et al., 2012, Synytsya and Novak, 2014). Signals in the spectral region of 800-
1200 cm–1 are important for the structural characterisation of polysaccharides 
(Coimbra et al., 2002, Černá et al., 2003).  
2.5.1.4. Monosaccharide Analysis 
As mentioned previously, monosaccharide units attached together through 
alpha or beta glycosidic linkages form repeating oligosaccharide units 
(polysaccharides) ranging from linear homopolysaccharides to highly branched 
heteropolysaccharides (Poli et al., 2011). Cleavage of the glycosidic linkages of 
the repeating unit structures is required in order to determine the type and the 
amount of monosaccharides that are present in a sample. Gas chromatography 
(GC) and high performance liquid chromatography (HPLC) are the most 
frequently used methods and provide qualitative and quantitative estimation of 
monosaccharide content. These techniques are preferred to enzymatic methods 
due to the latter being highly specific and only able to determine a limited number 
of monosaccharide (Preedy, 2012).  
In order to determine the monosaccharide constituents of the 
polysaccharide, the polysaccharide is firstly hydrolysed with the aid of an acid 
catalyst (HCl, H2SO4 or TFA) and heating to form sugar monomers, these are then 
analysed by High Performance Anion Exchange Chromatography with Pulsed 
Amperometric Detection (HPAEC-PAD) or assayed by (GC) after derivatization 
(premethylation, hydrolysis and acetylated) to alditol acetates. In recent years 
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HPAEC-PAD has become increasingly popular as an analytical method for 
monomer analysis in EPS (Leivers, 2011, Cataldi et al., 2000) being first 
introduced by (Rocklin and Pohl, 1983).  
2.5.1.5. Linkage Analysis 
Since bacterial EPS may contain a great number of possible 
monosaccharide combinations and each monomer can also possess a number of 
different linkages within the structure. It is clearly necessary to determine how 
each of the monomeric units are linked together in order to get a full appreciation 
of EPS structure. The most widely used method for linkage analysis is methylation 
followed by GC-MS (Biermann and McGinnis, 1988, Laine et al., 2002, Synytsya 
and Novak, 2014). 
2.5.1.6. Weight-average Molecular Weight (Mw) Determination 
Generally, the size of a polysaccharide is expressed by the number of 
monosaccharide units it contains; which is termed the degree of polymerisation 
(DP). The determination of polysaccharide molecular weight is not simple, 
because it cannot be attributed to one distinctive molecular weight as with 
monodispersed molecules (Leivers, 2011, Chadha, 2009). Polysaccharides are 
considered polydispersed molecules because they have a range of molecular 
weights rather than just one i.e. a polymer is composed of macromolecules of 
differing molar masses. Polysaccharides are generally characterized by measuring 
their polydispersity, which is the ratio of the weight-average molecular weight 
(Mw/Mn) divided by the number-average molecular weight (Gilbert et al., 2009). 
A polymer is considered monodispersed if the Mw/Mn is equal to one. Weight-
average molecular weights of several bacterial exopolysaccharide structures such 
as Pseudomonas sp, Lactobacillus sp have been determined by Multi-angle Laser 
Light Scattering (MALLS)(Fishman et al., 1997, Chadha, 2009).   
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Currently the method of choice for MW estimation for polysaccharides is 
High Performance Size Exclusion Chromatography combined with Multi-angle 
Laser Light Scattering (HP-SECMALLS) (Wyatt, 1993). HP-SEC-MALLS 
works on the principal of weight and size separation by passing the sample 
through a smaller analytical scale columns (Oliva et al., 2001, Ritter et al., 2010). 
Generally, the sample is then passed through an inline ultraviolet (UV) light 
detector which provides information on the presence of any residual proteins or 
nucleic acids which may be present in the sample. The system is then coupled 
with both a MALLS and differential refractive index (RI) detectors which allow 
for the determination of the accurate molecular mass of the EPS without the 
requirement of reference materials (Badel et al., 2011). 
2.5.2. EPS of Gram Negative Bacteria 
2.5.2.1. Stenotrophomonas maltophilia EPS structure  
Stenotrophomonas maltophilia EPS has been described as a highly 
charged EPS due to the presence of three uronic acids and an ether-linked D-
lactate substituent. Methylation analysis suggested 4-linked Glc, 4-linked GlcA 
and 3, 4-linked GalA in equal molar amounts in the native polymer as shown in 
(Figure 2.4) (Cescutti et al., 2011).  Data collected by Cuzzi (Cuzzi, 2012) using 
gas-chromatographic analysis confirmed that Stenotrophomonas maltophilia EPS 
is composed of Glucose (Glc), glucuronic acid (GlcA), galacturonic acid (GalA) 
and  3-Lac-Hex A residues. 
The molecular mechanisms of Stenotrophomonas maltophilia biofilm 
formation have not been well studied (Pompilio et al., 2011). Several genes like 
rmlA, rmlC, and xanB are necessary for Stenotrophomonas maltophilia WR-C 
biofilm formation and twitching motility, and any  mutations in rmlA, rmlC and 
xanB genes display contrasting biofilm phenotypes (Huang et al., 2006). Pompilio 
et al. (2011), indicated that the presence of rmlA, spgM or rpfF genes did not 
significantly affect the biofilm formed by Stenotrophomonas maltophilia.  
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Figure 2.4 Primary structure of the repeating unit of Stenotrophomonas maltophilia EPS 
contains one 4-linked D-Glc, one 4-linked D-GlcA, one 3,4-linked D-GalA and one terminal 
non reducing D-GalA substituted on C3 with a R lactate group (Cescutti et al., 2011). 
 
2.5.2.2. Pseudomonas aeruginosa EPS structure  
An additional survival strategy of P. aeruginosa is its ability to produce 
several types of EPS during environmental change (Franklin et al., 2011). 
Generally P. aeruginosa has the ability to produce several EPS compounds such 
as alginate, Pel and Psl, rhamnolipid and lipopolysaccharide (LPS) (Byrd et al., 
2009).  Pseudomonas spp. produce EPS that is composed of glucose, rhamnose, 
galactose, and mannose (Bajpai, 2015).  Alginate is the predominant EPS in 
mucoid strains, while in non-mucoid strains such as (PA01 and PA14) Pel and Psl 
are predominant (Colvin et al., 2012).  Alginate and Psl EPS have different 
chemical structures (Figure 2.3 and 2.4), while the structure of Pel has not been 
fully characterized. Physiological properties of the cells and the biofilm matrix 
depend on the type of EPS. In general, at any given time, P. aeruginosa strains  
produce predominantly one secreted polysaccharide EPS,  although these strains 
have the genetic capacity to produce all three polysaccharides EPS (Franklin et 
al., 2011). Rugose small colony variant (RSCV) isolates of P. aeruginosa from 
lung tissue from a cystic fibrosis sufferer are characterized by wrinkled, small 
colonies may be an exception to this rule, since they have been shown by 
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transcriptional analysis to express both the Psl and Pel operons simultaneously 
(Starkey et al., 2009).  
Alginate is a high molecular weight acetylated polymer composed of non-
repetitive monomers of β-1, 4 D-Mannuronic acids linked to α-1, 4 L-Guluronic 
(Mittal et al., 2009, Mann and Wozniak, 2012) (Figure 2.5). Biosynthesis of 
alginate required 12 genes which are encoded by the algD operon 
(algD/8/44/K/E/G/X/L/I/J/F/A) while another protein, AlgC, is encoded 
elsewhere (Rehman et al., 2013, Franklin et al., 2011).   
 
 
Figure 2.5  Alginate structure (Franklin et al., 2011) 
  
Non-alginate producing strains of P. aeruginosa may produce the other 
polysaccharides Pel and Psl during biofilm formation (Mittal et al., 2009). The Psl 
polysaccharide is composed of a repeating sub-unit of a neutral pentamer 
containing  mannose,  rhamnose and  glucose (Byrd et al., 2009, Franklin et al., 
2011) and possibly galactose  as seen in (Figure 2.6). Some studies have 
mentioned that the Psl EPS is a mannose rich polysaccharides (Friedman and 
Kolter, 2004b, Branda et al., 2005) whilst other studies have indicated that the Psl 
EPS is both galactose and mannose-rich with some glucose, and trace amounts of 
xylose, rhamnose, and  N-acetylglucosamine (GlcNAc) (Ma et al., 2007).  Twelve 
genes are required for the biosynthesis of Psl EPS (psl A, B, C, D, E, F, G, H, I, 
J, K, L) (Franklin et al., 2011, Colvin et al., 2012, Branda et al., 2005) with Psl of 
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the biofilm forming PA01 strain receiving considerable attention (Ma et al., 
2009). 
 
Figure 2.6 Psl polysaccharide structure. Composed of a repeating pentamer containing D-
mannose, L-rhamnose, and D-glucose (Franklin et al., 2011). 
 
The Pel EPS is formed at the air–liquid interface and is controlled by seven genes 
(pelA, B, C, D, E, F, and G) which are essential for biofilm formation in the P. 
aeruginosa PA14 strain. At present, the structure of Pel EPS has not been 
determined (Franklin et al., 2011, Wei and Ma, 2013, Colvin et al., 2011a, Colvin 
et al., 2012, Whitfield et al., 2015) but carbohydrate and linkage analyses provide 
evidence that Pel EPS is a glucose-rich matrix polysaccharide that is distinct from 
cellulose (Ryder et al., 2007, Ma et al., 2009, Lembre et al., 2012a).  This glucose-
rich polysaccharide (Pel EPS) is also essential for the formation of a wrinkled 
colony and a surface-associated biofilm (Colvin et al., 2011a, Sakuragi and 
Kolter, 2007).  
2.5.2.3. Enterobacteriaceae family and Citrobacter freundii EPS structure  
Some members of the clinically important Enterobacteriaceae such as 
Citrobacter spp. and Enterobacter spp. have the ability to produce cellulose EPS 
and or curli fimbriae (csg) during biofilm formation. Cellulose biosynthesis 
required genes that are encoded by the bcsA, B, Z, C operon. Among these genes, 
bcsA encodes the cellulose synthase while the exact functions of the other genes 
remain unknown, but curli fimbriae synthesis are encoded by the csgB, A, C 
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operon. Cellulose and curli fimbria biosynthesis is commonly regulated, either 
through adrA or directly by csgD (Zogaj et al., 2003). 
Zogaj et al. (2003) also indicated that Citrobacter spp. and Enterobacter 
sakazakii displayed an EPS, cell clumping, pellicle formation, and biofilm 
formation associated with the expression of cellulose and curli fimbriae. 
Citrobacter spp. produce curli fimbriae and cellulose while Enterobacter spp. 
produced cellulose.  In both bacteria the csgD-csgBA region and the cellulose 
synthase gene bcsA were conserved emphasising the importance of biofilm 
formation for these bacteria that are frequently associated with biofilm related 
catheter-associated UTI (Zogaj et al., 2003).  According to (Bajpai, 2015), all 
slime bacteria EPS contain uronic acid, and Citrobacter spp. EPS mainly consist 
of galactose, glucose and mannose and is similar in characteristics to chitosan 
(Jang et al., 2005). While in another study (Rättö et al., 2006),  Citrobacter spp. 
produced EPS that was composed mainly of fucose, rhamnose, and other sugars 
such as galactose, glucose, mannose, galacturonic acid, glucuronic acid and 
pyruvate. 
2.6. Hydrophobicity 
One key factor associated with the ability of bacteria to adhere to a surface 
(e.g. medical implants hydrocarbons, oral cavity, food products) is the surface 
hydrophobicity of the cells. Hydrophobicity or microbial adhesion studies are 
widespread in the biofilm research since this process is essential in the 
establishment of microbial biofilms on virgin surfaces e.g. medical implants, 
catheters, etc. The surfaces of bacteria are composed of numerous 
macromolecules such as polysaccharides, lipopolysacchrides (LPS), lipo-
proteins, lipids and lipoteichoic acids, and surface appendages such as fimbriae, 
pili and flagella. These surface structures generate the physicochemical properties 
of the bacteria such as its surface charge. Bacterial surface structures vary with 
ambient environmental conditions, mutations or gene expression (Saini, 2010). 
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Bacterial cell surface lipopolysaccharides (LPS) are a major  component in Gram-
negative bacterial outer membrane (Moran, 2009). The LPS molecule is an 
amphiphilic molecule composed of a hydrophobic glycolipid (Lipid A), a 
hydrophilic heteropolysaccharide (core polysaccharide), and an O-antigen or O 
chain which is a long chain polysaccharide (Saini, 2010).  
Bacterial surface hydrophobicity is an important determinant in the adherence of 
the bacteria to both living and non-living surfaces, and it may assist bacterial 
colonization on epithelial tissues and medical devices, consequently surface 
hydrophobicity is closely related to biofilm formation and pathogenicity 
(Polaquini et al., 2006, Mattos-Guaraldi et al., 1999). Adherence is considered a 
critical stage because once adhered bacteria produce biofilms and eradication 
becomes very difficult (Krepsky et al., 2003). Polaquini et al (2006) indicated that 
hydrophobic bacteria are more adherent to the surfaces of inanimate objects and 
have enhanced phagocytosis resistance than hydrophilic bacteria (Polaquini et al., 
2006).  
There are a wide range of methodologies for the measurement of microbial 
hydrophobicity, such as contact angle measurement, microbial adhesion to 
hydrocarbons (MATH), salt aggregation test (SAT) (Saini, 2010). Unfortunately, 
many of these methods are highly variable and inconsistent, making effective 
hydrophobicity measurements problematic.    
2.7. Outer membrane vesicles (OMV) 
Outer membrane vesicles (OMV) are spherical and bi-layered nano-
vesicles with a diameter of 20~250 nm that are secreted by a large variety of 
Gram-negative bacteria either during normal bacterial growth or as a stress 
response (MacDonald and Kuehn, 2013). OMV are part of the membranous 
structure in all Gram negative bacteria including pathogenic and non-pathogenic 
strains (Lim and Yoon, 2015). OMV contain much of the biological content that 
found within the parent bacterium including lipopolysaccharide (LPS), 
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phospholipids, periplasmic and membrane-bound proteins. Furthermore, several 
virulence factors, such as adhesions  enzymes, toxins, DNA, RNA and 
peptidoglycan can all be found in OMV (Kaparakis-Liaskos and Ferrero, 2015, 
Lee, 2012, MacDonald and Kuehn, 2013, Kulp and Kuehn, 2010). OMV provide 
an advantage to the parent bacterium by facilitating bacterial communication and 
transferring enzymes, DNA, and proteins, as well as promoting the survival and 
maintenance of bacterial communities (Kaparakis-Liaskos and Ferrero, 2015). 
These characteristics make OMV important during the initial stages of infection 
(Li et al., 1998) (Figure 2.7).  
OMV are produced from the outer membrane and periplasmic membrane, 
so they reflects these components of the bacteria concerned. S. maltophilia, P. 
aeruoginosa and C. freundii have all been shown to secrete OMV (Devos et al., 
2015, Kadurugamuwa and Beveridge, 1995, MacDonald and Kuehn, 2013). In P. 
aeruoginosa OMV are composed of alkaline phosphatase, phospholipase C, 
protease, and peptidoglycan hydrolase (Li et al., 1998). OMV plays a role in 
nutrient transformation, biofilm formation and resistance to antimicrobial (Lim 
and Yoon, 2015). OMV also play a role in communication between cells, the 
lysing and killing of competing bacteria and the modulation of host immune 
response, and as such they contribute to bacterial survival and virulence. For 
example OMV of Pseudomonas aeruoginosa PA01 are capable of lysing 
Staphylococcus aureus and Escherichia coli, while those generated by 
Citrobacter strains can lyse Mycobacterium strains (Li et al., 1998, Lee, 2012, 
Kulp and Kuehn, 2010).  
The small size and membrane component of OMVs provide protection 
from host proteases and may facilitate their dissemination into tissues beyond the 
area that the further bacterium can reach (MacDonald and Kuehn, 2013). In 
nosocomial associated S. maltophilia, the generation of OMV increases after 
treatment with β-lactam antibiotic carbapenem. In this case the OMV generated  
contained two chromosomes encoding for a β-lactamase (Devos et al., 2015). 
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OMV help P. aeruoginosa in pathogenesis due to their association with 
other virulence factors such as peptidoglycan hydrolase, hemolysin, 
phospholipase C and alkaline phosphatase. These OMV effect host cells by 
disrupting the electron transport chains and trafficking pathways of the cells. Due 
to these factors P. aeruoginosa OMVs can kill both Gram-negative and Gram-
positive competing bacteria in co culture or in the environment especially during 
infection (MacDonald and Kuehn, 2013). OMV production is affected by growth 
conditions such as media type, temperature and nutrient levels, for example an 
increase in temperature will increase OMV production (Kulp and Kuehn, 2010). 
In P. aeruginosa planktonic bacteria release OMV during normal growth, 
providing this bacterium with an highly potent host cell lysis mechanism (Eddy 
et al., 2014, Avila-Calderón et al., 2011). In common with other Gram negative 
bacteria the generation of OMV by P. aeruginosa is enhanced by the presence of 
stress factors such as the presence of antibiotics or nutrient limitations. OMV 
produced under stress condition are different from those that produced under 
normal growth condition (Chatterjee and Chaudhuri, 2012). This stress response 
explains why OMV production in P. aeruginosa increases following exposure to 
antibiotics such as gentamicin and carbenicillin. This increase in OMV secretion 
is mirrored by an increase in biofilm formation (Kadurugamuwa and Beveridge, 
1995, Yoon et al., 2011). 
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Figure 2.7 Gram negative bacterial outer membrane vesicle (OMV) containing biological 
contents that found within the parent bacterium (Kaparakis-Liaskos and Ferrero, 2015). 
 
2.8. The Galleria mellonella model for bacterial pathogenicity  
Recently the larvae of the wax moth (Galleria mellonella) has 
increasingly being used to study the virulence and pathogenicity of bacteria and 
fungi (Harding et al., 2013). In addition to the obvious ethical advantages there 
are a number of practical advantages to the use of the Galleria mellonella (G. 
mellonella) larvae including the fact that they are easy to handle, can be studied 
in large numbers and the experiments are cost-effective (Bender et al., 2013). 
Furthermore presence of similar tissues, anatomy, and physiological functions in 
insect and mammalian gastrointestinal tracts make them an ideal model for human 
pathogenicity. For example, the G. mellonella mid gut microvilli contain microbes 
that resemble those found associated with the mammalian intestinal microvilli 
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(Mukherjee et al., 2013). Another advantage of the Galleria model is that it can 
be maintained very easily, and can be injected and infected without anaesthesia. 
Although insects do not have the adaptive immune system found in mammals, the 
hemolymph of G. mellonella contains haemocytes that behave similarly to 
phagocytic cells in response to bacterial infection (Harding et al., 2013).  
G. mellonella has been used to study a wide range of bacterial pathogens 
and their virulence including: 
 The effects of inoculum size and pathogenicity of Acinetobacter baumannii 
versus the less pathogenic species Acinetobacter baylyi and Acinetobacter 
lwoffii (Peleg et al., 2009); 
 Wand et al. (2012) used G. mellonella to study pathogenicity of biofilm 
formation by Acinetobacter baumannii and its relation to virulence; 
 Whiley et al. (2013) investigated virulence of the Liverpool Epidemic Strain 
(LES) of P. aeruginosa isolated from Cystic Fibrosis patients; 
 Miyata et al. (2003) studied the pathogenesis of the type III secretion system 
in P. aeruginosa; 
 The pathogenicity of Klebsiella pneumoniae was comparing with the 
pathogenicity of none pathogenic Klebsiella strains (Insua et al., 2013).   
 Helicobacter pylori virulence (Giannouli et al., 2014); 
  Effects of inoculum size, antibacterial agents against Staphylococcus aureus 
and methicillin-resistant S. aureus (MRSA) infections (Desbois and Coote, 
2011); 
 The study of OMV biogenesis in Serratia marcescens (McMahon et al., 2012) 
and Campylobacter jejuni (Elmi et al., 2012). 
From this list of investigations it is clear that the wax worm model has gained 
some level of acceptance as a pathogenicity model for bacterial infections.  
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2.9. Bacterial gene expression study  
Gene expression can be used to study any changes in the physiological states and 
functional activities of a cell under environmental stresses. It has been observed 
that major differences in gene expression occur during the transition from the 
planktonic to the biofilm mode of growth (Sauer et al., 2002, Stoodley et al., 
2002). In a study of Escherichia coli, biofilm gene were differentially expressed 
by at least two-fold between biofilm and planktonic cells (Prigent-Combaret et 
al., 1999). Physiological activity studies of bacteria growing in biofilms are 
difficult due to the diversity of processes occurring simultaneously and temporally 
as the biofilm develops. The activities of a particular biofilm will be effected and 
shaped by the specific chemical and physical environment in which it grows. 
Consequently it is difficult to develop a consensus picture of the physiology of 
the biofilm as it developed, for example Folsom et al, (2010) found little overlap 
in the lists of genes differentially expressed between the planktonic and biofilm 
states of P. aeruginosa (Folsom et al., 2010).  
Several methods have been used for the study of bacterial physiology such as 
proteomic and transcriptomic analysis. The proteome is defined as the 
characterisation of the complete or whole protein complement of a genome 
(Graves and Haystead, 2002). Proteomic analysis is an alternative approach to the 
analysis of differential gene expression (Sauer et al., 2002, Monteoliva and Albar, 
2004). Proteomic analysis of an organism not only provides a list of all proteins 
encoded by the genome but also data on protein expression under defined 
conditions (Graves and Haystead, 2002).  Proteomic analysis has been used to 
investigate biofilm-specific gene expression in the biofilms of P. aeruginosa 
(Sauer et al., 2002). The results obtained from this approach indicated that a large 
number of genes are differentially expressed during biofilm development which 
differed from that seen in the planktonic profile, possibly correlating with the 
expression of a different biofilm phenotypes (Sauer et al., 2002).  Proteomics is 
still faced with a number of challenges such as the protein purification 
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requirements demanded by the study of low-abundance proteins such as 
transcription factors, protein kinases and regulatory proteins (Steyn, 2005). 
A transcriptome is a complete set of transcripts recovered from a cell 
(Nagalakshmi et al., 2010) and is essential for interpreting the functional elements 
of the genome and revealing the molecular constituents of cells and tissues, as 
well as understanding the development and disease. The key aims of 
transcriptomics are:  
 The cataloguing of all types of transcript, including (mRNAs, non-coding 
RNAs and small RNAs). 
 The determination of the transcriptional structure of genes. 
 The quantification of the changing expression levels of each transcript 
during development and under different conditions (Wang et al., 2009).  
The analysis of transcriptomes is of great value for the investigation of gene 
function, expression and regulation. Gene expression provides dynamic changes 
in information regarding the physiological state and functional activities of a cell 
under different environmental conditions (Zhou et al., 2004). 
A number of approaches are available for the analysis and quantification of the 
transcriptome, such as the hybridization sequence method (Sanger), microarray 
hybridization base methods and RNA sequencing (Nagalakshmi et al., 2010). 
hybridization sequence method (Sanger) are relatively low throughput, more 
qualitative and expensive. On the other hand hybridization based methods 
(Microarray) are high throughput, and relatively inexpensive however they do 
have several limitations, including reliance on existing knowledge about genome 
sequence. Also they require complicated normalisation methods because of the 
difficulty of comparing expression levels between experiments. These 
disadvantages limited the use of traditional sequencing technology in annotating 
the structure of transcriptomes. RNA sequencing methods have now been 
developed which allow the mapping and quantifying transcriptomes, this has a 
clear advantage over existing methods. In RNA sequencing a population of RNA 
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is converted to cDNA fragments with adaptors attached to one or both ends. Each 
molecule, is then sequenced to obtain short sequences from one end or both ends. 
Typically, the reads are 30–400 bp (Wang et al., 2009).  
RNA sequencing offers several advantages for the study of complex 
transcriptomes (Table 2.1). Unlike hybridization based methods (Microarray), 
sequencing is not limited to the detection of transcripts that correspond to defined 
genomic sequences. RNA sequencing can reveal the precise location of 
transcription limitations, to a single base resolution. RNA sequencing has no or 
very low background and does not have an upper limit for quantification of 
number of sequences. This means that this technology has a large dynamic range 
of expression levels over which transcripts can be detected. By contrast, DNA 
microarrays lack sensitivity for genes expressed either at low or very high levels 
(100 to a few-hundredfold). RNA sequencing has also been shown to be highly 
accurate for quantifying expression levels. The results of RNA sequencing also 
show high levels of reproducibility, for both technical and biological replicates. 
Consequently, RNA sequencing is the first quantitative sequencing based method 
with a very high-throughput allowing the analysis of the entire transcriptome. This 
allow annotation and the quantification of gene expression with lower costs than 
other methods (Wang et al., 2009).  
Due to these advantages, RNA sequencing is a highly useful approach for the 
investigation of bacterial transcriptomic dynamics during development and 
normal physiological changes, for the analysis of biomedical samples, and the 
comparison between normal and diseased tissues, as well as the classification of 
diseases (Wang et al., 2009). RNA sequencing has been used successfully in a 
number of studies such as monitoring gene expression during yeast vegetative 
growth, yeast meiosis and mouse embryonic stem cell differentiation, Sac 
charomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster 
and Bacillus halodurans (Nagalakshmi et al., 2010). 
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Table 2.1   Summary of RNA sequencing advantage comparing to the other methods 
 
Technology Hybridization 
sequence methods 
(EST) 
Hybridization 
based methods 
(Microarrays) 
RNA sequencing 
Principle Sanger sequencing Hybridization High throughput 
sequencing 
 
Resolution Single base Several -100 base Single base 
 
Throughput Low High High 
 
Background noise Low High Low 
 
Dynamic range to 
quantify gene 
expression 
Not practical Up to few 
Hundredfold 
˃8000 fold 
Required amount 
of RNA 
High High Low 
Large genome 
transcriptome 
mapping cost 
High High Low 
Expressed sequence tag (EST); collection of partial cDNA sequences 
3. Research Aims 
There are four research aims associated with this project: 
1. To determine the ability of Gram negative pathogenic bacteria to form 
biofilms on inanimate surfaces such as glass and plastic; 
2. To determine the chemical structure of the EPS generated by the Gram 
negative pathogens under investigation; 
3. To evaluate the pathogenicity of biofilm forming Gram negative pathogens 
on different carbon sources using the Galleria mellonella wax worm model; 
4. To employ genomic and transcriptomic approaches to determine the 
molecular basis of biofilm formation and associated pathogenicity of the 
Gram negative pathogens growth on different carbon sources under 
investigation. 
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4 Material and Methods  
4.1 Bacterial strains 
A wide range of bacterial strains including both type or lab and isolated 
strains were investigated in this study. These bacteria are outlined in (Table 4.1). 
Several hospital isolates of Stenotrophomonas maltophilia were kindly provided 
by Dr Jane Turton, Laboratory of Health Care Associated Infection (LHCAI), 
Health Protection Agency (HPA), London, UK. Pseudomonas aeruginosa strains 
had been previously isolated from a discarded wound dressing provided 
anonymously from a local skin integrity practitioner (Shoukat et al., 2015).  
All strains used in this investigation were preserved at -80˚C using the 
Cryobank bacterial preservation systems. Cultures were recovered from 
Cryobanks by sub culturing onto TSA and grown aerobically overnight at 37˚C. 
Stock plates were then kept in the fridge at 4˚C and grown overnight at 37˚C on 
TSA prior to use.  Prior to media inoculation, overnight fresh bacterial cultures 
were grown on TSA from stock plates. Bacterial suspensions of 108 or 109 CFU/ml 
were then prepared from the stock plates in small conical flask containing 
Maximum recovery dilution (MRD) and glass beads by adjusting the OD at 
620nm (EN, 2009). 
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Table 4.1 Bacterial strains used in this study 
 
 
Species Type of strain 
Culture 
collection 
or patient (ID) 
Short 
identifier 
Source 
Stenotrophomonas 
maltophilia 
Clinical strain H09*****18 St 18 
Strains provided 
by Dr J. Turton, 
LHCAI, HPA 
London. 
Clinical strain H08*****51 St 51 
Clinical strain H09*****53 St 53 
Lab strain 
NCIB 9203 
(ATCC 13637) 
St 9203 ATCC 
Pseudomonas 
aeruginosa 
Clinical strain 
 
N/A 
Ps 1 
Isolated from 
dressing 
removed 
from infected 
wounds. 
 
Clinical strain Ps 3 
Clinical strain Ps 5 
Lab strain 
NCIB 10421 
(ATCC 15442) 
Ps 10421 ATCC 
Acinetobacter 
baumannii 
Clinical strains 
OXA-23 Clone 
1 
Clone 1 
Strains provided 
by Dr J. Turton, 
LHCAI, HPA 
London. 
Culture 
collection 
CIP 106882 882 
Pasteur Institute, 
Paris, France 
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4.2. Media, reagent and other preparations 
Several microbiological media and modified media were used throughout 
this study. Mineral media with a range of carbon sources (MM Glc, MM Gly and 
MM Eth) were prepared according (Shoukat, 2014) with modification as shown 
in (Table 2.2). All material in mineral media are from Fisher Scientific Ltd, except 
casein which is from Fluka. 
 
Table 4.2 Mineral media with different carbon source  
 
No.  Components Formula 
MM Glc 
g/l 
MM Gly 
g/l 
MM Eth  
g/l 
1 
Dipotassium 
phosphate 
K2HPO4 4.5 4.5 4.5 
2 Ammonium sulphate (NH4)2SO4 1 1 1 
3 
Magnesium sulphate 
heptahydrate 
MgSO4.7H2O 1 1 1 
4 Sodium chloride NaCl 0.1 0.1 0.1 
5 Calcium chloride Cacl2 0.1 0.1 0.1 
6 Ferric chloride Fecl3 0.02 0.02 0.02 
7 Casein Casein 1, 2 or 3 1 1 
8 Glucose Glucose 5,10,15, 20 - - 
9 Glycerol Glycerol - 5,10,15, 20 - 
10 Ethanol 99% Ethanol 99% - - 
5.29, 10.57 
,15.86 
  pH 7 7 7 
 
Mineral medium glucose (MM Glc), Mineral medium glycerol (MM Gly), Mineral medium ethanol (MM Eth)  
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Note: Glucose and glycerol were added prior to autoclaving, while ethanol were 
added after autoclaving  
Note: Different concentration of carbon source and casein were used according to 
the purpose of the experiment in order to optimise the quantification of biofilm.  
Note: All ethanol volume (ml/l) converted to (g/l) by using density of ethanol 
which is 0.789 g/cm3. 
A range of other media were also used in this investigation including: 
 Tryptone Soy Agar - TSA (LabM Ltd), prepared by dissolving 37g in 1liter 
of deionised water.  
 Tryptone Soy Broth - TSB (LabM Ltd), Prepared by dissolving 30g in 1liter 
of deionised water.  
 Maximum Recovery Diluent - MRD (LabM Ltd), Prepared by dissolving 9.5g 
in 1liter of deionised water. 
  Simulated Wound Fluid (SWF) prepared by mixing equal volume of filtered 
Foetal calf serum (Sigma-Aldrich Ltd) and sterilised MRD. 
 Phosphate Buffer Saline (PBS) prepared by dissolving 8g/l NaCl, 0.2g/l KCl, 
1.44 g/l Na2HPO4 and 0.24g/l KH2PO4 (Fisher) in UPW with the pH adjusted 
according to the purpose of experiment.  
 Luria Bertani Broth (LB) prepared by dissolving 10g Tryptone, 5g Yeast 
Extract, and 5g Sodium Chloride in 1liter of deionised water.   
(Note: TSA, TSB, MRD, LB and PBS were autoclaved at 121˚C for 15 min). 
 Agarose gel (1%) was prepared by dissolving and melting 1g agarose gel 
powder (Bio line) in 100ml 1x Tris-acetate-EDTA (TAE). 1μl gel stain was 
added before pouring the gel. 
 Primers for PCR reactions were prepared by mixing 10µl (100pmol) forward 
primer (F) with 10µl (100pmol) reverse primer (R) and making up to 100µl 
with diethylpyrocarbonate (DEPC) water.  
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 Dialysis tubing (14000 typical molecular weight cut-off (MWCO) cellulose 
membrane dialysis tubing, 33 mm width (Sigma Aldrich Ltd)) was prepared 
by washing the tubing under flowing tap water for at least 4 h or overnight, 
and then washed in 0.3% (w/v) sodium sulphide solution at 80˚C for 1 min 
followed by washing in hot deionized water at 60˚C for 2 min, followed by 
washing in 0.2% (v/v) sulphuric acid solution for 1 min and then finally 
rinsing with hot deionized water at 60˚C for 2 min. Finally the dialysis tubing 
was rinsed with deionized water and stored at 4˚C in a container containing 
deionized water.  
 To prepare a protein dye stock 100mg Coomassie Blue G–250 was dissolved 
in 50 ml of 95% Ethanol and then mixed vigorously with 100 ml of 85% (w/v) 
phosphoric acid (H3PO4) and then made up to 200ml with UPW. The dark red 
solution were formed and stored in a dark bottle at 4˚C. The assay reagent was 
prepared by mixing 1 volume of dye stock with 4 volume of UPW, and 
filtering through Whatman paper before use. 
 4 M sulfamic acid (H3NSO3) solution was prepared by dissolving 3.884g of 
sulfamic acid in 5 ml UPW under continuous mixing whilst adding potassium 
hydroxide (KOH) until completely dissolved. The final volume was 
completed with UPW (10ml final volume). 
  0.15% (w/v) m-hydroxydiphenyl reagent was prepared by dissolving 15 mg 
of m-hydroxydiphenyl in 10 ml of 0.5% (w/v) sodium hydroxide (NaOH) in 
the dark bottle and stored in the fridge.   
 2.86% (w/v) borax reagent was prepared by dissolving sodium tetraborate 
2.86g in 100 ml of concentrated sulfuric acid. 
 50mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer (HEPES) 
was prepared by dissolving 11.915g in 1litter of sterilised UPW and then 
sterilised by filteration. 
 Congo Red agar (CRA) media were prepared according to (Freeman et al., 
1989). By weighting 37 g/l brain heart infusion broth, 50 g/l sucrose, 10 g/l 
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agar and 8 g/l Congo red indicator. Congo red stain was prepared as a 
concentrated solution and sterilized separately. It was then added to the 
autoclaved brain heart infusion agar before solidifying. 
4.3 Bacterial identification  
After recovering bacterial isolates from storage, several tests were 
performed in order to confirm the identification of the bacterial strains concerned.  
 
4.3.1. Bacterial morphology and Gram stain  
Overnight fresh cultures were used for Gram staining and cell 
morphological investigations. The bacterial film or smear was prepared by 
spreading pure bacterial colonies mixed with a drop of sterilised distilled water 
on a clean slide and then fixed by heating. After that the slide stained (crystal 
violet, iodine, alcohol and safranin) and washed by water after each stain (Estridge 
et al., 2000). Finally, the slide left to dry and observed under oil immersion 
objective lens (100x). 
4.3.2. Biochemical tests 
4.3.2.1 Oxidase Test 
The test was performed according to manufacturer’s instruction (Prolab 
Diagnostics Ltd). Briefly, 1-2 drops of oxidase reagent was added to the filter 
paper and left to dry for 30-60 seconds. A loop full of bacteria from an overnight 
fresh bacterial plate culture was then mixed with the reagent on the filter paper.  
A positive result was recorded if a deep blue/purple colour developed within 30 
seconds. 
4.3.2.2 Catalase test 
The catalase test was performed by smearing samples taken from fresh 
overnight bacterial cultures grow on TSA to the centre of the clean slide. A few 
drops of H2O2 were then added to the smear. The rapid evolution of bubbles was 
taken as evidence of a positive result (catalase positive).  
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4.3.2.3 Triple sugar iron agar (TSI) test 
TSI medium was prepared by mixing 20g/l peptone, 3g/l beef extract, 3g/l 
yeast extract, 10g/l lactose, 10g/l sucrose, 1g/l dextrose, 0.2g/l ferrous sulphate, 
5g/l sodium chloride, 0.3 sodium thiosulphate, 0.025g/l phenol red and 12 g/l agar. 
The mixture was dissolved in distilled water and the pH adjusted to 7.4± 0.2 and 
sterilised by autoclaving at 15 lbs. at (121°C) for 15 min. The tubes were 
inoculated with a fresh overnight culture using straight loop. Interpretation of 
result were checked after incubation at 37°C by monitoring bottom of the tubes 
(acid, acid and gas or alkaline), slant surface (acid, acid and gas, alkaline or no 
change) and also observing the black precipitate in the bottom.   
4.3.3 Molecular identification of bacteria 
4.3.3.1 DNA extraction  
Bacterial DNA was extracted from pure cultures via the UltraClean 
Microbial DNA isolation kit (Cambio Ltd, USA) following the manufacturer’s 
instructions. Briefly, several colonies from fresh overnight cultures were added to 
approximately 1.8ml of PCR grade water, mixed and then centrifuged at 10,000xg 
for 30 seconds. The supernatant was then discarded and re-centrifuged under the 
same condition and the remained supernatant removed. The pellet was suspended 
in 300μl MicroBead solution and vortexed gently and then transferred to a 
MicroBead tube. 50μl of solution MD1 were added and the MicroBead tube, 
vortexed at a maximum speed for 15-20 min using the MO BIO vortex adapter. 
After that the MicroBead tube was centrifuged at 10000xg for 30 seconds at room 
temperature and the supernatant transferred to a new clean 2ml Eppendorf tube. 
100μl of solution MD2 were then added to the supernatant, vortexed and 
incubated for 5 min at 4°C. The tubes were centrifuged at 10000xg for 1 min at 
room temperature then the supernatant carefully transferred to a new Eppendorf 
tube with a pipettes without touching the pellet. 900μl MD3 were added to the 
supernatant and vortexed for 5 seconds, after that approximately 700μl transferred 
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into the Spin Filter and centrifuged at 10000xg for 30 seconds.  Flow through 
were discarded and remaining supernatant were added to the spin filter once more 
and centrifuge at 10000xg for 30 seconds at room temperature. 300μl Solution 
MD4 were then added and centrifuged at room temperature for 30 seconds at 
10000xg and the flow through were discarded then centrifuged at room 
temperature for 1 min at 10000xg. The spin filter was then transferred carefully 
to a new clean Eppendorf tube and 50μl of solution MD5 were added to the centre 
of the white filter membrane, centrifuged at 10000xg for 30 seconds. Finally, the 
spin filter was discarded and the DNA concentration measured by micro volume 
spectrophotometer (Jenway, Genova Nano) against solution MD5 as a blank. The 
amount of genomic DNA extracted was measured by agarose gel electrophoresis 
using 1% (w/v) agarose gel. The extracted DNA was mixed with 5xDNA Loading 
Buffer Blue (Bioline) and run against 5μl of a 1kb HyperLadder (Bioline).  
4.3.3.2 Polymerase Chain Reaction PCR 
Amplification of the 16S rRNA gene was performed by using a Techne 
Thermocycler (Bibby Scientific Ltd., Stone, UK). A 50μl final volume PCR 
mixture was prepared by mixing 25μl Biomix red, 17μl PCR grade water, 3μl 
primer (F&R) and 5μl template. PCR was completed under the following 
conditions: heated lid at 100°C, 95˚C for 5 min followed by 35 cycles of 94˚C for 
1 min, 60˚C for 45 seconds, and 72˚C for 1 min and then by a temperature period 
of 72˚C for 2 min, and holding at 4˚C.  PCR products were analysed directly by 
1% (w/v) agarose gel electrophoresis alongside 5μl of a 1kb HyperLadder. 
4.3.3.3 PCR products purification.  
PCR products were purified using a QIAquick PCR Purification Kit 
according to manufactures protocol. Briefly 5 volumes of Buffer were added to 1 
volume of the PCR sample product and mixed. Then 10μl of 3M sodium acetate 
was added and mixed. The mixture was transferred into the QIAquick spin column 
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and centrifuged for 30–60 seconds at 13000 rpm, and the flow through decanted. 
After that 750μl of Buffer PE were added into the QIAquick column and 
centrifuged at 13000 rpm for 30–60 seconds, the flow though is discarded and the 
sample re-centrifuged for 1 min. The DNA was eluted by adding 50μl Buffer EB 
to the centre of the QIAquick membrane and centrifuged at 13000 rpm for 1 min. 
The concentration of DNA was measured by micro volume spectrophotometer 
and analysed once more by agarose gel electrophoresis under the same condition 
outlined above. Finally, 15μl of of 10μg/ml purified PCR product was mixed with 
2μl forward (F) or reverse primer (R) in an Eppendorf tube and sent for 16S rRNA 
sequencing at (Eurofins Genomics-UK).   
4.3.3.4 Analysis of bacterial sequences  
After the 16S rRNA genes were sequenced, the sequences were processed 
and analysed by several online databases. Initially the software provided by the 
Ribosomal Database Project (RDP) (RDP Release 11, Update 4: May 26, 2015) 
(Cole et al., 2013) was used, this is a free online gene sequence database analyses 
tool. Initially the RDP - classifier program (RDP Naive Bayesian rRNA Classifier 
Version 2.10, October 2014) was employed to classify the bacteria concerned in 
the higher order bacterial taxonomy (domain and genus) (Wang et al., 2007). The 
programme provides a 95% confidence threshold for the analysed sequences. 
The RDP sequence match program (version 3) was used to find closest direct 
sequence matches to the gene sequences generated by this research. Here,  10000 
sequences are included in the search with the ability to selecting up to 20 match 
bacteria (Cole et al., 2003). After uploading unknown sequenced gene data in this 
program, the top 4 nearest neighbours in the system were selected for further 
analysis.  
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4.3.3.5. Construction of phylogenetic trees  
Initially the 16s rRNA gene sequence was subjected to chimeric testing  
using the mothur software (Schloss et al., 2009).  Both the RDP and the 
MEGABLAST programmes were used to construct phylogenetic trees of the 
bacterial strains under investigation. The MEGA BLAST software (version 5.05) 
is a reliable and commonly used tool for the generation phylogenetic tree from 
bacterial 16s rRNA gene sequences (Tamura et al., 2011). BLAST is designed to 
look for local alignments or finding matches to a query sequence within a large 
sequence database, such as Gene bank (Altschul et al., 1990). Phylogenetic 
analysis is performed by selecting all sequence close to the sequence from the 
unknown sample, these are then aligned using the muscle software (Edgar, 2004). 
For pairwise distances computation, the Kimura 2-parameter model (Kimura, 
1980) was used with 1000 replicate bootstraps. After the application of the 
neighbour joining method (Saitou and Nei, 1987) to generate the relative 
evolutionary history, the phylogenetic tree is plotted.  
4.4. Whole Genome Sequencing (WGS) 
In order to perform whole genome sequencing overnight cultures were 
grown in TSB at 37˚C for 24 h. Bacterial DNA was then extracted by the same 
method previously described (See Section 4.3.3.1), however in this case a greater 
concentration and purity was required. Greater than 100µl of DNA were prepared 
at >50 µg/ml with the purity of 1.8-2.0 at OD 260/280. The draft genome 
sequences were generated by BaseClear Ltd (NL) using an Illumina High 
sequencing 2500 system and Paired-end 125 cycles sequence reads were 
generated. FASTQ sequence files were generated using the Illumina Casava 
pipeline version 1.8.3 and the assembly prepared using CLC Genomics 
Workbench version 7.0.4. The contigs were linked and placed into scaffolds or 
supercontigs. The orientation, order, and distance between the contigs was 
estimated using the insert size between the paired-end and/or meta pair reads 
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using the SSPACE Premium scaffolder version 2.3 (Boetzer et al., 2011). The 
WGS were then analysed or annotated by the rapid annotation using subsystem 
technology (RAST) (Aziz et al., 2008), National Centre for Biotechnology 
Information (NCBI)  and the SEED viewer which provides a comparative analysis 
using the latest curated data sets (Overbeek et al., 2005). 
4.5 Biofilm formation 
4.5.1 Congo red agar assay for biofilm formation (CRA) 
CRA medium (Freeman et al., 1989) was prepared as described in (Section 
4.2). CRA medium were inoculated with overnight bacterial culture and incubated 
at 37˚C for 24h. Black colonies indicated a biofilm producing strain.  
4.5.2 Estimation and quantification of biofilm formation  
The ability of bacteria to form biofilms was tested using the approach 
described by (Stepanović et al., 2007) with slight modifications. Briefly, instead 
of adding media to the 96 well plate and then inoculated the wells, the test 
suspensions were made up in Eppendorf or universal tubes and then transferred 
to the wells. This approach allowed a wider range of parameters to be investigated 
such as inoculum size, carbon source, nitrogen source and growth media. After 
24 h incubation at 37˚C, the contents of each well were discarded and each well 
was washed  4 times with 200- 220μl of sterile distilled water (SDW) and for left 
5-10 min to dry, then 190-200μl of 0.1% crystal violet stain was added to each 
well. After 30 min, the stains were decanted, and the plate was rinsed off 4 times 
with 200- 220μl SDW and left 5-10 min to dry. After that 200μl of 95% (v/v) 
ethanol was added to each well for 20 min then the optical densities (OD) of 
stained adherent bacterial films were read using a Multiscan microtiter-plate 
reader (Thermo Labsystems -Finland) at OD 570 nm.  
Each isolate was tested in triplicate. Non inoculated medium controls (ODc) were 
included. The cut-off value (ODc) was established which was defined as three 
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standard deviations above the mean ODc i.e. (ODc=average OD of negative 
control + (3×SD of negative control). The final OD value of a tested strain was 
expressed as average OD value of the strain reduced by ODc value (OD=average 
OD of a strain - ODc). The ODc value was calculated on each microtiter plate 
separately. Any negative value were presented as zero, while any positive value 
indicates biofilm production. For easier interpretation of the results, strains were 
divided into the following categories (Stepanović et al., 2000):  
OD ≤ ODc= Non biofilm producer;  
ODc<OD ≤ 2xODc= weak biofilm producer;  
2xODc<OD≤ 4xODc=moderate biofilm producer;  
4xODc ≤ OD=strong biofilm producer.  
4.6 Bacterial growth measurements, carbon source residue, total 
carbohydrate and polysaccharide estimation 
Bacterial growth curve were performed using two methods. The first being 
the measurement of OD at 450-580nm (wideband) using a Bioscreen C automated 
growth curve monitor (OY, Finland). Growth was measured using a 107 CFU/ml 
inoculum for 72h at two different temperatures 30˚C and 37˚C. The average of 5 
replicates per each strain in a medium were used to generate the growth curves 
for each strain studied, media without inoculation was used as a control (Tauk-
Tornisielo et al., 2007). In addition growth curves were also measured via viable 
counts (CFU/ml) in shake flask cultures. Growth in these cultures was also 
assessed via the degradation of the carbon source, total carbohydrate profiles and 
polysaccharide levels. This was carried out on a range of carbon sources (glucose, 
glycerol and ethanol) at different temperatures (30˚C and 37˚C). In these 
investigations 99ml of fresh sterilised medium (MM Eth 10.57g/l, and MM Glc 
10g/l) were prepared in 250ml conical flask (Ethanol and glucose were added 
separately after autoclaving), and then inoculated with 1ml from adjusted fresh 
stock culture (overnight bacterial culture prepared in MRD) 109 or 106 CFU/ml, 
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respectively. The cultures were then incubated with shaking 100-120 rpm/min at 
(30˚C and 37˚C) and samples were taken at various time points during incubation 
and analysed.  
 
4.6.1 Bacterial viable count 
Samples were serially diluted in MRD and then cultured on TSA using an 
automated spiral plater (Don Whitely Ltd, England). The plates were then inverted 
and incubated at 37˚C for 24 h. After incubation the colonies were counted 
electronically using a colony counter (DW Scientific Ltd, UK) and the result were 
expressed as colony forming units (CFU/ml). 
4.6.2 Quantitative estimation of ethanol 
Quantitative determination of ethanol from was performed by using 
Quanti Chrom Ethanol Assay Kit (DIET-500) from Bio assay systems (Harvard 
USA). According to the manufactures protocol, samples were treated by mixing 
250μl of samples with 500μl 10% TCA, centrifuged at 14000 rpm for 5 min then 
the supernatant were carefully transferred to an Eppendorf tubes. For standard 
curve, 2%, 1.5%, 1% and 0.5% (v/v) standards ethanol was prepared from the 
10% (v/v) ethanol standard provided and sterilised distilled water used as a blank 
control (Figure 4.1). 400μl of each diluted standard and sample were transferred 
to separate Eppendorf tubes and then 400μl of reagent A were added to each tube 
and mixed quickly. The tubes were incubated at room temperature for 30 min. 
Then 400μl reagent B were added quickly and mixed well. Finally 1ml of mixture 
was transferred to cuvettes and read by spectrophotometer (Cary 50 Bio UV, 
Varian Inc. Corporation, Palo Alto, CA, USA) at a wave length 570-600 nm (OD 
580nm). 
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Figure 4.1 Ethanol standard curve for quantification of ethanol. 
 
4.6.3 Quantitative estimation of glucose 
Glucose was determined using a Pico trace analyser (Freital-Germany). 
Briefly 10μl of filtered or centrifuged supernatant culture were added to 500μl 
buffer, mixed and read by Pico trace. 
4.6.4 Total carbohydrate estimation 
Total carbohydrate and sugar content was estimated 
spectrophotometrically via the phenol sulphuric acid method described by 
(Dubois et al., 1956). The test was calibrated using a series of glucose standards 
(0, 20, 40, 60, 80 and 100 ppm) prepared in deionized water. 1ml of standards and 
0.1 ml of sample were transferred to clean universal tubes and adjusted to 1ml 
with deionized water. 1ml 5% (w/v) phenol solution was then added to each tube 
and mixed, 5ml of concentrated sulphuric acid was then added quickly to the 
surface of the mixture, and then the tubes were tighten and mixed.  The tubes were 
placed in the water bath at 70- 80˚C for 20 min and then placed in a cool water 
bath at 10°C for a further 10 min. The absorbance was measured 
spectrophotometrically (Cary 50 Bio UV) at 490nm against a blank (deionised 
water mixed with phenol and sulphuric acid). The unknown samples absorbance 
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were compared to a graph generated from the results obtained from the glucose 
standards (Figure 4.2).  
 
 
 
Figure 4.2 Total carbohydrate assay standard curve for quantification of carbohydrate. 
 
4.6.5 Protein estimation 
The Bradford test method (Bradford, 1976) was used to estimate the total 
protein concentrations. Cultures or media were pre-treated by centrifugation and 
the supernatant retained for analysis. A standard curve was constructed by using 
a dilution series (50, 100, 150, 200, 250 and 300 mg/l or µg/ml) of a Bovine Serum 
Albumin protein (BSA) dissolved in ultrapure water. 1ml of each sample, 
standards and water (blank) were added to a glass tube and then 5ml of protein 
reagent (Coomassie Brilliant Blue G-250) was added to the each test tube and the 
content were mixed by vortexing. Absorbance readings were taken 
spectrophotometrically within 60 min at a wavelength 595nm against a blank. The 
standard curves were plotted according to series standards and the unknown 
protein weight determined according to plotted standard curve (Figure 4.3). 
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Figure 4.3 Bovine Serum Albumin (BSA) protein standard curve for quantification of 
protein. 
 
4.6.6 Uronic Acid Estimation 
The colorimetric meta-hydroxydiphenyl assay (Bhaskar, 2003) was used 
to estimate the uronic acid content of samples. Briefly, a standard stock solution 
was prepared by dissolving 10mg of galacturonic acid in 100ml of ultrapure water. 
The stock solution was serially diluted to prepare a series of standards (20, 40, 60, 
80 and 100 mg/l). 0.4 ml of the standards, sample or water (blank) was transferred 
to a tube, and then 40 μl of 4 M sulfamic acid was added and mixed. Then 2.4 ml 
of 0.5% (w/v) Sodium tetraborate or borax were added to each tube, vortexed 
thoroughly and heated at 100°C in a water bath for 20 min, after that the tubes 
were immediately cooled on ice. Once cool 80μl m-hydroxydiphenyl reagent was 
added and mixed. Finally the absorbance was measured spectrophotometrically 
(Cary 50 Bio UV) at 520nm against a blank and compared to the galacturonic acid 
standard curve (Figure 4.4). 
 
 
y = 0.0008x + 0.0012
R² = 0.9934
0
0.05
0.1
0.15
0.2
0.25
0 50 100 150 200 250 300 350
O
D
 5
9
5
n
m
BSA µg/ml
67 
 
 
 
Figure 4.4 Galacturonic acid standard curve for quantification of uronic acid. 
 
4.6.7 EPS sugars estimation using HPAEC 
The quantification of EPS sugar monomers were performed by HPAEC. 
Serial concentrations of each sugar D(+)-fucose 99%, maltitol 99%, 2-Deoxy-D-
glucose 99%, D(+)-galactosamine 99%,  L-rhamnose 99%,   D(+)-glucosamine 
99%, D-(+)-galactose 99%, D-(+)-glucose 99% and D-(+)-mannose 99%, were 
prepared in UPW and measured by HPEAC allowing a standard curve to be 
plotted for each sugar. EPS was hydrolysed to the individual sugar components, 
the concentration of which was determined via HPAEC and reference to the 
appropriate standard curve (Figure 4.5). 
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Figure 4.5 HPAEC monomer analysis standard curve for sugar quantification. a) fucose, 
b) maltitol, c) 2-Deoxy-D-glucose, d) galactosamine,  e) rhamnose,  f) glucosamine, g) 
galactose, h) glucose and i) mannose  
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4.7 Hydrophobicity tests 
Several methods of hydrophobicity determinations were performed with 
different hydrocarbons. In all hydrophobicity test the MM Glc media employed 
contained 10 g/l glucose and 1 g casein while MM Eth media contained 13.4 ml/l 
(10.57 g/l) ethanol and 1 g casein. 
4.7.1 Microbial Adhesion to Hydrocarbons (MATH) Test  
The MATH test was used as described by (Saini, 2010). Overnight cultures plate 
cultures (TSA) were used to inoculate a series of media; TSB, MM Glc and MM 
Eth. These were incubated overnight at 30˚C, and then 100µl of each culture were 
transferred to another set of medium and incubated overnight at 30C. The cultures 
were the centrifuged at 8500xg for 7 min and the supernatant discarded. The 
bacterial pellets were washed with either TSB or 10mM potassium chloride (KCl) 
and resuspended in the same medium (two sets for each medium) while the other 
bacterial pellets from MM Glc and MM Eth were washed with phosphate buffer 
saline (PBS) and resuspended in two sets of PBS for each as shown in table 
(Figure 4.6). All suspensions were mixed and the OD (wavelength 600 nm) and 
volume of the resuspended pellet were adjusted to close to 0.8 (Initial absorbance) 
and 8ml, respectively. The resuspension media was used as a blank. The 
suspensions were then transferred to sterilised clean universal tube. A range of 
hydrocarbons were evaluated in the test, i.e. 1ml 0.8% tween 80 (w/v) (fisher) or 
1ml hexadecane. The hydrocarbons were added separately to each set of cell 
suspension (TSB, KCl, PBS (MM Eth) and PBS for (MM Glc)) in a universal tube 
and vortexes for 2 min and then the suspensions were allowed to stand at room 
temperature for 15 min to allow the hydrocarbon and aqueous phases to separate. 
After that 1ml of the aqueous phase at or near the bottom of the tube was carefully 
removed by pipette and transferred to a cuvette. The absorbance (Final 
absorbance) of the removed media was measured against the media blank. Finally 
the cell surface hydrophobicity was calculated and interpreted as follows:  
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 (%) = (Initial absorbance - Final absorbance)/ Initial absorbance x 100 
Interpretation: 
20 ≥ % Hydrophobicity = Hydrophilic  
20≥ % Hydrophobicity ≤ 50 =Moderate Hydrophobicity  
50≤ % Hydrophobicity = Strong Hydrophobicity 
 
 
Figure 4.6 Microbial Adhesion to Hydrocarbons (MATH) test steps 
 
 
4.7.2 MATH test salting out  
The MATH test protocol as outlined by (Saini, 2010) was employed in 
this study. After two growth cycles on TSB, the bacterial culture was centrifuged 
and the supernatant were discarded. The pellet was resuspended in 10mM 
potassium chloride solution and centrifuged. The pellet was resuspended in 2mM 
ammonium sulphate in 10mM potassium chloride buffer solution and transferred 
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to clean tube as shown in (Figure 4.7) The absorbance (Initial absorbance) was 
adjusted at 600 nm to be close to 0.8 against the same solution as a blank. A range 
of hydrocarbons were evaluated e.g. 1ml 0.8% Tween 80 (w/v), 1ml hexadecane, 
1ml dodecane and 1ml p-xylene.  These were added to the cell suspension in a 
glass culture tube and vortexes for 2 min and then allowed to stand at room 
temperature for 15 min. After that 1ml from the aqueous phase near the base of 
the tube was taken and transferred to cuvette. At a wavelength of 600 nm, the OD 
were measured (Final absorbance) against the blank control. The cell surface 
hydrophobicity was calculated by the same equation that outlined above. 
 
 
 
*2mM ammonium sulphate prepared in 10mM potassium chloride buffer solution. 
 
Figure 4.7 MATH test salting out steps 
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4.7.3 Hydrophobicity-the modified adherence and aggregation test (MAA). 
The hydrophobicity test as previously described by (Rosenberg et al., 
1986) was evaluated with the some slight modifications. A range of media (TSB, 
SWF, MM (without carbon and casein), 2mM ammonium sulphate in KCl, MM 
Glc and MM Eth) were used to make stock culture from an overnight culture 
grown on TSA. The OD of each stock culture was adjusted to approximately 0.8 
at OD600 (Initial OD) and the volume was adjusted to 4ml in each tube. Then 0.5 
ml 0.8% Tween 80 (w/v) and 0.5ml hexadecane were added to each set of tubes 
as shown in (Figure 4.8). The tubes were vortexed for 2 min and left to stand for 
15 min to allow phase separation. Then 1ml of the aqueous phase was withdrawn 
and measured at OD600 (Final OD). Surface hydrophobicity was expressed as a 
percentage according to the following formula: [1- (Final OD / Initial OD)] x 100 
with the same interpretation as mentioned above. 
 
 
 
Figure 4.8 Modified adherence and aggregation steps 
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4.7.4 Salt aggregation test-SAT 
The Salt Aggregation Test (SAT) was performed as outlined by (Krepsky 
et al., 2003). Serial dilutions of ammonium sulphate (NH4)2SO4 (Fisher) (4, 3, 2, 
1.5, 1, 0.75, 0.5, 0.25, 0.125, 0.0625, 0.031 and 0.0078 mM) were prepared in 
Phosphate buffer saline (PBS) at pH 7. Bacterial cultures were prepared in three 
different way; 1) overnight culture on TSA medium, 2) overnight bacterial culture 
in MM Eth and 3) overnight bacterial culture in MM Glc Both bacterial broth 
cultures (MM Eth and MM Glc) were centrifuged and the pellet suspended in 
PBS, while bacterial culture on TSA were picked off and suspended in PBS, 
centrifuged and re suspended in PBS. 15µl of bacterial suspension (OD620=1.00) 
were mixed with equal volume of different concentrations of ammonium sulphate 
and mixed on the slide. For more visibility 5µl 0.1% crystal violet (filtered twice 
through a filter paper and 0.45µm filter) was also added to the mixture. The lowest 
concentration of ammonium sulphate giving bacterial aggregation or clumping 
was recorded as an indication of the level of bacterial surface hydrophobicity. 
surface hydrophobicity intensity was classified according to the approach outlined 
by (Lee and Yii, 1996) and expressed as: 
< 1 M       = Strong hydrophobic,  
1 – 2 M    = Moderate hydrophobic, 
 >2 ≤ 4 M = Weak hydrophobic, 
 ≥4 M       = Hydrophilic 
 
4.8 Bacterial pellicle formation 
This assay were performed according to that described by (Friedman and 
Kolter, 2004b). In this procedure 9.9ml of either MM Eth, MM Glc or TSB were 
placed in glass tubes (18- 150mm) and inoculated with 0.1ml of a 109 CFU/ml 
overnight culture and incubated at room temperature in a stable condition, without 
shaking. Pellicle formation was determined by checking the air-liquid interface of 
the standing culture. Pellicle formation was considered positive when the surface 
of the broth was completely covered by a dense or solid layer of bacteria and 
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matrix material. The same protocol was also used for pellicle formation at a larger 
scale using a 2 liter (270-130mm) container and 1 litter of culture media at 30˚C.   
4.9 Drip Flow Reactor (DFR)  
A four chamber drip flow biofilm reactor system was used in this study 
with a range of coupons, media and bacteria.  The DFR was prepared according 
to the operators manual provided by the centre for biofilm engineering, 
standardized biofilm methods laboratory, Bio surface technologies, Inc. (2007). 
The method described by (Hassett et al., 1999) was employed. All equipment and 
media used were sterilised and two different coupon were used (glass slides and 
plastic). The first two chambers were filled with 10ml MM Eth (Ethanol 10.57g/l) 
and the others with MM Glc (Glucose 10gm/l). The chamber were then inoculated 
with the relevant overnight culture and incubated at room temperature for 4-6 h 
on a flat surface i.e. zero position. After that each chamber was connected to a 
continuous flow media (same media in the chamber) reservoir at a flow rate of 
approximately 0.75ml/min. During drip flow operation the system was set at a 10° 
angel to allow the media to flow across the surface. The biofilms were grown 
under a continuous flow of media and incubated at room temperature for 24 and 
48 h. After incubation, the coupons washed with SDW then fixed with 2.5% 
formalin or by passing through a Bunsen burner flame three times. The slides were 
then stained with diluted ethidium bromide 1mg/ml and left for 15 min. The 
coupons were then washed in distilled water and stained with 0.1% calcofluor or 
fluorescent brighter 28 (Sigma Aldrich, UK) for 15min. finally the coupons were 
observed under the fluorescence microscope. Fluorescent brighter 28 stains 
exopolysaccharide as blue, while ethidium bromide stains bacterial cell (DNA) as 
red (Hill et al., 2010). 
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4.10 RNA sequencing (Transcriptome) 
4.10.1 Total RNA extraction and purification from bacteria 
RNA was extracted and purified from bacteria by using an ISOLATE- II 
Mini Kit (Bioline) and RNeasy MinElute Cleanup Kit (Qiagen). The extraction or 
isolation was performed according to manufacturer’s instruction, briefly, two 
mineral media, one with glucose (10g/l) and other with ethanol (10.57g/l), were 
inoculated with a stock culture from fresh overnight bacterial culture (Ps 3). After 
incubation for 24 h, both cultures were mixed very well and centrifuged at 8000xg 
for 10 min, the supernatant was discarded and the pellet were suspended in 100µl 
TE buffer containing 1mg/ml lysozyme and then mixed well and incubated for 10 
min at 37˚C. After incubation, 350µl lysis buffer and 3.5 µl β-ME were added to 
the suspension and mixed vigorously. The mixture transferred to ISOLATE II 
Filter (violet) and filtered at 11000xg for 1 min. 350 µl 70% (v/v) ethanol added 
to the filtrate and mixed and then transferred to ISOLATE II RNA mini filter 
(blue) and centrifuged at 11000xg for 30 seconds. After discarding the 
supernatant, 350 µl Membrane Desalting Buffer (MEM) were added and 
centrifuged for 1 min at 11000xg then the supernatant were discarded. 95µl 10% 
DNase I reaction mixture (10µl DNase I in 90µl RDN buffer) added directly in to 
the centre of the filter and incubated for 15 min at room temperature. The mini 
filter was then washed by adding 200µl wash buffer RW1 and centrifuged at 
11000xg for 30 seconds and then the filtrate decanted and the filter tube 
transferred to new Eppendorf tube. After that the mini filter was washed for a 
second time by adding 600µl of wash buffer RW2 and centrifuged for 30 seconds. 
The filtrate was discarded and the mini filter washed for a last time with 250µl 
wash buffer RW2 and centrifuged for 2 min at 11000xg. Finally the mini filter 
was transferred to a new tube and the RNA eluted by adding 60µl RNase free 
water and centrifugation at 11000xg for 1 min. The concentration of the total RNA 
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was measured by micro volume spectrophotometer and RNase free water used as 
a blank.  
4.10.2 RNA clean-up  
A RNeasy MinElute Cleanup Kit (Qiagen) was used for the purification 
and clean-up of the extracted RNA. According the manufacturers protocol, the 
volume of extracted RNA sample was adjusted to 100 µl with RNase-free water, 
mixed and topped up with 350μl Buffer RLT. At this point 250μl of 99% (v/v) 
ethanol was added to the diluted RNA, and mixed and transferred to a RNeasy 
MinElute spin column and centrifuged at 8000xg for 15 seconds with the flow-
through being discarded. 500μl Buffer RPE was then added to the spin column 
and centrifuged at 8000xg for 15 seconds and once again the flow-through was 
decanted. This was followed by the addition of 500μl of 80% (v/v) ethanol to the 
RNeasy MinElute spin column which was then centrifuged for 2 min at 8000xg. 
After that the flow-through was decanted off and the RNeasy MinElute spin 
column was transferred to new Eppendorf tube which was centrifuged at 
maximum speed for 5 min. The spin column was then placed in a sterilised 
Eppendorf tube and 25μl RNase-free water added directly to the centre of the spin 
column membrane, the tube was centrifuged for 1 min at full speed to elute the 
RNA. The concentration and purity of RNA was measured by a 
spectrophotometer and running gel. For RNA sequencing, more than 350μl of 
each pure RNA sample were prepared with >170 µg/ml or ng/µl and purity 1.8-
2.0 at OD 260/280 nm and approximately 2.0 at OD 260/230 nm. 
4.10.3 RNA sequencing (Next Generation Sequencing). 
After the preparation of the RNA, the samples were sent for RNA 
sequencing via Next Generation Sequencing (NGS) (Baseclear Ltd, Netherlands). 
The standard protocol for NGS of RNA starts with rRNA depletion using 
Epicentre bacteria Ribo-zero rRNA depletion kit to deplete Ribosomal RNA from 
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total RNA. This is followed by Illumina strand-specific mRNA-seq library 
preparation and sequencing. Once the purity of the RNA has been confirmed (RIN 
value >8.0), strand-specific mRNA-seq libraries are generated by the “dUTP 
method” that includes barcoding which is compatible with either single-read or 
paired end sequencing (Parkhomchuk et al., 2009, Levin et al., 2010). Then 
purified mRNA is then fragmented and converted to double-stranded cDNA. 
DNA adapters with sample-specific barcodes are ligated and a PCR amplification 
is performed with the outputs being subjected to further quality control including 
purity and concentration measurements. The Illumina libraries are then diluted, 
clustered and sequenced on the Illumina HiSeq 2500 or MiSeq instruments. The 
Illumina sequencing data produced is processed removing the sequence reads that 
are of too low quality (only PF “passing filter” reads are used) and are 
demultiplexed based on the sample-specific barcodes. An additional filtering step 
using in house scripts was applied to remove reads containing adaptor sequences 
or the Illumina PhiX control sequences. The sequence data are provided to the 
customer in FastQ format and the final step is bioinformatics. The sequence reads 
were filtered and trimmed and these reads are aligned against the reference 
sequences using the CLCbio “RNA-Seq” software. In addition expression values 
are calculated and compared between the samples. Quality control is performed 
through boxplot analysis, principle component analysis (PCA) and hierarchical 
clustering of the normalized expression values.    
For a two-group experiment the 'Fold Change' means how many times 
bigger the mean expression value in group 2 (MM Eth) is relative to that of group 
1 (MM Glc). If the mean expression value in group 2 (MM Eth) is bigger than 
that in group 1 (MM Glc) this value is the mean expression value in group 2 (MM 
Eth) divided by that in group 1 (MM Glc). If the mean expression value in group 
2 (MM Eth) is smaller than that in group 1 (MM Glc)   the fold change is the mean 
expression value in group 1 (MM Glc)   divided by that in group 2 (MM Eth) with 
a negative sign. In terms of gene expression profiles, fold changes and their 
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significance (P values), representing differential expression, those mRNAs with 
p values < 0.01 were considered to be differentially expressed (Rumbo-Feal et al., 
2013).  
4.11 Isolation and quantification of outer membrane vesicles (OMV)  
The isolation of OMV was performed using the protocol described by  
Kadurugamuwa and Beveridge (Kadurugamuwa and Beveridge, 1995) (Figure 
4.9), while the quantification was performed by Bradford test. Both Ps 3 and Ps 
10421 grown on both MM Glc and MM Eth were examined for OMV production.  
Overnight cultures grow on MM Eth (Ethanol 10.57g/l) and MM Glc (Glucose 
10g/l) broth were inoculated (107 CFU/ml as final inoculum size) and incubated 
at 30oC for 18-24 h with shaking 100 rpm. After the incubation, the broth cultures 
were centrifuged at 10000xg for 10-15 min (Avanti J-26 XPI centrifuge, using 
with JSP F250 rotor, Beckman Coulter Ltd UK, High Wycombe, UK) and the 
cells discarded. The supernatants were filtered through Millipore filters (EMD 
Millipore Steritop Sterile Vacuum Bottle-Top Filters -0.22µm pore size – Fisher) 
to remove residual cells. The filtrate was ultra-centrifuged at 40000xg for 90 min 
at 5°C using Optima L- look Ultra Centrifuge with 50.2 Ti rotor (Beckman 
Coulter Ltd UK, High Wycombe, UK), the supernatant was decanted and the 
pellets suspended in 50mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
buffer (HEPES) at pH 6.8 and recentrifuged for 60-90min at 40000xg at 5˚C. The 
supernatant was then discarded and the pellet suspended in 50mM HEPES buffer 
(pH 6.8) and filtered through 0.45μm syringe filter. A 100μl aliquot of the filtrate 
was cultured on TSA media to confirm purity and the concentration of vesicles 
quantified by the Bradford assay before storage at 4˚C (Figure 4.9). 
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Figure 4.9 OMV production and extraction diagram on mineral media containing 
different carbon source.  
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4.12 Isolation and characterisation of bacterial EPS 
A range of analytical techniques were employed to characterise the EPS 
recovered from the bacteria under investigation. 
4.12.1 Developing an alternative media for EPS production (Control) 
A range of specific media such as MM Glc (10g/l glucose, 1g/l casein), 
MM Gly (10g/l glycerol) and MM Eth (10.57g/l ethanol) were used for to study 
bacterial EPS production and characterisation alongside a range of more 
conventional media (TSB, SWF and LB broth).  
4.12.2 Optimisation of bacterial EPS production and extraction 
Several culture media were tested for EPS production with the effects of 
different inoculum size, media, incubation period, and trichloroacetic acid (TCA) 
concentrations on the quantity and the quality of the extracted EPS evaluated 
(Figure 4.10). Generally speaking 495ml of media was inoculated with 5ml of 
fresh overnight bacterial culture adjusted to 109 CFU/ml and then incubated at 
30°C with shaking at 100-120 rpm/min for 72-80 h. The extraction of EPS was 
carried out by the method described by (Marshall et al., 2001). After incubation, 
the culture were heated in water bath at 60-65°C for 30 min (optional) and then 
centrifuged  at 10000xg  (Avanti J-26 XPI centrifuge, Beckman Coulter Ltd UK, 
High Wycombe, UK) (F250 Rotor) for 10 min at 5˚C to remove the cell. 5% TCA 
(w/v) (sigma-Aldrich) were added to the supernatant with shaking and left 
incubated at 5˚C overnight for protein precipitation. The solution was then 
centrifuged at 20000xg (Avanti J-26 XPI) for 20 min at 4˚C to remove the protein 
and then 2 volumes of chilled Ethanol  (Methylated spirit industrial-fisher) were 
added and mixed well and then left at 4˚C for two days to precipitate the EPS. The 
EPS was then recovered by centrifugation at 25000xg (Avanti J-26 XPI) for 30-
35 min at 4˚C. The supernatant was discarded and the pellet (EPS) dissolved in 
the ultra-pure water (UPW) and dialysed (dialysis tubing cellulose membrane – 
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sigma) in UPW for 48-72 h at 4˚C, with 2-3 changes of water per day to remove 
small sugars. After dialysis, the samples were taken and analysed by Pico trace to 
detect glucose residues. The EPS solution was then freeze-dried (frozen and 
lyophilised) in a pre-weighed bottle or round-bottom flask for 24-48 h using liquid 
nitrogen and a freeze-drier (Christ Alpha 2-4 LD plus- SciQuip Ltd, UK). Once a 
freeze dried product had been obtained several tests such as EPS composition, 
NMR, monomer analysis using HPAEC, FTIR and MALLS analysis were 
performed. 
 
 
Figure 4.10 EPS production and extraction optimisation diagram. 
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4.12.3 EPS dry weight  
After freeze drying, The EPS dry weight was determined either through 
removal and weighing or by weighing the container with and without the EPS 
material.  
4.12.4. Estimation of glucose content 
Glucose was measured by dissolving 1mg of extracted EPS in 1ml UPW. 
The suspension were then filtrated or centrifuged and the supernatant analysed 
using the Pico trace analyser (Section 4.6.3).   
4.12.5. Estimation of total carbohydrate content 
This test were performed by dissolving 1mg of extracted EPS in 1ml of 
UPW and then analysed by the phenol sulphuric acid method as described by 
Dubois et al (1956)(Section 4.6.4). 
4.12.6 Estimation of protein content 
The Bradford assay was used to determine the protein content of the EPS. 
In this analysis, 1mg of extracted EPS was dissolved in 1ml UPW, mixed and 
analysed as mentioned in (Section 4.6.5) 
4.12.7 Estimation of uronic acid content 
In this analysis 1mg of extracted EPS was dissolved in 1ml of UPW and 
then analysed colorimetrically by m-hydroxydiphenyl assay as described in 
(Section 4.6.6).  
4.12.8 Nuclear Magnetic Resonance (NMR) analysis of EPS 
Nuclear magnetic resonance (NMR) spectra of the extracted EPS and 
media controls were analysed by Dr. Neil McLay, University of Huddersfield  
using a Bruker Avance DPX500 500.13MHz. NMR spectra were recorded at an 
elevated probe temperature of 70˚C. Proton NMR (1HNMR) were achieved by 
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dissolving 5-7 mg of EPS in 550µl deuterium dioxide > 99.9 % D (D2O) (Goss 
Scientific Instruments Limited, UK) with heating or sonicating if required. Top 
spin 3.1 software was used to process the resulting data. 
4.12.9 Monosaccharide composition or monomer analysis of EPS.  
In order to determine the monosaccharide constituents of the extracted 
EPS via High Performance Anion Exchange Chromatographic with a Pulsed 
Amperometric Detector (HPAEC-PAD) the EPS was firstly treated (hydrolysed) 
with an acid catalyst such as trifluoroacetic acid (TFA) (Sigma Aldrich, UK). In 
this case 3mg of extracted EPS was dissolved in 2ml of 2M TFA in a pressure 
tube and then heated for 2 h at 120˚C. After heating, the sample was left to cool 
at room temperature. The pressure tube was then opened and the sample 
evaporated to dryness under a constant stream of nitrogen gas at 50-60˚C or the 
samples were transferred to a small tube and dried by a TurboVap LV 
Concentration Workstation (Caliper Life Sciences, USA).  
Following drying 3ml of UPW was added to the dried sample and mixed 
via vortexing or sonicating to make a 1000ppm (stock) which was then filtered 
through either a 0.45 or 0.22μm filter. This sample was then compared with 
several standard sugar solutions (20ppm) of: D-(-)-Arabinose 98%D, (+)-
glucosamine 99%, D(+)-galactosamine 99%, D(+)-fucose 99%, 2-Deoxy-D-
glucose 99%, maltitol 99%, L-rhamnose 99%, D-(+)-glucose 99%, D-(+)-
galactose 99%, D-(+)-mannose 99%, D-(+)-raffinose 98%, D-(+)-Galacturonic 
acid monohydrate 97% (Sigma Aldrich & Fisher Scientific, UK) and hydrolysed 
alginate (mannuronic acid and guluronic acid).   
All sample and standards were analysed by HPAEC-PAD (Dionex ICS -
3000, Dionex Corporation, CA, USA or Dionex ICS -5000, Dionex Corporation, 
CA, USA) using a Sodium hydroxide (10mM, Isocratic) mobile phase at 0.45ml 
or 0.5ml/min. Analysis, separation and quantification of neutral monosaccharide 
sugars and uronic acid sugars derived from the extracted bacterial EPS was 
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performed according to (Wang et al 2012).  Briefly, three eluents were prepared 
1) 10mM NaOH (Mobile phase), 2) 200mM NaOH and 3) 500mM NaOAc + 
200mM NaOH, then the Isocratic elution program was used to analysis neutral 
and uronic acid sugars using ICS -500 at 0.5ml/min flow rate. After the run, the 
generation time of the standard peaks and the samples peaks were compared. To 
quantify each sugar within the EPS, the peak area of any sugar were compared to 
a graph generated by HPAEC from a series of sugar standards. 
4.12.10 Bacterial EPS treatment with enzyme dextranase  
After the optimisation of EPS production the bacterial EPS were treated 
by dextranase enzyme from Chaetomium erraticum (Sigma Aldrich, UK) to 
confirm the presence of dextran. The effects of the enzyme dextranase was first 
tested on a commercial dextran diluting to 100mg of dextran in a 25 ml conical 
flask volume containing 10 ml D2O. The mixture were divided in two and 0.1ml 
of the dextranase were added to one of them and then both mixture were incubated 
at 50ºC for 3 h in a shaking incubator. After that 0.25g of TCA was added to each 
mixture and processed as described in (Section 4.12.2), after dialysis, the solution 
were analysed by proton NMR. Dextranase enzyme interference were also 
investigated by mixing 1ml dextranase enzyme with 9 ml UPW and incubated at 
50˚C for about 3 h. Prior and post dialysis were analysed by proton NMR.     
In order to investigate the bacterial EPS, a broth culture grown on 990ml 
of MM Eth was inoculated with 10ml of  ≈109 CFU/ml stock culture prepared 
with MRD from an overnight culture and then incubated at 30 ºC for about 80h 
with 120 rpm in shaking incubator. After that the broth was incubated at 60-65˚C 
in a water bath for 30 min and then cooled and centrifuged at 10000xg to remove 
cells. The supernatant was then divided in two, one portion was treated with 
dextranase (1% v/v final concentration) and the other half left without any enzyme 
treatment.  Both broths were then incubated at 50˚C for 3-4 h in shaking incubator, 
after which both conical flasks were treated with trichloroacetic acid 5% (w/v) 
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overnight at 4ºC before being centrifuged at 20000xg to remove proteins and any 
residual cells. Then 2 volumes of ice-cold ethanol (Methylated spirit- fisher) were 
added to the supernatant and left at 4°C for two days, following a further 
centrifugation (25000xg) at 4°C for 30 min to precipitate EPS. The supernatant 
was discarded and the EPS pellet was reconstituted in ultra-pure water and 
dialysed against ultra-pure water for 72 h with 2-3 water changes daily. The 
contents of the dialysis tubing were then freeze dried. The crude EPS was 
dissolved in D2O and 
1H-NMR carried out. 3mg of crude EPS was boiled in 2 ml 
trifluoroacetic acid (TFA) for 2 h prior to monomer analysis via HPAEC-PAD 
eluting 10mM sodium hydroxide at a flow rate of 0.5 ml/min, while for HPSEC-
MALLS analysis, 1000ppm of EPS were prepared by dissolving 3mg EPS in 3ml 
UPW.   
4.12.11 EPS characterisation by FTIR analysis 
The bacterial EPS and other crude substances were characterised using a 
Fourier transform infrared spectrophotometer (FTIR) (Magna-IR 750, Nicolet 
Instrument, USA). The most commonly region used for analysis is 400-4000     
cm-1 as all the molecules of interest possess characteristic absorbance frequencies 
and primary molecular vibrations in this region. Small amount of sample or crude 
EPS were subjected to IR spectra measurement in the frequency range of 400 and 
4000 cm-1 (Castro et al., 2014).  
4.12.12 Molecular Weight Determination of EPS 
High-performance size exclusion chromatography (HPSEC) and a multi-
angle laser light scattering detection (MALLS) was used to determine the weight-
average molecular weight (Mw) and polydispersity (Mw/Mn) of bacterial EPS 
and dextran standard control (BDH, Grade A) MW 200000-270000 Da. A dextran 
or pullulan 800000 Da polysaccharide was used as a control to check the HPSEC-
MALLS was working correctly.  
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Bacterial EPS and dextran solutions were prepared by dissolving 3mg in 
3ml of UPW and mixing overnight on magnetic stirrer. Solutions were filtered 
through 0.2 or 0.45μm syringe filters and then approximately 0.5ml of solutions 
were injected into the SEC-MALLS through a 7125 injection port (Rheodyne 
LLC, California, USA) onto an analytic size exclusion column composed of three 
Aqua gel-OH-mixed columns (40,50 and 60 with 15μm particle size, 250 x 4mm,  
Varian, Oxford, UK). The samples were first passed through a UV detector 
(Prominence SPD-20A, Shimadzu, Milton Keynes, UK) to detects the presence 
of any DNA residue in the sample at a wavelength 260 nm. The concentration of 
sample (EPS, dextran or pullulan) was then detected by a refractive index detector 
(RI) (Optilab Rex, Wyatt technology, Santa Barbara, USA) while a multi-angle 
laser light scattering (MALLS) photometer with the laser set to 690 (Dawn 
HELEOS, Wyatt Technology, Santa Barbara, USA) was used to measure the 
weight-average molecular weight (Mw). Astra -6 software was used to processing 
the outcome data. 
4.13 Bacterial virulence (Pathogenicity) 
The greater wax moth larvae Galleria mellonella (G. mellonella) were 
used to study bacterial pathogenicity. In this study, the impact of bacterial biofilm 
formation, bacterial culture composition and the production of outer membrane 
vesicle on pathogenicity. G. mellonella larvae were purchased from a commercial 
supplier, maintained in the dark on wood chips at 4˚C and used within 1 week. 
Before starting the experiments the larvae were left at room temperature for 
several hours. At the time of inoculation, larvae were selected on the basis that 
they were active, ≥ 2 cm in length, cream coloured with no visible signs of 
melanisation and pupation. These larvae were then placed in a sterilised tube or 
flask and put in the ice. The larvae were then held between the thumb and 
forefinger and injected very carefully with 10µl of each experimental condition 
through the end rear pro leg into the hemocoel using a 10µl GC syringe. The 
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syringe needle was cleaned and sterilised between each experiment by washing 
twice with 70% isopropyl alcohol, followed by 3 washings with sterilised DW. 
The injected larvae were put in labelled petri dishes and then incubated at 37˚C 
and monitored each hour (Figure 4.11 a). Larvae were examined for pigmentation 
and their survival recorded every hour. Larvae were considered dead when they 
showed no movement in response to touch. 
Initial investigations were performed according to (Harding et al., 2013) 
with some modification. Here the bacterial of interest were grown in conical flasks 
incubated in a shaking incubator at 30°C with 100 rpm for 40 h. In these 
experiments 99ml of media was placed in a 250 ml conical flaks and inoculated 
with 1ml of a 109 CFU/ml stock culture. In order to investigate the impact of the 
bacterial cells 0.1ml culture was diluted in 9.9 ml of sterile MRD prior to 
injection. To investigate the impact of the supernatant 0.1ml of culture was mixed 
with 9.9ml MRD and then centrifuged at 10000xg for 10 min at room temperature, 
the pellet was discarded and the supernatant filtered twice through 0.45 & 0.22µm 
sterile filters prior to injection. In order to study the effect of OMV, the OMV 
were prepared as described in Section 4.11. In all these initial investigations 7 
larvae were used per experiment.  
Further studies were performed according to (Desbois and Coote, 2011) 
with slight modification. In these studies bacterial cultures were grown in the 
same manner as described above with different incubation times i.e. 24 and 80 h. 
In this case lethal dose (LD50) experiments were carried out by using a dilution 
series (108,107,106 and 105 CFU/ml) prepared in sterile PBS. Cultures were diluted 
to an absorbance of 1.115 at 620 nm to give an approximate suspension of 109 
CFU/ml. Supernatant and OMV investigations were carried out as outlined above 
but with sterile PBS replacing sterile MRD. In all these investigations 10 larvae 
were used per experiment (Figure 4.11b). 
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Alongside each experiment, a range of control larval incubations were 
prepared, these were either injected with 10 µl of each media or solution used e.g. 
MRD, PBS, MM Glc, MM Eth and HEPES to determine if these solutions had 
any negative impacts on the larvae. There was also, always a set none injected 
worms used to ensure that the incubation conditions did not impact on the viability 
of the larvae.  
 
 
 
a 
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Figure 4.11 Bacterial pathogenicity diagram in wax worms a) pathogenicity of bacterial 
culture dilution directly, supernatant and OMV at 40h b) pathogenicity of bacterial culture 
directly, supernatant and washed bacterial cells at 24 and 80h.  
 
4.14 Bacterial survival in Ultra-Pure Water (UPW) 
Bacterial survival in sterilised UPW was investigated by preparing 
suspensions of each bacterial strain in UPW using overnight cultures. Before 
autoclaving, conical flasks were well washed and then filled with 99 ml of UPW, 
after autoclaving, the UPW was inoculated with a 1ml of bacterial suspension of 
approximately 106 CFU/ml that prepared in sterilised UPW. These were then 
incubated at 30˚C and then monitored daily for 40 days. The same experiment 
were repeated focusing on (St 53, St 10421, Ps 3, Ps10421,  and C. freundii) but 
with 107 CFU/ml as a final inoculum size and incubated at 30°C for about 1 year.  
 
b 
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5. Results  
5.1. Characterisation and re-identification of bacteria. 
The bacterial isolates used in this study originated from various sources, 
see section 4.1. The identity of the strains used in this study was confirmed by 
both conventional and molecular techniques. In addition two culture collection 
strain were included to act as controls, these were Stenotrophomonas maltophilia 
9203 (St 9203) and Pseudomonas aeruginosa 10471 (Ps 10471) from National 
Collection of Industrial Bacteria (NCIB). 
5.1.1 Colony morphology, Gram stains and biochemical tests of bacteria 
Fresh overnight cultures were prepared on TSA, individual colonies were 
selected and Gram stained (Figure 5.1), followed by the oxidase and catalase tests. 
During this identification process, isolate Ps 5 originating from a wound dressing 
that was presumed to be a Pseudomonas spp., was shown to be contaminated. 
Streak plating was used to obtain pure cultures of the two bacteria present. Both 
isolates were Gram negative but had different oxidase and triple sugar iron agar 
(TSI) results (Table 5.1). With the exception of the contaminant found in Ps 5 all 
the isolates conformed to what would be expected for Stenotrophomonas spp. and 
Pseudomonas spp. isolates. The unknown contaminant had characteristics that 
suggested it was a member of the Enterobacteriace family. 
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Figure 5.1 Gram stained bacterial smears (1000x). a)St 18 b)St 51 c)St 53 d)St 9203 e)Ps 1 
f)Ps 3 g)Ps 5 h)Ps 10421 and k) Unknown. All bacterial strains (a-k) are Gram negative bacilli. 
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Table 5.1 Culture characterisation, Gram reaction and biochemical test of isolate 
bacteria.  
 
Bacteria *Colony morphology 
Gram 
reactio
n 
Shape 
Oxidase 
Test 
Catalase 
Test 
TSI 
Slant/Butt 
St 18 
Less than 1mm, circular, 
creamy yellow, smooth, 
entire margin, slightly 
convex, glistening, no odour 
-ve Bacilli - + K/K 
St 51 
2 mm ,circular, creamy 
yellow, smooth, entire 
margin, slightly convex, 
glistening, odour 
-ve Bacilli - + K/K 
St 53 
Less than 1mm,circular, 
creamy yellow, smooth, 
entire margin, slightly 
convex, glistening, no odour 
-ve Bacilli - + K/K 
St 9203 
Less than 1mm,circular, 
creamy yellow, smooth, 
entire margin, slightly 
convex, glistering, no odour 
-ve Bacilli - + K/K 
Ps 1 
3 mm, wrinkled, dark 
green pigmentation  
irregular margins, opaque, 
odour 
-ve Bacilli + + K/K 
Ps 3 
4 mm, wrinkled, green 
pigmentation  irregular 
margins, opaque, odour 
-ve Bacilli + + K/K 
Ps 5 Different 
**Ps 5 -ve Bacilli + + K/K 
***Unknown -ve Bacilli - + A/A 
Ps 
10421 
4 mm, circular, lemon to 
green pigmentation, smooth 
entire margins, convex, 
opa-que, no odour 
glistening 
-ve Bacilli + + K/K 
(A: Acid) the colour changed to yellow. (K; Alkaline) the colour remains red. *Colony morphology at 24hours. 
**3-4mm in size, wrinkled, yellow, convex, irregular margins, opaque, no odour. ***3-4mm in size, smooth, 
creamy white, convex, entire margins, glistening, strong odour. 
   
5.1.2. Molecular identification of bacterial  
The identification of the individual isolates was confirmed by the 
sequencing of the 16s rRNA gene and subsequent comparison with the relevant 
data bases (Section 4.3.3.1). Taxonomy of bacterial sequences were estimate via 
the RDP-classifier program as shown in (Table 5.2).With the exception of the 
unknown contaminating isolate, all the other isolates were identified as either 
Stenotrophomonas maltophilia or Pseudomonas aeruginosa while the unknown 
isolate was identified as Citrobacter freundii (Table 5.3). The phylogenetic trees 
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(figure 5.2) illustrated that the clinical and lab strains Pseudomonas aeruginosa 
(Ps1, Ps3, Ps5 and Ps 10421) and unknown bacteria were closely related to 
Pseudomonas aeruginosa and Citrobacter freundii groups, respectively. While 
Stenotrophomonas maltophilia (St 18, St 51, St 53 and St 9203) sequences were 
related to Stenotrophomonas maltophilia groups that containing also 
Pseudomonas hibsicula and Pseudomonas geniculate, both of which are now 
reclassified as Stenotrophomonas maltophilia. 
 
Table 5.2 Taxonomy of bacterial gene sequences analysed by Ribosomal Database Project 
(RDP) - classifier program  
 
Taxonomy 
ST 18 
ST 51 
ST 53 
Ps 1 
Ps 3 
Ps 5 
Unknown 
Domain Bacteria Bacteria Bacteria 
Phylum Proteobacteria Proteobacteria Proteobacteria 
Class Gammaproteobacteria Gammaproteobacteria Gammaproteobacteria 
Order Xanthomonadales Pseudomonadales Enterobacteriales 
Family Xanthomonadaceae Pseudomonadaceae Enterobacteriaceae 
Genus Stenotrophomonas Pseudomonas Citrobacter 
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Table 5.3 Tope four nearest neighbours for each bacterial sequences analysed by 
Ribosomal Database Project (RDP) – sequence match program, showing ; S_ab score, 
unique common oligomers and sequence full name with its passport number 
 
Bacteria  
S_ab 
score 
Oligomers Match bacteria Strain Passport 
St 18, 863 
unique 
oligomers 
0.988 1444 Stenotrophomonas maltophilia IAM 12423 
0.962 1392 Stenotrophomonas pavanii ICB 89 
0.946 1400 Pseudomonas hibiscicola ATCC 19867T 
0.943 1388 Pseudomonas beteli ATCC 19861T 
St 51, 861 
unique 
oligomers 
0.988 1444 Stenotrophomonas maltophilia IAM 12423 
0.962 1392 Stenotrophomonas pavanii ICB 89 
0.950 1388 Pseudomonas beteli ATCC 19861T 
0.945 1345 Pseudomonas geniculata ATCC 19374T 
St 53, 920 
unique 
oligomers 
 
0.983 1444 Stenotrophomonas maltophilia IAM 12423 
0.964 1392 Stenotrophomonas pavanii (T) ICB 89 
0.959 1388 Pseudomonas beteli (T) ATCC 19861T 
0.941 1400 Pseudomonas hibiscicola ATCC 19867T 
Ps 1, 924 
unique 
oligomers 
 
0.973 1456 Pseudomonas aeruginosa 
DSM 50071; 
X06684 
0.897 1444 Pseudomonas otitidis MCC10330 
0.895 1460 Pseudomonas aeruginosa 
DSM 50071; 
HE978271 
0.870 1344 Pseudomonas panipatensis Esp-1 
Ps 3, 901 
unique 
oligomers 
0.997 1460 Pseudomonas aeruginosa 
DSM 50071; 
HE978271 
0.921 1444 Pseudomonas otitidis MCC10330 
0.908 1344 Pseudomonas panipatensis Esp-1 
0.906 1456 Pseudomonas aeruginosa 
DSM 50071; 
X06684 
Ps 5, 463 
unique 
oligomers 
0.976 1460 Pseudomonas aeruginosa 
DSM 50071; 
HE978271 
0.916 1444 Pseudomonas otitidis MCC10330 
0.911 1427 Pseudomonas nitroreducens IAM 1439 
0.903 1417 Pseudomonas indica AF302795 
Unknown, 
942 unique 
oligomers 
0.989 1410 Citrobacter freundii DSM 30039 
0.975 1434 Citrobacter braakii CDC 80-58 
0.966 1434 Citrobacter murliniae CDC 2970-59 
0.938 1397 Citrobacter werkmanii CDC 0876-58 
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Figure 5.2 Phylogenetic relationships dendrogram between sequences of bacterial samples 
strains marked as    (St 18, 51, 53, 9203, Ps 1, 3, 5, 10421 and unknown bacteria) 
and (Staphylococcus aureus as a control) and closely related type or lab strains of the 
genera Stenotrophomonas, Pseudomonas and Citrobacter based on 16S rRNA gene 
sequence similarity using Neighbour-joining method with 1000 replicates boots trap. 
Branches reproduced in >50% of the replicates are collapsed. 
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5.1.3. Whole genome sequencing (WGS) 
Three isolates (St 53, Ps 3 and C. freundii) were chosen for further 
investigation and whole genome sequencing based on their strong biofilm 
formation in the case of both St 53 and Ps 3 while C. freundii was chosen because 
it’s not a well characterised EPS producer (See chapter 6). A draft whole genome 
sequence was obtained for Stenotrophomonas maltophilia (St 53), Pseudomonas 
aeruginosa (Ps 3) and Citrobacter freundii (SA79) by the application of a whole 
genome shotgun sequence strategy. RAST and SEED programs showed that the 
St 53 genome sequencing generated 128 contigs with a draft genome 4,637,878 
bp in length and a G_C content of 66.3%. The draft genome contained a total of 
4,082 coding sequences (CDS), where 77 pseudogenes, 3 genes coding for rRNA 
(5S, 16S, 23S), 64 genes coding for tRNAs, and 1 for noncoding RNA. RAST 
annotation (Figure 5.3) showed that 31 genes were present encoding multidrug-
resistance efflux pumps, 21 were involved in cobalt-zinc-cadmium resistance and 
10 genes were involved in the production of β-lactamases. Also present were 
genes involved in the resistance to arsenic and fluoroquinolones, as well as 
tripartite efflux pumps and a single gene encoding an aminoglycoside adenylyl 
transferase. In addition, genes were present that were responsible for encoding 
proteins involved in the synthesis of biofilms, which are likely to enhance its 
pathogenicity (Liaw et al., 2010). Overall, the strain demonstrates the potential 
for resistance to a wide range of antimicrobial strategies within the clinical setting.  
The draft genome sequencing of strain Ps 3 generated 165 contigs, with a 
sequence length of 6,799,547 bp (66.2% G_C content). The draft genome 
contained a total of 6,161 coding sequences (CDSs), where 35 pseudogenes, 2 
genes coding for rRNA (16S, 23S), 57 genes coding for tRNA, and 1 noncoding 
RNA (ncRNA) gene. Citrobacter freundii strain SA79 was 4,870,483 bp in length 
across 19 contigs with a G_C content of 51.7%. The draft genome contained a 
total of 4,480 CDSs, 36 pseudogenes, 3 genes coding for rRNA (5S, 16S, 23S), 
72 genes coding for tRNA, and 9 ncRNAs were present. Further analysis of the 
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two genomes (Pseudomonas aeruginosa strain PS3 and Citrobacter freundii 
strain SA79) using RAST indicated that both organisms carried genes encoding 
resistance to antibiotics and toxic compounds such as beta lactamase (BLI and 
BLc) genes and multi drug resistance efflux pump. In addition, the presence of 
genes involved with exopolysaccharide and biofilm synthesis such as Pel genes 
in Ps 3 and pga genes in C. freundii suggests that these organisms may be of 
further clinical interest as shown in (Figure 5.3). These sequences (whole-genome 
shotgun projects) were submitted to Genbank under the accession numbers; 
-JRJA00000000 (Stenotrophomonas maltophilia strain 53) 
-JRGP00000000 (Pseudomonas aeruginosa strain PS3)  
-LAZI00000000 (Citrobacter freundii strain SA79). 
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    a               b                 c 
           
Figure   5.3    Subsystem category distribution (pie chart) and its subsystem feature count (table) using RAST program; a) Stenotrophomonas 
maltophilia 53, b) Pseudomonas aeruginosa ps3 and c) Citrobacter freundii SA79.
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5.1.4. Discussion 
Culture characteristic and biochemical test proved to be a good starting 
point to ensure that the isolates used for the entirety of the study were pure and 
correctly identified. Confirmation of isolate identification by 16s rRNA gene 
sequencing indicated that isolate Pseudomonas aeruginosa Ps 5 was 
contaminated with Citrobacter freundii SA79. All the P. aeruginosa isolates and 
Citrobacter freundii were clustered around P. aeruginosa and Citrobacter 
freundii group, respectively. While Stenotrophomonas isolates (St 18, 51, 53, and 
9203) were clustered among Stenotrophomonas maltophilia groups that also 
containing Pseudomonas geniculate and Pseudomonas hibiscicola, however these 
species have been re-classified as a member of genus  Stenotrophomonas (Anzai 
et al., 2000). 
Bacterial whole genome sequencing is an important tool for mapping the 
genomes of novel bacteria, bacterial identification and comparing genomes with 
other bacteria. Whole genome sequencing provides an indication of the ability of 
the bacteria under investigation to form biofilms formation and antimicrobial 
resistance, (biofilm formation by these bacteria were further studied in next 
chapter). 
The St 53 genome revealed the presence of 5 genes previously identified 
as being involved in biofilm formation, 118 features for virulence, disease and 
defence, 95 genes for resistance to antibiotic and toxins including 31 Multidrug 
Resistance Efflux Pump (MREP) genes, and 9 genes encoding invasion and 
intracellular resistance. This was similar to S. maltophilia K29a (Taxonomy ID 
40324.1) (http://rast.nmpdr.org/ ) (Overbeek et al., 2014), which has fewer biofilm 
associated genes (4) but a greater number of resistance and virulence genes (109 
and 124 respectively) and a lower number of MREP genes (21) and similar 
number of genes encode invasion and intracellular resistance (11).  
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Pseudomonas aeruginosa Ps 3 contains a full complement of pel 
(PA3058-PA3064), psl (PA2231-2245) and alginate biosynthesis operons 
(PA3540-3548) associated with Pseudomonas aeruginosa PA01 (Sharma et al., 
2014) (http://www.pseudomonas.com).  In addition Ps 3 contains 149 genes 
associated with virulence, disease and defence, 131 genes for resistance to 
antibiotic and toxins including 22 Multidrug Resistance Efflux Pump (MREP), 
and 13 genes encode invasion and intracellular resistance. This suggests that Ps 3 
is more virulent and has greater resistance potential than well studied 
pseudomonas such as PA01 and UCBPP-PA14. For example PA01 (Taxonomy 
ID 208964.1) (http://rast.nmpdr.org/ ) (Overbeek et al., 2014) has 122 genes 
associated with resistance to antibiotic and toxins including 18 MREP, and 11 
genes encode invasion and intracellular resistance. In the case of Pseudomonas 
aeruginosa UCBPP-PA14 (Taxonomy ID 208963.3) (http://rast.nmpdr.org/ ) 
(Overbeek et al., 2014) there are 113 antibiotic resistance features present, 11 
genes are associated with MREP, and invasion and intracellular resistance are 
encoded by 11 genes. 
Whole genome sequencing showed the presence of the entire pgaABCD 
locus in St 53 and C. freundii. This locus which is recognised to encode the 
synthesis of a polysaccharide poly-β-1,6-N-acetyl-D-glucosamine (β-1,6-
GlcNAc, PGA) which is present in the extracellular matrix of biofilms in a wide 
range of bacteria. It also mediates cell-to-cell and cell-to-surface adhesion and 
stabilization of biofilm formation in a variety of bacteria including E. coli (Wang 
et al., 2004), the cystic fibrosis pathogen Achromobacter xylosoxidans (Jakobsen 
et al., 2013), Pectobacterium atrosepticum (Pérez-Mendoza et al., 2011), 
Acinetobacter baumannii  (Choi et al., 2009), Klebsiella pneumoniae, 
Enterobacter cloacae, S. maltophilia, and Burkholderia cepacia (Skurnik et al., 
2012).  
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The presence of these genes in those bacteria suggesting that they may 
synthesize related polysaccharides that contribute to biofilm formation and 
potentially biofilm-mediated diseases. Surprisingly, there is increasing evidence 
that many of the MDR bacterial species involved in both community and hospital 
acquired infections share the genes that involved in surface polysaccharide PNAG 
synthesis (pga loci) (Roux et al., 2012). None of the pga genes have been 
identified in P. aeruginosa (Wang et al., 2004). Chromosomal deletions of each 
of the pga genes role have been performed in E. coli in order to determine their 
purpose. These investigations have shown that all the pga genes are required for 
optimal biofilm formation. The cytoplasmic membrane proteins (PgaC and PgaD) 
are necessary for PGA synthesis and the outer membrane proteins (PgaA and 
PgaB) are needed for PGA export (Jakobsen et al., 2013) 
5.1.5 Key findings 
 
 All of bacteria chosen for this study were confirmed to belong to the species 
expected. 
 Stenotrophomonas maltophilia 53, Pseudomonas aeruginosa ps3 and 
Citrobacter freundii SA79 were all identified as novel biofilm forming 
strains.  
 Whole genome sequencing revealed that Stenotrophomonas maltophilia 
53, Pseudomonas aeruginosa ps3 and Citrobacter freundii SA79 all 
possessed a number of genes related to biofilm formation, antimicrobial 
resistance and pathogenicity.    
 
The works represented in this chapter are published as follows: 
 
Akbar, S., Rout, S. P. & Humphreys, P. N. 2015a. Draft genome sequence of the biofilm-
forming Stenotrophomonas maltophilia strain 53. Genome announcements, 3, e00312-15.  
 
Akbar, S., Rout, S. P. & Humphreys, P. N. 2015b. Draft genome sequences of 
Pseudomonas aeruginosa strain PS3 and Citrobacter freundii strain SA79 obtained from a 
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5.2 Bacterial biofilm formation and hydrophobicity  
In this chapter, the ability of the bacterial strains under investigation to form 
biofilms was tested using a range of methodologies. In a number of cases a period 
of method development was required to ensure the tests could be performed in a 
reproducible manner.  
5.2.1 Strength of biofilm formation (96 well plate) 
All bacterial strains were tested for their ability to form biofilms using the 
standard 96 well plate method by (Stepanović et al., 2007) as described in Section 
4.5.2 (Figure 5.4). Initial work focussed on the impact of inoculum size and the 
concentration of carbon and nitrogen sources on biofilm formation.  In order to 
do this bacterial numbers (CFU/ml) were calibrated against optical density to 
remove the need to count bacterial numbers prior to setting up the experiment 
(Figure 5.5).  
 
 
 
Fig 5.4 Bacterial biofilm formation in 96 well plates. 
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Figure 5.5. Calibration of optical density against bacterial numbers at approximately 108 
or 109 (CFU/ml). Error bars represent standard error of the mean of three replicates.  
 
5.2.2. Effect of inoculum size on biofilm formation  
In those strains that biofilms were formed, the strength of biofilm 
formation increased with inoculum size particularly once the inoculum was 
greater than 1.0x107 CFU/ml i.e. 2.0x106 cells per 200µl in the well (Figure 5.6). 
Of all the strains tested only St 18, Ps 5 and C. freundii were unable to form 
biofilms under the some of the conditions investigated (Figure 5.6). In view of the 
lack of research into C. freundii, this strain was included in further biofilm 
investigations despite its poor biofilm formation under some conditions.  
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Figure 5.6   Effects of inoculum size on biofilm formation in different media a) Tryptone 
soya broth (TSB) and b) Simulated wound fluid (SWF). Error bars represent standard error of 
the mean of three replicates. 
5.2.3. Media development, the impact of carbon and nitrogen sources on 
biofilm formation.  
After optimising inoculum size, three media formulations were developed 
based on a range of primary carbon (glucose, glycerol and ethanol) (MM Glc, 
MM Gly and MM Eth) and nitrogen (casein) sources in order to allow a reliable 
analysis of EPS. These media were formulated in order to exclude components 
such as yeast extract, beef extract or any other substance that may contain 
compounds that will interfere with EPS analysis via NMR (Alhudhud et al., 2014).  
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Increasing the casein concentration led to decreasing biofilm formation 
among some P. aeruginosa strains (Figure 5.7), which contrasted with S. 
maltophilia and C. freundii where casein concentrations had no observable impact 
on biofilm formation. Consequently the casein concentration was set at 1g/l for 
all the future biofilm investigations. As illustrated in (Figure 5.8), S. maltophilia 
and P. aeruginosa had quite distinct responses to increasing glucose 
concentrations. Biofilm formation by S. maltophilia increased up to 10g/l of 
glucose after which biofilm formation began to decline. Biofilm formation by P. 
aeruginosa on the other hand, increased as glucose concentration increased across 
all concentrations investigated.  Finally, biofilm formation by C. freundii 
decreased as glucose concentration increased with the strength of biofilm 
formation being lower at all concentrations than any of the other bacteria 
investigated.  
 
 
MM Glc. Cas.: Mineral media containing glucose and casein  
ODc MM Glc. Cas. : Optical density control of mineral media containing glucose and casein  
 
Figure 5.7   The effects of casein concentration on bacterial biofilm formation on 96 well 
plates inoculated with approximately 107 cells/ml in the presence 10 g/l glucose. Error bars 
represent standard error of the mean of three replicates.  
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MM Glc. Cas.: Mineral media containing glucose and casein  
ODc MM Glc. Cas. : Optical density control of mineral media containing glucose and casein  
 
Figure 5.8 Effects of glucose concentration on bacterial biofilm formation with fixed 
concentration of casein 1g/l inoculated with approximately 107 cells/ml. Error bars represent 
standard error of the mean of three replicates.  
 
The response to increasing glycerol concentrations was similar to that seen 
with glucose (Figure 5.9) i.e. S. maltophilia demonstrated an increase followed 
by a decrease in biofilm formation and biofilm formation by P. aeruginosa 
increased as glycerol concentration increase. The situation with C. freundi was 
however quite different with the bacteria exhibiting much greater biofilm 
formation than observed with glucose (Figure 5.8). Biofilm formation by C. 
freundi increased with increasing glycerol concentration up to 15 g/l glycerol 
(Figure 5.9) beyond which biofilm formation was reduced.  In general the 
response in biofilm formation seen with increased ethanol concentration was 
similar to the observed with glucose and glycerol (Figures 5.8 to 5.10), that is an 
initial increase followed by a decrease at the higher concentrations. There were 
exceptions however, in the case of St 51 and 9203 biofilm formation declined with 
increasing ethanol concentration which contrasts with Ps 10421 where biofilm 
formation increased across all ethanol concentrations (Figure 5.10).   
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MM Gly. Cas. : Mineral media containing glycerol and casein  
ODc MM Gly. Cas. : Optical density control of mineral media containing glycerol and casein  
Figure 5.9 Effects of different glycerol concentration on bacterial biofilm formation after 
inoculation with approximately 107 cells/ml. Error bars represent standard error of the mean 
of three replicates.  
 
 
 
 
 
MM Eth. Cas.: Mineral media containing ethanol and casein.  
ODc MM Eth. Cas. : Optical density control of mineral media containing ethanol and casein.  
Figure 5.10   Effects of series concentration of ethanol on bacterial biofilm formation after 
inoculation with approximately 107 cells/ml. Error bars represent standard error of the mean 
of three replicates. 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
St 18 St 51 St 53 St 9203 Ps 1 Ps 3 Ps 5 Ps 10421 C.
freundii
O
D
5
7
0
n
m
/B
F
Bacterial Strains
MM Gly. 5g/l, Cas. 1g/l MM Gly. 10g/l, Cas. 1g/l
MM Gly. 15g/l, Cas. 1g/l MM Gly. 20g/l, Cas. 1g/l
ODc MM Gly. 5g/l, Cas. 1g/l ODc MM Gly. 10g/l, Cas. 1g/l
ODc MM Gly. 15g/l, Cas. 1g/l ODc MM Gly. 20g/l, Cas. 1g/l
0.0
0.2
0.4
0.6
0.8
1.0
1.2
St 18 St 51 St 53 St 9203 Ps 1 Ps 3 Ps 5 Ps 10421 C. freundii
O
D
 5
7
0
n
m
/B
F
Bacterial 
Strains
MM Eth. 5.29g/l, Cas. 1g/l
MM Eth. 10.57g/l, Cas. 1g/l
MM Eth. 15.86g/l, Cas. 1g/l
ODc MM Eth. 5.29g/l, Cas. 1g/l
ODc MM Eth. 10.57g/l, Cas. 1g/l
ODc MM Eth. 15.86g/l, Cas. 1g/l
108 
 
5.2.4 Impact of media on bacterial biofilm formation  
Alongside the evaluation of mineral media two other media (TSB and 
SWF) were also evaluated for their impact on biofilm formation. All bacteria 
produced strong biofilm when grown in both TSB and SWF except St 18, Ps 5 
and C. freundii.  Ps 3 was a strong biofilm producer in all media as was St 53 
except in MM Glc in which a moderate biofilm was produced (Figure 5.11).   
 
 
 
 
TSB: Trypton soy broth. SWF: Simulated wound fluid,  
MM Glc. Cas.: Mineral media containing glucose and casein,  
MM Gly. Cas. : Mineral media containing glycerol and casein,  
MM Eth. Cas.: Mineral media containing ethanol and casein,  
ODc: Optical density control for each media. 
Figure 5.11 Effects of different media (TSB, SWF, MM Glc, MM Gly and MM Eth) on 
bacterial biofilm formation using 96 well plates after inoculation with approximately 107 
cells/ml. Error bars represent standard error of the mean of three replicates. 
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5.2.5 Bacterial growth vs biofilm formation  
The relationship between bacterial growth and their biofilm formation was 
investigated in both TSB and SWF by analysis of the OD of bacterial growth prior 
biofilm quantification using a multiscan microtiter-plate reader. As shown in 
Figure 5.12, St 53 and Ps 5 grown in SWF reached an OD of about 0.6 and 0.8, 
while after staining or biofilm quantification, St 53 and Ps 5 produced strong and 
weak biofilm, respectively. The growth (OD) of St 51 and St 9203 were about 0.8 
and 1.4 in TSB, respectively (Figure 5.13), while after quantification of biofilm, 
production of biofilm were stronger in St 53 than in St 9203. Although all bacterial 
strains grew well in TSB, SWF and the other media as indicated by the increase 
in optical density detected using the bioscreen growth technology (Bioscreen 
Growth Curve C) (OY, Finland) (Appendix). However, strong or high growth was 
not correlated with strong biofilm formation, in fact no obvious correlation 
between bacterial growth and biofilm formation could be found (Figure 5.12 and 
5.13). 
 
 
CV: Crystal violet 
Figure 5.12 Bacterial growth (turbidity measurement) relation to biofilm formation (CV 
measurements) in SWF medium. Error bars for both CV and turbidity measurements 
represent standard error of the mean of three replicates measurement.  
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Figure 5.13 Bacterial growth (turbidity measurement) relation to biofilm formation (CV 
measurements) in TSB medium. Error bars for both CV and turbidity measurements represent 
standard error of the mean of three replicates measurement. 
 
5.2.6 Evaluation of bacterial biofilm formation using Congo Red Agar 
(CRA). 
The CRA method is often used to screen bacteria for biofilm formation 
and EPS production (Freeman et al., 1989) (Section 4.5.1). However, after 
growing all bacterial strains on CRA media, only S. maltophilia 53, 9203, and C. 
freundii were identified as biofilm producers (Positive) (Figure 5.14) an 
observation at odds with the data generated by the 96 well biofilm assay (See 
Section 5.2.1). An observation that suggests this approach is not universally 
applicable to screening for biofilm formation.   
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Figure 5.14 Qualitative analysis of bacterial biofilm production by (CRA) method. a) CRA 
medium without inoculation (control).  b) Black colonies biofilm production (+ve) such (St 53, 
9203, C. freundii), while non-biofilm production (-ve) such as (Ps 3 and 10421). 
 
 
5.2.7 Bacterial pellicle formation 
Bacterial pellicles are biofilms formed at the air liquid interface (Wu et 
al., 2012, Martí et al., 2011), the evaluation of pellicle formation was performed 
as described in (Section 4.8) using a range of media (Figure 5.15). All the P. 
aeruginosa strains investigated demonstrated the ability to form a pellicle 
irrespective of the media employed (Table 5.4). Pellicle formation in S. 
maltophilia was media dependent with a variety of responses depending on strain 
involved (Table 5.4). The largest contrast was seen between St 18 that did not 
form a pellicle and St 53 which formed a pellicle in all media. In the case of C. 
freundii a pellicle was only formed in the presence of ethanol.  
 
 
 
a b 
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Table 5.4 Pellicle biofilm formation in different media (TSB, MM Eth 10.57 g/l and MM 
Glc 10 g/l) at room temperature for different incubation times.  
 
Bacterial 
strains 
TSB MM Eth. MM Glc. 
3 Days 7 Days 3 Days 7 Days 3 Days 7 Days 
St 18 - - - - - - 
St 51 + + - - - - 
St 53 + + + + + + 
St 9203 + + - - - - 
Ps 1 + + + + + + 
Ps 3 + + + + + + 
Ps 5 + + + + + + 
Ps 10421 + + + + + + 
C. freundii - - + + - - 
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Figure 5.15 Pellicle biofilm formation during growth in different media (TSB, MM Eth 
10.57 g/l and MM Glc 10 g/l) at room temperature A) TSB, MM Eth and MM Glc media 
control, B) St 53, C) St 9203, D) Ps 3, E) Ps 10421, F) C. freundii G) H) I) Ps 3 pellicle biofilm 
formation grow in MM Eth using 2 litter bottle after 24 and 48 h. 
 
5.2.8 Bacterial biofilm formation under low shear condition  
The strains demonstrating the greatest biofilm formation among each 
hospital groups (St 53, Ps 3) and C. freundii as a bacterium with very little biofilm 
related research (Section 5.2.1) were investigated for their ability to produce 
biofilms under low shear condition using the DFR method (See section 4.9) 
(Hassett et al., 1999). The DFR was used to simulate moist aerobic environments 
such as those found around sinks etc. In addition to the clinical strains two lab 
strains St 9203 and Ps 10421 were also tested. Under fluorescence microscope, 
bacteria or nucleic acid appeared as red colour, while biofilm (EPS) appeared as 
a blue colour (Hill et al., 2010). As shown in (Figure 5.16 a-t), all 5 bacterial 
E 
H G I 
F 
24 h 48 h 
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strains (St 53, St 9203, Ps 3, Ps 10421 and C. freundii) were able to produce 
biofilms on glass (hydrophilic) and plastic polystyrene (hydrophobic)  slides after 
24 h in the presence glucose or ethanol as sole carbon source.  
 
 
 
 
           
a) St 53 biofilm formation in (MM Glc) on glass slide after 24 and 48 h 
 
            
b) St 53 biofilm formation in (MM Eth) on glass slide after 24 and 48 h 
 
EPS 
Bacteria 
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c) St 53 biofilm formation in (MM Glc) on plastic slide after 24 and 48 h 
 
 
 
 
 
 
       
d) St 53 biofilm formation in (MM Eth) on plastic slide after 24 and 48 h 
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e) Ps 3 biofilm formation in (MM Glc) on glass slide after 24 and 48 h 
 
 
 
 
            
f) Ps 3 biofilm formation in (MM Eth) on glass slide after 24 and 48 h 
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g) Ps 3 biofilm formation in (MM Glc) on plastic slide after 24 and 48 h 
 
 
 
       
h) Ps 3 biofilm formation in (MM Eth) on plastic slide after 24 and 48 h 
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i) St 9203 biofilm formation in (MM Glc) on glass slide after 24 and 48 h 
 
 
 
       
j) St 9203 biofilm formation in (MM Eth) on glass slide after 24 and 48 h 
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k) St 9203 biofilm formation in (MM Glc) on plastic slide after 24 and 48 h 
 
 
 
             
l) St 9203 biofilm formation in (MM Eth) on plastic slide after 24 and 48 h 
 
 
120 
 
            
m) Ps 10421 biofilm formation in (MM Glc) on glass slide after 24 and 48 h 
 
 
 
 
            
n) Ps 10421 biofilm formation in (MM Eth) on glass slide after 24 and 48 h 
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o) Ps 10421 biofilm formation in (MM Glc) on plastic slide after 24 and 48 h 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
p) Ps 10421 biofilm formation in (MM Eth) on plastic slide after 24 and 48 h 
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q) C. freundii biofilm formation in (MM Glc) on glass slide after 24 and 48 h 
 
  
       
 
 
r) C. freundii biofilm formation in (MM Eth) on glass slide after 24 and 48 h 
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s) C. freundii biofilm formation in (MM Glc) on plastic slide after 24 and 48 h 
 
 
 
 
 
 
            
t) C. freundii biofilm formation in (MM Eth) on plastic slide after 24 and 48 h 
 
 
St: Stenotrophomonas maltophilia, Ps: Pseudomonas aeruginosa and Citrobacter freundii 
Figure 5.16 Bacterial growths in MM Eth and MM Glc and biofilm formation on glass 
microscope slide and plastic slide (polystyrene) under low shear condition using DFR.    
a-d) St 53, e-h) Ps 3, i-l) St 9203, m-p)Ps 10421 and q-t) C. freundii. 
124 
 
5.2.9 Bacterial hydrophobicity 
Bacterial hydrophobicity has been associated with bacterial adhesion by a 
number of authors (Jones et al., 1996, Soo, 2012, Rosenberg and Doyle, 1990, 
Rozgonyi et al., 1985, Ljungh and Wadström, 1982). Several methods were used 
to analysis the hydrophobicity as described in section 4.7, Figure 5.17 illustrates 
the difference between hydrophobic and hydrophilic bacteria.  
 
Figure 5.17 Hydrophobic and hydrophilic bacteria after adding hydrocarbon and mixing. 
Phase separation in hydrophobic bacteria. 
 
5.2.9.1 MATH test 
The MATH test (Section 4.7.1) was used to study the effects of several 
factors (effects of growth media, suspension solution, and hydrocarbons) on the 
hydrophobicity of the cells. Results showed that after centrifugation and washing, 
suspension of the cells in PBS or KCl was more effective than TSB, also the use 
of hexadecane generated higher estimates of hydrophobicity than Tween 80 
(Figure 5.18a). Bacteria also demonstrated a greater hydrophobicity when grown 
in MM Eth. than when grown in MM Glc (Figure 5.18b). Overall the MATHs test 
for hydrophobicity was more effective when strains were grown in MM Eth, 
washed and resuspended in PBS or KCl, and hexadecane is used as the 
partitioning agent (Figure 5.18c). All strains were moderately hydrophobic with 
the exception of Ps 10421 which was strongly hydrophobic (Figure 5.18c) 
a 
Hydrophobic Hydrophilic 
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Figure 5.18 Effects of growth media, suspension solution, and hydrocarbons (Tween 80 
and hexadecane) on bacterial hydrophobicity. Error bars represent standard error of the mean 
of two replicates. a) Bacterial growth in TSB, washed and suspended in TSB and KCl,   b) 
Bacterial growth in MM Glc and MM Eth, washed and suspended in PBS and KCl. c) Bacterial 
growth in MM Eth and TSB, washed and suspended in KCl and PBS, respectively.  
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5.2.9.2 MATH test with salting out 
This approach was used to evaluate a range of partitioning substrates i.e. 
dodecane, Tween 80, xylene, and hexadecane. The tests showed that after washing 
cells in 10mM KCl and suspension in 2mM ammonium sulphate (prepared in 
10mM KCl buffer solution) hexadecane was the best of the three hydrocarbons 
evaluated (Figure 5.19). When hexadecane was used in the MATH test with 
salting out two strains (Pseudomonas aeruginosa 1 and 10421) were identified as 
strongly hydrophobic and the rest moderately hydrophobic.  
 
 
 
Figure 5.19 Comparing four different hydrocarbons in MATH salting out test after 
bacterial strains grown in TSB, washed by KCl and suspended in 2mM ammonium 
sulphate (prepared in 10mM potassium chloride buffer solution).  Error bars represent 
standard error of the mean of two replicates. 
 
 
5.2.9.3 The modified microbial adherence and aggregation (MAA) test 
As with previous methods this approach was optimised by using several 
suspension agents and hydrocarbons. As shown in (Figure 5.20), suspension in 
mineral media without carbon source and casein (MM) led to increase bacterial 
adherence to the hydrocarbon than other suspension solutions (Figure 5.20a). 
Hexadecane was more effective than Tween 80 for the evaluation of adherence 
by bacterial (Figure 5.20b). The effects of MM, MM Glc. and MM Eth. as 
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suspension solution were also studied, in some strains Stenotrophomonas 
maltophilia 9203 and Pseudomonas aeruginosa 5 there wasn’t any obvious 
difference between any of the suspension media, while in the other strains except 
C. freundi, MM led to increase adherence to hexadecane hydrocarbon and 
increase hydrophobicity. MM Glc. had a significant effect on bacterial adherence 
generating hydrophilic behaviour (0% hydrophobicity) in Stenotrophomonas 
maltophilia 51 and C. freundii (Figure 5.20c).  
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Figure 5.20 Modified MATH test, comparing suspension media and hydrocarbon. a) 
Effects of different suspension solution on bacterial adherence to Tween 80. b) Comparison 
between Tween 80 and hexadecane hydrocarbons on bacterial hydrophobicity. c) Effects of 
MM Glc, MM Eth and MM as a suspension on bacterial adherence to hexadecane. Error bars 
represent standard error of the mean of two replicates. 
 
 
5.2.9.4 Bacterial hydrophobicity by SAT test 
The salt aggregation test (SAT) were performed as described in Section 
4.7.4. In this test positive and negative results are recorded on the basis of 
aggregation or clumping of bacteria in the presence of ammonium sulphate 
(Figure 5.21). There were no obvious difference between SAT results in bacteria 
grown in MM Glc or MM Eth and the suspension of TSA grown bacteria in PBS. 
With one exception (Ps 5 grown on TSA) all P. aeruginosa strains demonstrated 
strong hydrophobicity using this method. Results for the S. maltophilia were more 
diverse with the type strain (St 9203) and St 18 demonstrating strong 
hydrophobicity, St 53 giving moderate results and St 51 being weakly 
hydrophobic. C. freundii was also weakly hydrophobic under all test conditions 
(Table 5.5). 
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Figure 5.21 SAT test represents positive and negative reaction of bacterial aggregation. 
 
 
Table 5.5 Hydrophobicity intensity comparisons between bacterial strains grow in MM 
Glc, MM Eth and bacterial suspension from TSA culture.  
 
Bacterial strains MM Glc MM Eth TSA 
St 18 0.75 (S) 0.75 (S) 0.75 (S) 
St 51 3 (W) 3 (W) 3 (W) 
St 53 2 (M) 2 (M) 2 (M) 
St 9203 0.007 (S) 0.007 (S) 0.007 (S) 
Ps 1 0.007 (S) 0.007 (S) 0.007 (S) 
Ps 3 0.007 (S) 0.007 (S) 0.007 (S) 
Ps 5 0.007 (S) 0.007 (S) 0.007 (S) 
Ps 10421 0.007 (S) 0.007 (S) 0.007 (S) 
C. freundii 4 (W) 3 (W) 4 (W) 
≤1 = (S) Strong hydrophobic, >1-≤2 = (M) Moderate hydrophobic, >2-≤4 = (W) Weak hydrophobic, 
>4= (H) Hydrophilic 
 
5.2.10 Comparison of hydrophobicity results with biofilm formation  
Having compiled all the different approaches to hydrophobicity alongside 
the biofilm formation data it is clear that there is no consistency between the 
hydrophobicity tests employed and that there is limited correlation between these 
tests and the ability of the bacteria studied to form biofilms  (Table 5.6). Attempts 
to make correlations between hydrophobicity and biofilm formation are 
complicated by the fact that across the bacteria studied growth media had a major 
impact on biofilm formation (Table 5.6) particularly in the case of S. maltophilia. 
Except biofilm formation in (MM Glc and MM Eth) and SAT test (MM Glc and 
Eth) were showed very high correlation.    
+ve -ve 
Bacterial aggregation 
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Table 5.6 Comparison and relation bacterial hydrophobicity tests and biofilm formation 
on 96 well plates using different methods and media. 
 
B
a
cteria
l stra
in
s 
Biofilm formation 96 well plate  
(different media) 
Hydrophobicity test  
(different methods) 
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M
 G
lc 
M
M
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ly
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M
 E
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A
T
H
 test 
M
A
T
H
 test 
S
a
ltin
g
 o
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t 
M
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ified
 
M
A
A
 
S
A
T
 (M
M
 
E
th
 o
r G
lc) 
St 18 N W M M S M M S S 
St 51 S S M W W M M M W 
St 53 S S M S S M M M M 
St 9203 S S S S S M M H S 
Ps 1 S S S S S M S S S 
Ps 3 S S S S S M M S S 
Ps 5 W W S S S M M M S 
Ps 
10421 
S S S S S S S S S 
C. 
freundii 
W W W S M M M H W 
 
H: Hydrophilic, N: No Biofilm W: Weak Biofilm or Hydrophobic, M: Moderate Biofilm or Hydrophobic and S: 
Strong Biofilm or Hydrophobic. 
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5.2.11 Discussion  
After confirming the identification of the bacterial strains under 
investigation (Section 5.1) the ability of these bacteria to form biofilms was 
investigated. The process of bacterial biofilm formation is influenced by various 
factors including nutrients level, temperature, incubation period, culture 
concentration. etc. (O'Toole et al., 2000). The microtiter plate assay employed in 
this study is a popular approach for the study of biofilm formation (O'Toole et al., 
2000). The use of this approach in this study showed that all bacterial strains 
produced biofilms in all media (TSB, SWF, MM Glc, MM Gly and MM Eth) with 
the exception of St 18 that failed to produce biofilm in TSB. In general the 
response in biofilm formation seen with increased ethanol concentration was 
similar to that observed with glucose and glycerol (Figures 5.8 to 5.10), which is 
an initial increase followed by a decrease at the higher concentrations. There were 
exceptions however, in the case of St 51 and 9203 biofilm formation declined with 
increasing ethanol concentration, which contrasts with Ps 10421 where biofilm 
formation increased across all ethanol concentrations (Figure 5.10).  The strength 
of these biofilms varied, however, from weak to strong (Figure 5.11). This 
approach also demonstrated that biofilm formation by the isolates under 
investigation was affected by inoculums size, nutrient concentration and 
composition (Figure 5.6). In most studies using the 96 well plate method for 
biofilm formation no data on the inoculum size is reported e.g. biofilm formation 
by Gram negative bacteria (Zubair et al., 2011), or Stenotrophomonas maltophilia 
(Huang et al., 2006), or Pseudomonas aeruginosa (Head and Yu, 2004).  
As demonstrated in this study, the strength of the biofilm rises with increasing 
initial inoculum size which agreed with previous studies on Staphylococci  
(Stepanović et al., 2007, Stepanović et al., 2003). The impact of inoculum size on 
biofilm formation may be in part explained by quorum sensing, which has been 
shown to be a key process in biofilm formation in Pseudomonas aeruginosa (Sifri, 
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2008). This observation indicates that an optimisation phase is needed prior to the 
presentation of results from this approach especially when comparing several 
bacteria. The strains used here also changed their biofilm formation behaviour in 
response to nutrient concentrations (carbon and nitrogen source) and the type of 
media being used (Figure 5.7-5.11) this observation agreed with previous studies 
on Citrobacter spp. (Allan et al., 2002) and Escherichia coli (Reisner et al., 2006, 
Davey and O'toole, 2000).  
The CRA assay was not successful in identifying biofilm formation, or the 
strength of that formation with a third of strains (33%) failing to produce biofilms 
(Figure 5.14). This finding shows that the CRA test produces a high number of 
false negatives. This observation has also been made in a number of previous 
studies (Mathur et al., 2006, Melo et al., 2013, Hassan et al., 2011). Consequently 
the CRA method was not used in the remainder of the study.  
When the bacterial strains were screened for pellicle formation only St 18   failed 
to produce a pellicle (Table 5.4) indicating that pellicle formation was a common 
capability of the Gram negative wound and mucous membrane associated 
pathogens. The ubiquity of pellicle formation amongst Gram negative pathogens 
has been reported in previous studies (Veeranagouda et al., 2011, Zogaj et al., 
2003). 
The major risk factor for Stenotrophomonas maltophilia, Pseudomonas 
aeruginosa and Citrobacter freundii infections in hospitalized patients is the 
implantation of medical devices such as urinary tract catheters, central venous 
catheters and prosthetic heart valves, and wound infections (Hill et al., 2010, 
Harrison‐Balestra et al., 2003, Di Bonaventura et al., 2004, Chen et al., 2013, 
Song et al., 2013). Evaluation of the biofilm formation capability by 
Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Citrobacter 
freundii  in this study indicated that these bacteria possess the capacity for biofilm 
formation on glass and plastic surfaces (Figure 5.16) as reported by (Jucker et al., 
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1996, Huang et al., 2006, Tran et al., 2014, Pereira et al., 2010). This indicates 
that these strains are able to adhere to implants and surfaces in healthcare 
environments and maintain a level of contamination through the formation of 
biofilms.   
Attachment to surface such as plastics has been associated with microbial surface 
hydrophobicity. Bacteria with the highest hydrophobicity usually show maximum 
capability of microbial adhesion on both hydrophobic and hydrophilic support 
surfaces (Liu et al., 2004). However, a screening of the various hydrophobicity 
tests available (Table 5.6) indicated that there is an issue with the reproducibility 
between methods and the correlation with biofilm formation. These issues have 
been raised by previous studies such as that of Krepsky et al. (2003) and Mattos-
Guaraldi et al. (1999). Selecting proper method for hydrophobicity may be 
consider key point to make correlation to biofilm formation. Among several 
methods for hydrophobicity only SAT test (MM Eth or MM Glc) were showed 
high correlation with biofilm formation in MM Eth and MM Glc.   In view of this 
the use of hydrophilic and hydrophobic surfaces in drip flow biofilm reactors (see 
section 5.2.8) may be provide further approach for the investigation of surface 
hydrophobicity.  
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5.2.12 Key finding 
According to parameters were used in this study: 
 The optimum inoculum size for the screening of biofilm formation is 1-5x107 
cells/ml; 
 The optimum carbon source concentration for the screening of biofilm 
formation is 10 g/l of glucose (Except for Pseudomonas which is 20g/l), 10 
g/l of glycerol and 13.4 ml/l (10.57 g/l) of ethanol with 1g/l casein as a 
nitrogen source; 
 Bacteria can grow and form biofilms (weak to strong) on a wide range of 
carbon source such as glucose, glycerol and ethanol; 
 Bacterial growth does not always lead to biofilm formation; 
 The Congo red agar test underestimates the ability to form biofilms amongst 
bacteria; 
 Pellicle formation is effected by the type of media  
 Pellicle formation is a common capability of Gram negative pathogens; 
 Bacterial strains (St 53, 9203, Ps 3, 10421 and C. freundii) produce biofilms on 
both glass and polystyrene under low shear condition when grown on MM Glc. 
and MM Eth. Media; 
 Most of the approaches available to determine bacterial surface hydrophobicity 
are unreliable and fail to correlate with biofilm formation except (SAT test).  
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5.3 EPS production and characterisation  
This chapter focuses on the generation of EPS by those bacteria identified 
as the strongest biofilm producers (See section 5.2). It also covers media 
development and the characterisation of the EPS produced. The research reported 
on media development and associated growth and EPS production was carried out 
on Stenotrophomonas maltophilia 53 and Pseudomonas aeruginosa 3. 
5.3.1 Media selection 
A range of media were investigated for their ability to support EPS 
investigations. In order to do this media were processed via the EPS extraction 
and analysis procedure outlined in section 4.12 before they were used to grow 
bacteria. As shown in (Figure 5.22), the anomeric region of the proton NMR 
showed that TSB and LB broth both contained EPS equivalent components that 
would have interfered with the analysis of bacterial EPS. In addition to the 
presence of significant amounts of tryptone in both media, TSB also contained 
soybean meal while LB contained yeast extract. SWF on the other hand did not 
generate any EPS signals during proton NMR analysis, however it did generate a 
large amount of crude substance (3.55 g/l) that could mask EPS production by the 
bacteria under investigation. Analysis of this crude extract for carbohydrates and 
proteins indicated that it contained 9.3% w/w carbohydrate and 28.6 % w/w 
protein (Table 5.7). In addition, monomer analysis of the SWF crude substance 
(EPS) showed the presence of several sugars (Figure 5.22). In view of these results 
TSB, LB and SWF were rejected as candidate media for EPS characterisation 
studies.  
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Figure 5.22 NMR analysis and monomer analysis of different media. a) Proton NMR 
analysis and monomer analysis of different media (TSB, SWF and LB) showing the signal 
spectra of EPS in the anomeric region in TSB and LB broth media b) Crude substance (EPS) 
extracted from SWF medium c) monomer analysis of EPS extracted from SWF medium shows 
present of   Rhamnose (Rha), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc) and 
Mannose (Man). 
Anomeric 
region  
TSB 
SWF 
LB 
 
a 
b 
c 
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 5.3.2 Development of EPS free media and growth optimisation  
As described in Chapter 6, several mineral media were prepared and 
optimised for biofilm formation as well as EPS production and characterisation. 
Mineral media with different carbon source were investigated for compounds that 
would generate NMR signals in the anomeric (EPS) region. In order to do this 
500ml of each media was processed for EPS analysis (Section 4.12) with and 
without TCA treatment. The resulting crude substance ranged from 1 to 2 mg and 
the associated proton NMR analysis showed no interfering peaks in the anomeric 
region (Figure 5.23). The extracted crude substance was also checked for 
carbohydrate and protein content with the exception of MM Glc all media extracts 
were soluble carbohydrate and protein free. In the case of MM Glc, 0.001% w/w 
protein was detected (Table 5.7). 
 
 
Figure 5.23 Proton NMR analysis of different modified carbon source mineral media 
treated with 0 and 5% TCA shows free EPS spectra in the anomeric region.  
 
MM Glc, 5%TCA 
MM Gly, 0%TCA 
MM Eth, 5%TCA 
MM Eth, 0%TCA 
Anomeric 
region  
MM Gly, 5%TCA 
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Table 5.7 Carbohydrate and protein analysis of the crude substance extracted from 
several media (without bacterial inoculation).  
 
Media TCA% Carbohydrate content (%) Protein content (%) 
*TSB 5 - - 
SWF 5 9.3 28.6 
*LB 5 - - 
MM Glc 5 0 0.001 
MM Gly 5 0 0 
MM Gly 0 0 0 
MM Eth 5 0 0 
MM Eth 0 0 0 
 
*Carbohydrate and protein test were not performed  
 
EPS production was optimised on the basis of inoculum size, incubation 
temperature, incubation time and the concentration of TCA used in the EPS 
extraction process (TCA is employed to remove proteins). When bacteria were 
grown on MM Eth, the total carbohydrate concentration was equal to the 
polysaccharide (EPS) concentration, however when grown on MM Glc, the 
polysaccharide (EPS) concentration was calculated by subtracting the total 
carbohydrate concentration from the glucose concentration. 
 
5.3.3 Stenotrophomonas maltophilia 53 EPS production optimisation. 
When grown at 37˚C for more than 80 h in MM Glc broth using a 104 
CFU/ml as starting concentration. St 53 demonstrated poor growth with >60% of 
glucose remaining unused and approximately 74.07 mg/l of polysaccharide (EPS) 
produced (Figure 5.24a). When the initial inoculum was increased to 107 CFU/ml 
and incubated at 37 and 30˚C for 80h all the glucose was metabolised and 
approximately 558 and 948 mg/l polysaccharide was produced (Figure 5.24 b & 
c).  
139 
 
 
 
 
 
Figure 5.24    Glucose utilisation and polysaccharide formation during growth of  
Stenotrophomonas maltophilia 53 on MM Glc (10g/l) at different inoculum culture size and 
temperature a) 104 CFU /ml, 37˚C, b) 107 CFU /ml, 37˚C, c) 107 CFU /ml, 30˚C. 
0
10
20
30
40
50
60
70
80
0
2
4
6
8
10
12
0 20 40 60 80 100
P
o
ly
sa
cc
h
ar
id
e
 (
m
g/
l)
Lo
g 
b
ac
te
ri
al
 n
o
. (
C
FU
/m
l)
To
ta
l c
ar
b
o
h
yd
ra
te
 (
g/
l)
G
lu
co
se
  (
g/
l)
Times (h)a
Bacterial growth Glucose Total carbohydrate Polysaccharide
0
100
200
300
400
500
600
0
2
4
6
8
10
12
0 20 40 60 80 100
P
o
ly
sa
cc
h
ar
id
e
 (
m
g/
l)
Lo
g 
b
ac
te
ri
al
 n
o
. 
(C
FU
/m
l)
To
ta
l c
ar
b
o
h
yd
ra
te
 (
g/
l)
G
lu
co
se
  (
g/
l)
Times (h)b
Bacterial growth Glucose Total carbohydrate Polysaccharide
0
200
400
600
800
1000
1200
0
2
4
6
8
10
12
0 20 40 60 80 100
P
o
ly
sa
cc
h
ar
id
e
 (
m
g/
l)
Lo
g 
b
ac
te
ri
al
 n
o
. 
C
FU
/m
l
To
ta
l c
ar
b
o
h
yd
ra
te
 (
g/
l)
G
lu
co
se
  (
g/
l)
Times (h)c
Bacterial growth Glucose Total carbohydrate Polysaccharide
140 
 
When grown on MM Eth, St 53 (37˚C, 80 h) generated approximately 29.4 
mg/l polysaccharide during growth when a 104 CFU /ml starting inoculum was 
employed. Increasing the inoculum size to 107CFU/ml resulted in an increase of 
polysaccharide production to 109 mg/l after 72-96 h at 37°C (Figure 5.25 a & b). 
Using the same starting inoculum but a reducing the incubation temperature to 
30°C resulted in 125 mg/l polysaccharides being produced after 80 h of incubation 
which increased to 129.8 mg/l after 96 h of incubation (Figure 5.25 c). Under all 
condition (104 or 107 CFU/ml starting inoculum and incubation temperature at 30 
or 37˚C) ethanol were completely consumed by the bacteria within 48 h. 
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Figure  5.25   Ethanol utilisation and polysaccharide formation during growth of  St  53 
on MM Eth (10.57 g/l) at different inoculum culture size and temperature a) 104 CFU /ml, 
37˚C, b) 107 CFU /ml, 37˚C, c) 107 CFU /ml, 30˚C. 
 
5.3.4 Pseudomonas aeruginosa 3 EPS production optimisation 
Ps 3 also produced more polysaccharides (594.0 mg/l) at 30˚C using a 107 
CFU/ml inoculum size (Figure 5.26c) than when grown at 37˚C using either a 104 
(97.9 mg/l) or 107 CFU/ml (498.2 mg/l) (Figure 5.26 a & b). Approximately 55% 
of the available glucose remained un-degraded after 96 h of incubation when an 
initial inoculum of 104 CFU/ml was used. 
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Figure 5.26 Polysaccharides production and glucose utilisation during Ps 3 growth on MM 
Glc (10g/l glucose) at different initial inoculum size and temperature a) 104 CFU /ml, 37˚C, 
b) 107 CFU /ml, 37˚C, c) 107 CFU /ml, 30˚C. 
 
When grown on MM Eth at 37˚C and an initial inoculum of 104 CFU/ml 
Ps 3 generated 77.0 mg/l after 72 h of incubation. As before increasing the initial 
inoculum size to 107 CFU/ml increased the amount of polysaccharide generated 
at both 37˚C (95.0 mg/l) and 30˚C (119 mg/l) (Figure 5.27). In all cases the ethanol 
feed was depleted within 48 h of incubation.  
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Figure  5.27 Ethanol utilisation and polysaccharide formation during growth of  Ps 3 on 
MM Eth (10.57 g/l) at different inoculum culture size and temperature a) 104 CFU /ml, 
37˚C, b) 107 CFU /ml, 37˚C, c) 107 CFU /ml, 30˚C. 
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5.3.5 MM Glc and MM Eth control 
Sterile media control incubations were established to ensure there were no 
abiotic losses of glucose or ethanol from the two media employed (Figure 5.28).  
 
 
Figure 5.28 Control curve of glucose and ethanol estimation within MM Glc (10 g/l 
glucose) and MM Eth (10.57 g/l ethanol) without any bacterial inoculation at 37˚C for 96 
h. 
 
5.3.6 Optimisation and analysis of bacterial EPS production 
After the extraction of EPS from the broth cultures the material was 
analysed for the presence of carbohydrate, protein and uronic acid. The material 
was then subjected to structural analysis via proton NMR and HPAC-PAD as 
described in Sections 4.12.8 and 4.12.19 respectively. 
5.3.6.1 NMR analysis of Pseudomonas aeruginosa 3 EPS 
EPS production and extraction were optimised by varying a range of 
growth and extraction parameters (Figure 5.29). When MM Glc was inoculated 
with 104 CFU/ml of Ps 3 and incubated for 48 h at 37°C and then treated with 
14% TCA (to precipitate protein),  18 mg/l of crude product was recovered. 
However, when subjected to proton NMR analysis the material failed to generate 
any signals in the anomeric region (figure 5.29a).  When the incubation period 
was increased to 72 h or the TCA concentration decreased to 10%, peaks in the 
anomeric region indicative of the presence of EPS were seen (Figure 5.29 b & c).  
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Figure 5.29 Proton NMR analysis of extracted EPS from Ps 3 grow on MM Glc at different 
inoculum size, incubation period, incubation temperature and TCA concentration 
treatment. All NMR recorded in D2O at 70˚C. 
 
By increasing the initial inoculum size to 107 CFU/ml and employing 10% TCA 
(w/v) in the extraction process, similar EPS spectra were generated from broths 
grown at both 30 and 37˚C (Figure 5.29 d & e ). However, more product was 
generated at 30˚C than 37˚C (Table 5.8). Further increases in incubation time up 
to 96 h at 30˚C with 0 and 5% TCA concentrations resulted in a degradation of 
the NMR spectra and a reduction in the amount of crude substance recovered 
(Figure 5.29 f, g, i & j) (Table 5.8). Consequently, the optimum growth and 
extraction conditions for Ps 3 grown on MM Glc (Figure 5.29 h) (Table 5.8) were 
30˚C, 72h and 5% TCA. 
a) 104 CFU/ml, 48h, 37˚C, 14%TCA 
b) 104 CFU/ml, 72h, 37˚C, 14%TCA 
c) 104 CFU/ml, 72h, 37˚C, 10%TCA 
d) 107 CFU/ml, 72h, 37˚C, 10%TCA 
j) 107 CFU/ml, 96h, 30˚C, 0%TCA 
i) 107 CFU/ml, 96h, 30˚C, 5%TCA 
f) 107 CFU/ml, 72h, 30˚C, 5%TCA 
g) 107 CFU/ml, 72h, 30˚C, 0%TCA 
e) 107 CFU/ml, 72h, 30˚C, 10%TCA 
h) 107 CFU/ml, 80h, 30˚C, 0%TCA 
Anomeric 
region 
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Table 5.8 Conditions, characteristics and analysis of the crude substance (EPS) produced 
by Ps 3 on different carbon source mineral media. 
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a 
MM 
Glc 
37 48 14 18  16.13 0.35 0 0.00 
b 37 72 14 22.2 19.33 0.60 0 0.07 
c 37 72 10 29.4 24.38 0.85 0 0.62 
d 37 72 10 35 29.23 0.85 0 0.92 
e 30 72 10 33 32.11 0.98 0 1.17 
f 30 72 5 44 53.56 0.98 0 1.17 
g 30 72 0 56.4 49.12 1.73 0 0.52 
h 30 80 0 59.6 50.15 1.98 0 1.22 
i 30 96 5 26.4 25.10 1.23 0 1.12 
j 30 96 0 36.4 26.55 2.35 0 0.52 
k MM 
Gly 
30 72 5 29 25.10 3.60 0 2.02 
l 30 72 0 55 34.48 4.98 0 1.12 
m MM 
Eth 
30 72 5 30.2 21.80 2.48 0 1.42 
n 30 72 0 51.6 33.76 3.10 0 1.02 
 
The process carried out for Ps 3 grown on MM Glc was repeated with MM 
Gly and MM Eth (Figure 5.30, Table 5.8).  There are not any obvious difference 
in the presence of peaks when 0 or 5% TCA were used to treat EPS extracted from 
MM Gly grown cultures although the peaks were stronger in the absence of TCA 
(Figure 5.30 k & l). In the case of MM Eth grown cultures the use of 5% TCA 
resulted in a less diverse spectra when compared to treatment without TCA 
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(Figure 5.30 m & n, Table 5.2). In both cases (MM Gly and MM Eth) the absence 
of TCA treatment increased the amount of crude substance and the amounts of 
protein and carbohydrate present in the material recovered from the broths (Table 
5.8). 
Figure 5.30 Proton NMR analysis of extracted EPS from Ps 3 grow on different media for 
72h with different TCA concentration treatment. k & l) MM Glycerol  and m & n) MM 
Ethanol. All NMR recorded in D2O at 70˚C. 
 
5.3.6.2 NMR analysis of Stenotrophomonas maltophilia 53 EPS 
The optimisation of EPS production and extraction from St 53 was carried 
out in the same manner as that outlined above for Ps 3. However, in this case 
(Figure 5.31) when grown on MM Glc the use of 10% TCA reduced the diversity 
of the spectra when compared to the extracts generated when 0 or 5% TCA was 
used (Table 5.9). Also the amount of crude extract generated with 10% TCA was 
lower than that seen with 5 and 0%, in addition the amount of carbohydrate 
k) 107 CFU/ml, 72h, 30˚C, 5%TCA 
l) 107 CFU/ml, 72˚h, 30C, 0%TCA 
m) 107 CFU/ml, 72h, 30˚C, 5%TCA 
n) 107 CFU/ml, 72h, 30˚C, 0%TCA 
Anomeric 
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present in the extract was actually lower (Table 5.9). The amount of EPS 
recovered decreased when the incubation period was extended to 96 h and this 
decrease was associated with a loss of diversity in the NMR signal spectra in 
anomeric region. When MM Gly and MM Eth were used the only main 
observation was the loss of spectral diversity when 5% TCA was used along with 
MM Gly (Figure 5.31 f). Generally speaking the spectra and compositions of the 
EPS did not differ markedly between EPS treated with and without TCA when 
the same growth conditions were used. 
Figure 5.31 Proton NMR analysis of extracted EPS from St 53 grow on different carbon 
source mineral media, inoculum size, incubation period, incubation temperature and 
TCA concentration treatment. a-e) MM Glc, f & g) MM Gly and h & i) MM Eth. All NMR 
recorded in D2O at 70˚C. 
 
a) 107 CFU/ml, 72h, 37˚C, 10%TCA 
b) 107 CFU/ml, 72h, 30˚C, 5%TCA 
c) 107 CFU/ml, 72h, 30˚C, 0%TCA 
d) 107 CFU/ml, 80h, 30˚C, 5%TCA 
f) 107 CFU/ml, 72h, 30˚C, 5%TCA 
g) 107 CFU/ml, 72h, 30˚C, 0%TCA 
h) 107 CFU/ml, 72h, 30˚C, 5%TCA 
i) 107 CFU/ml, 72h, 30˚C, 0%TCA 
e) 107 CFU/ml, 96h, 30˚C, 0%TCA 
Anomeric 
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Table 5.9 Conditions, characteristics and analysis of the crude substance (EPS) produced 
by St 53 on different carbon source mineral media. 
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a 
MM 
Glc 
37 72 10 20.05 28.40 0.35 0 1.87 
b 30 72 5 31 41.91 0.73 0 1.97 
c 30 72 0 38.8 47.16 2.35 0 1.42 
d 30 80 5 43.8 56.55 0.85 0 2.02 
e 30 96 0 39 42.42 2.73 0 1.37 
f MM 
Gly 
30 72 5 30 43.97 4.10 0 1.27 
g 30 72 0 42.2 47.37 4.98 0 1.42 
h MM 
Eth 
30 72 5 24.4 45.31 1.10 0 1.87 
i 30 72 0 36.4 51.91 1.98 0 2.22 
 
 
5.3.6.3 NMR analysis of C. freundii EPS 
The optimisation of EPS production and extraction from C. freundii was 
carried out in the same manner as that outlined above for Ps 3 and St 53. However 
in the case of C. freundii successful NMR spectra were only generated when the 
bacteria was grown on MM Glc (Figure 5.32) even though crude extract with a 
significant carbohydrate content was generated with other media (Table 5.10). 
This poor NMR performance may be due to the crude extract having a low 
solubility and does not necessarily mean that no EPS was generated. EPS 
production and extraction on MM Glc was more effective after 80 h than 96 h an 
observation that is common across all three bacteria investigated. The use of 5% 
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TCA caused the disappearance of some peaks in anomeric region (Figure 5.32, 
Table 5.10). 
 
Table 5.10 Conditions, characteristics and analysis of the crude substance (EPS) produced 
by C. freundii on different carbon source mineral media 
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a 
MM 
Glc. 
30 80 5 28.2 46.55 1.73 0 1.47 
b 30 80 0 46.2 52.73 2.48 0 1.62 
c 30 96 5 27.6 33.66 2.10 0 1.47 
d 30 96 0 44.2 35.82 3.48 0 1.42 
e MM 
Gly. 
30 80 5 22 49.23 1.23 0 0.82 
f 30 80 0 30 54.28 1.85 0 1.02 
g MM 
Eth. 
30 80 5 30.6 39.54 0.98 0 0.72 
h 30 80 0 38 42.73 1.60 0 0.67 
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Figure 5.32 Proton NMR analysis of extracted EPS from C. freundii grow on different 
carbon source mineral media, incubation period, and TCA concentration treatment. a-d) 
MM Glc, e & f) MM Glc and g & h) MM Eth. All NMR recorded in D2O at 70°C. 
 
5.3.7. EPS monomer analysis  
5.3.7.1 Ps 3 EPS monomer analysis  
After hydrolysis, the monosaccharide composition of the EPS was 
analysed by HPAEC-PAD as described in Section 4.12.9 (Figure 5.33). Ps 3 EPS 
grown on MM Glc (107 CFU/ml, 30 C, 72 h, 5% TCA) was 67.49 % neutral sugar 
with some uronic acid and an additional unidentified neutral sugar. While the 
polysaccharide content in the EPS not treated with TCA was about 52.38% neutral 
sugar. These overall sugar compositions are greater than the carbohydrate 
estimates generated by the phenol sulphuric acid method (Table 5.8) this reflects 
a) 107 CFU/ml, 80h, 30C, 5%TCA 
b) 107 CFU/ml, 80h, 30C, 0%TCA 
e) 107 CFU/ml, 80h, 30C, 5%TCA 
c) 107 CFU/ml, 96h, 30C, 5%TCA 
d) 107 CFU/ml, 96h, 30C, 0%TCA 
f) 107 CFU/ml, 80h, 30C, 0%TCA 
h) 107 CFU/ml, 80h, 30C, 0%TCA 
g) 107 CFU/ml, 80h, 30C, 5%TCA 
Anomeric 
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the greater accuracy of the monomer analysis and the fact that the phenol method 
can only be calibrated against a single carbohydrate. 
The composition of TCA treated EPS was dominated by glucose (61.18%) 
with lesser amounts of rhamnose, glucosamine and mannose while the non TCA 
treated EPS also contained the same composition plus trace amounts of galactose 
(Figure 5.34). 
 
 
 
Unknown (unkn), Rhamnose (Rha), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc), Mannose (Man) and Uronic acid 
(UA). 
Figure 5.33 HPAEC-PAD monomer analysis of Ps 3 extracted EPS on MM Glucose 
(107CFU/ml as initial culture) after 72 h incubation at 30˚C treated with a) 5%TCA b) 
0%TCA. 
 
 
a 
b 
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Under same condition but with an increased incubation period (107 CFU/ml, 30 
˚C, 80 h, without TCA treatment) on MM Glc, Ps 3 produced more crude 
substance than 72 h (Table 5.8) and with the same general composition (Figure 
5.36). 
The EPS neutral sugar content of the material extracted from MM Gly and 
MM Eth with 5% TCA were 28.6 and 25.42% with additional uronic acids and an 
additional unidentified neutral sugar. The neutral sugar content of the EPS 
extracted without TCA treatment increased to 40.95% on MM Gly and 60.95% 
on MM Eth. This is the opposite to that seen when Ps 3 was grown on MM Glc, 
suggesting that the TCA treatment was degrading the EPS generated when Ps 3 
was grown on MM Gly and MM Eth. This is supported by the fact that the glucose 
and mannose concentrations within EPS extracted from MM Gly cultures 
decreased after treatment with TCA from 20.62 and 11.15% to 13.58 and 5.67% 
respectively, while the rhammnose and galactose contents remain the same. The 
same trend is seen in MM Eth grown cultures where all sugar components within 
the EPS decreased with TCA treatment.   
 
5.3.7.2 St 53 EPS monomer analysis  
In the case of St 53 the use of 5% TCA in the extraction process had a 
significant impact on the amount and composition of the EPS extracted (Figure 
5.34 and 5.35). In all cases the use of 5% TCA increased the overall amount of 
sugars recovered on all mineral media. The use of TCA changed the relative 
compositions of the recovered EPS for example in the presence of TCA glucose 
(21.08%) and mannose (16.34) were the main components on all mineral media 
(Figure 5.34). When the TCA treatment was excluded glucose (23.19%) and 
galactosamine (14.27%) became the main components of the EPS extracted MM 
Glc grown cultures. This changed with the MM Eth grown cultures where the 
absence of TCA resulted in an EPS dominated by approximately equal amounts 
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of glucose (15.44%) and mannose (15.26%).  The analysis of the EPS from MM 
Gly grown cultures extracted in the absence of TCA also showed glucose and 
mannose to be the main components (Figure 5.34). When incubation for 80 h (107 
CFU/ml, 30°C, 5%TCA treatment) on MM Glc, St 53 (Figure 5.36) produced 
more crude substance than 72 h (Table 5.8) and with the same general 
composition. 
 
 
 
Unknown (unkn), Fucose (Fuc), Galactosamine (GalN), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc) Mannose (Man) 
and Uronic acid (UA)  
Figure 5.35 HPAEC-PAD monomer analysis of extracted EPS from St 53 growth on MM 
Glucose (107 CFU/ml as initial culture) after 72 h incubation at 30˚C treated with a) 
5%TCA b) 0%TCA.  
 
 
a 
b 
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Figure 5.36 Bacterial EPS composition analysed by HPAEC-PAD after bacterial growth 
in MM Glc for 80 h at 30˚C with 107 CFU/ml as initial culture.  a) Ps 3 EPS treated with 0% 
TCA and b) St 53 EPS treated with 5% TCA. 
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Figure 5.34 HPAEC-PAD monomers analysis of Ps 3 and St 53 extracted EPS (after 72 h incubation at 30 C) on different carbon source 
mineral media treated with 5% TCA (inner circle) and 0% TCA (outer circle).   a) Ps 3 EPS on MM Glc  b) Ps 3 EPS on MM Gly c) Ps 3 EPS 
on MM Eth d) St 53 EPS on MM Glc  e) St 53 EPS on MM Gly f) St 53 EPS on MM Eth.
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5.3.7.3 C. freundii EPS monomer analysis 
Monomer analysis showed several sugars within the EPS of C. freundii 
(Figure 5.37). Glucose and mannose were the major components present in 
extracts from all media (MM Glc, MM Gly and MM Eth) (Table 5.11). The total 
sugar content of EPS extracted from MM Gly cultures (with the exception of 
unknown peaks) were higher at 66.56% than seen on the other media (Table 5.11). 
The use of TCA slightly changed some of compositions of the recovered EPS 
from MM Eth but with the same amounts (Table 5.11). 
  
 
Unknown (unkn), Galactosamine (GalN), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc) Mannose (Man) and Uronic 
acid (UA). * Peaks from program (not sugars). 
Figure 5.37 HPAEC-PAD monomer analysis of extracted EPS from C. freundii growth on 
MM Glucose (107 CFU/ml as initial culture) after 80 h incubation at 30˚C treated with 0% 
TCA. 
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Table 5.11 HPAEC-PAD monomers analysis of C. freundii extracted EPS (%) on different 
carbon source mineral media. 
Media 
T
C
A
 %
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O
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*MM Glc 0 5.4 0.00 0.59 6.49 33.03 13.34 41.14 
*MM Gly 0 2.92 0.46 0.53 0.91 38.44 23.31 33.44 
MM Eth 0 3.59 0.41 0.44 5.15 31.66 10.08 48.66 
MM Eth 5% 5.39 0.61 0.67 7.72 47.50 15.13 48.67 
*The data for 5% TCA are not studied    
 5.3.8 Presence of alginate within the Ps 3 EPS 
Alginate is a common EPS generated by some Pseudomonas species. In 
order to check to see if Ps 3 generated an alginate the Ps 3 EPS was compared 
with an alginate (Protanal LF 240 D from algae source) via monomer analysis 
using HPAEC-PAD. In addition hydrolysed alginate and hydrolysed Ps 3 EPS 
were mixed and analysed via monomer analysis. The monomer analysis indicated 
that the Ps 3 EPS did not share any peaks with the alginate and therefore did not 
contain any alginate components (Figure 5.38). 
 
 
a 
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Unknown (unkn), Rhamnose (Rha), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc) Mannose (Man), Uronic acid (UA), 
Guluronic acid (GulA) and Mannuronic acid (ManA) 
Figure 5.38 HPAEC-PAD monomer analysis of extracted Ps 3 EPS compared and spiked 
with alginate a) Alginate b) Ps 3 EPS c) Ps 3 EPS mixed with alginate and the peaks referred 
to unknown UA because they are not spiked with alginate components peaks. 
 
5.3.9 Dextran production by St 53, Ps3 and C. freundii 
Whilst bacterial EPS generally generate peak in the anomeric region of a 
proton NMR spectra, it was noticed that the EPS spectra produced by St 53, Ps3 
and C. freundii contained peaks in other regions of the spectra that were consistent 
with polysaccharide dextran (Figure 5.39).  
 
 
b 
c 
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I) MM Glc, II) MM Gly and III) MM Eth   
Figure 5.39 Proton NMR analysis spectra of the dextran as control compared to  extracted 
EPS from different bacteria after growing on different carbon sources mineral media a) 
St 53, b)Ps 3 and c) C. freundii . All NMR recorded in D2O at 70˚C. 
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In order to confirm the presence of dextran, a dextranase treatment process 
was employed (Section 4.12.10). Initially the dextranase enzyme was investigated 
via proton NMR to ensure no interfering compounds were present in the enzyme 
powder. Analysis of the dextranase before and after dialysis found no interfering 
spectral peaks in the region associated with dextran polymer (Figure 5.40). 
 
Figure 5.40 Proton NMR analysis spectra of the dextranase enzyme.  a) Before dialysis b) 
after dialysis. All NMR recorded in D2O at 70˚C.  
Once the possibility of interference had been ruled out, the impact of the 
dextranase was first tested on a commercial dextran, as shown in Figure 5.41 the 
enzyme treatment removed all the peaks associated with the dextran polymer.  
Proton NMR spectra of dextranase treated  EPS from Ps 3 grown on MM Eth and 
MM Gly, and  St 53 and C. freundii grown on MM Eth resulted in the loss of 
NMR spectral peaks associated with dextran (Figure 5.42 and 5.43). This 
treatment did not completely remove all indications of an EPS from the NMR 
spectra, rather the remaining spectral peaks provided evidence that these bacteria 
(Ps 3, St 53 and C. freundii) produced a complex EPS that may be composed of 
two polysaccharides and that one of them has dextran like properties (Figure 5.42 
and 5.43). 
 
 a 
b 
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Figure 5.41 Proton NMR analysis spectra of the dextranase enzyme effects on dextran 
after dialysis.  a) Dextran prior to enzyme treatment b) Dextran after enzyme treatment. All 
NMR recorded in D2O at 70˚C. 
 
 
*    EPS Dextran peaks. 
 **   Post EPS dextran treatment with dextranase shows vanishing dextran peaks. 
Figure 5.42 1H-NMR spectra of Gram negative bacterial EPS in mineral media containing 
ethanol as a sole carbon source with and without dextranase treatment after incubation 
for 80h. Spectra are representative of:  un-inoculated control media (A), analytical grade 
A 
C 
B 
E 
D 
HOD 
F 
a 
b 
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dextran (B), Stenotrophomonas maltophilia strain 53 (C&D) and Citrobacter freundii strain 
SA79 (E&F). All NMR recorded in D2O at 70˚C. 
 
 
*    EPS Dextran peaks. 
 **   Post EPS dextran treatment with dextranase shows vanishing dextran peaks. 
Figure 5.43 1H-NMR spectra of Pseudomonas aeruginosa strain (Ps3) EPS in mineral 
media containing ethanol, glycerol or glucose as a sole carbon source with and without 
dextranase treatment after incubation for 80h. Spectra are representative of:  analytical 
grade dextran (A), Ps3 EPS in MM Eth (B&C), Ps3 in MM Gly (D&E) and Ps3 in MM Glc 
(F&G). All NMR recorded in D2O at 70˚C.  
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5.3.9.1 Monomer analysis of dextranase treated EPS  
Monomer analysis of the dextranase treated EPS generated by Ps 3 grown 
on MM Eth, MM Gly and MM Glc and St 53 and C. freundii grown on MM Eth 
showed that the removal of the dextran like polymer resulted in a shift from a 
glucose rich polymer to one high in mannose (Figure 5.44, Table 5.12).  
 
 
 
Unknown (unkn), Rhamnose (Rha), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc) Mannose (Man), Uronic acid (UA), 
Guluronic acid (GulA) and Mannuronic acid (ManA). *Peaks of program (not sugar peaks).  
Figure 5.44 HPAEC-PAD monomer analysis of extracted EPS from Ps 3 growth on MM 
Glycerol after dialysis. a) prior to dextranase treatment b) after dextranase treatment. 
 
 
 
a 
b 
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Table 5.12 HPAEC-PAD monomer analysis of prior and post enzyme dextranase 
treatment of extracted EPS from Ps 3, St 53 and C. freundii.  
Bacterial 
strains 
Media Dextranase 
Neutral sugar composition of EPS (%) 
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Dextranase 
enzyme 
UPW 
* 
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Ps 3 MM 
Eth 
Untreated 0.00 0.00 7.67 0.99 0.00 64.71 26.62 
Treated 0.00 0.00 11.37 2.73 0.45 5.99 79.46 
Ps 3 MM 
Gly 
Untreated 0.00 0.00 27.78 6.12 0.43 44.03 21.56 
Treated 0.00 0.00 8.81 2.50 2.91 8.01 77.76 
Ps 3 MM 
Glc 
Untreated 0.00 0.00 1.37 0.70 0.00 91.08 6.85 
Treated 0.00 0.00 5.94 2.11 0.44 7.28 84.24 
St 53 MM 
Eth 
Untreated 19.79 19.09 0.00 2.75 1.98 28.89 27.50 
Treated 7.06 6.48 0.00 1.78 0.57 2.22 81.89 
C. freundii MM 
Eth 
Untreated 0.00 7.00 0.79 0.86 10.03 61.68 19.64 
Treated 0.00 0.58 1.10 4.14 1.08 5.40 87.71 
 
* After dialysis analysed directly by HPAEC 
 
5.3.9.2 Acinetobacter baumanni EPS analysis (negative control) 
In contrast to Ps 3, St 53 and C. freundii (Figure 5.42 and 5.43), proton NMR 
analysis showed that the EPS generated by both Acinetobacter baumanni 882 and 
Clone 1 strains showed no evidence of dextran indicating that not all Gram 
negative bacteria generated dextran like polymers in their EPS.  Additionally 
monomer analysis showed that mannose was the dominant sugar (Figure 5.45) 
rather than glucose.  
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Unknown (unkn), Galactosamine (GalN), Glucosamine (GlcN), Galactose (Gal), Glucose (Glc) and Mannose (Man). 
Figure 5.45 Proton NMR and HPAEC-PAD monomer analysis of extracted Acinetobacter 
baumanni EPS without dextranase treatment.  a) Proton NMR analysis of 882 clone 1 strains 
EPS compared to dextran control, b) Monomer analysis of 882 strain EPS c) Monomer analysis 
of clone 1 strain EPS.  
a 
b 
c 
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5.3.10 FTIR spectra of EPS 
  EPS crude extracts from St 53, Ps 3 and C. freundii were analysed by 
FTIR with the focus on the characteristic spectral region of 4000–400 cm–1 (see 
appendix). As shown in Figure 5.46 all samples contained absorption bands 
indicative of the presence of hydroxyl group (–OH), amine (N-H), carboxylic acid 
(COOH) or (C (O) OH), amide groups (C=O) and ether (C-O or C-O-C). Spectra 
around 3300 indicate the presence of (O-H) and (N-H) groups (Batool et al., 2015, 
Mangwani et al., 2014, Mahapatra and Ramachandra, 2013) while the weak band 
near 2925 cm–1  is attributed to methylene (C–H) vibrations (Batool et al., 2015, 
Manuzon, 2009, Mangwani et al., 2014, Sathiyanarayanan et al., 2015, Mahapatra 
and Ramachandra, 2013). Another spectral brand around 2357 & 2330 cm–1  
indicated to the presence of atmospheric CO2 and adsorbed water (Xueref and 
Dominé, 2003, McGoron et al., 2009, Mahapatra and Ramachandra, 2013). Bands 
between  ~ 1740–1640 cm–1 are due to the presence of (C=O) vibrations in esters 
or fatty acids of lipids (Mahapatra and Ramachandra, 2013). Two signals near 
1633 cm–1 (amide I) and 1538 cm–1 (amide II) represents (N-H) bending of protein 
(Batool et al., 2015, Manuzon, 2009, Mahapatra and Ramachandra, 2013, Lembre 
et al., 2012b). A small band near 1240 cm–1 may be indicated to (P=O) stretch by 
the phosphodiester bond suggesting the presence of nucleic acids in the crude 
extract (Mahapatra and Ramachandra, 2013, Lembre et al., 2012b). The spectral 
region from 1200 -900 cm–1 especially near 1000 cm–1  is  due to (C-O-C or  C-
O) which is caused by ring-stretching vibrations of carbohydrates and 
polysaccharides (Lembre et al., 2012b, Batool et al., 2015, Manuzon, 2009, 
Mangwani et al., 2014, Mahapatra and Ramachandra, 2013, Naumann, 2000). The 
few small bands found ~ 800–550 cm–1 are attributed to aromatic C–H bending 
(Mahapatra and Ramachandra, 2013).  
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Figure 5.46 FTIR analysis of EPS produced by different bacteria a) St 53 b) Ps 3 and c) C. freundii showing different functional group 
and band assignment.  I) O-H or N-H group II) C-H group III) CO2 or water IV) Protein and V) Polysaccharide.    
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MMGly 
MMEth 
c 
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5.3.11 Determination of Weight-average Molecular Weight for EPS 
The weight-average molecular weight (Mw) of the EPS produced by Ps3, 
St 53 and C. freundii on MM Eth was determined using the HP-SEC-MALLS. As 
mentioned in Section 4.12.12, prior to the analysis of EPS, the accuracy of the 
HP-SEC-MALLS instrument was evaluated using a pullulan standard of known 
Mw 800,000 or/and dextran 200000-270000 Dalton (Da) with low polydispersity 
(DP) (Mw/Mn = ~1.23 or 1.25) respectively. The results generated showed that 
the HP-SEC-MALLS provided good accurate and precise results for the pullulan 
and dextran (Figure 5.47). 
 
 
 
LS: Light scattering   dRI: Differential refractive index 
Figure 5.47 Chromatogram of standard polysaccharides (1000 ppm, flow rate 0.7ml/min, 
mobile phase UPW solvent RI 1.330, laser wavelength 690.0 nm, dn/dc 0.147 ml/g).  
a) Pullulan and b) Dextran. 
a 
b 
MW=7.822x105 
Mw/Mn=1.011 
dn/dc=0.147 
MW=2.263x105 
Mw/Mn=1.32 
dn/dc=0.146 
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Ps3 EPS (with and without dextranase treatment) was shown to be a high 
molecular weight compound. In the case of Ps 3 EPS without dextranase 
treatment, MALLS analysis (Figure 5.48) indicated that the sample comprises of 
a number of different molecular weight EPSs. The SEC chromatogram trace 
shows 6 distinct peaks with different molecular weight ranged from (1.1x105 to 
9.5x105) Da with a low DP ranged from (1.025 to 1.573) while the MALLS 
analysis of dextranase treated Ps 3 EPS showed one main peak with very small 
peaks. The Mw and DP of the main peak was 6.9x105 Da with 1.320 while Mw 
and DP of the rest were not available potentially due to very small molecular 
weight (Table 5.13).  
MALLS of St 53 EPS without dextranase treatment showed three distinct peaks 
indicative of high molecular weight compounds while treated EPS showed two 
high Mw peaks and one with non-available data .The MALLS of treated and non-
treated EPS of C. freundii showed high molecular weight molecules ranging from 
105 to 106 Da. In all bacterial strains (Ps 3, St 53 and C. freundii), the MALLS of 
the treated EPS, showed that the concentration of the first peak increased while 
the rest of peaks were decreased comparing to the non-treated EPS (Table 5.13). 
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LS: Light scattering   dRI: Differential refractive index 
Figure 5.48 HP-SEC-MALLS analysis of Ps 3 EPS a) EPS without dextranase treatment b) 
EPS treated with dextranase. 
 
a 
b 
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Table 5.13 HP-SEC-MALLS analysis of dextranase treated and non-treated extracted EPS from Ps 3, St 53 and C. freundii.  
Bacterial EPS MALLS analysis Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 
Ps 3 EPS (Without 
dextranase treatment ) 
^Mw & Dist. 
5.7x10
5
 
(20.41%) 
1.1x10
5
  
(12.11%) 
3.1x10
5
 
(6.32%) 
4.7x10
5
 
(15.65%) 
3.9x10
5
 
(42.99%) 
9.5x10
5
  
(2.52%) 
Polydispersity 1.573 1.139 1.102 1.016 1.130 1.025 
Ps 3 EPS  
(Dextranase treatment ) 
Mw & Dist. 
6.9x10
5
 
(97.4%) 
n/a 
(0.87%) 
n/a 
(0.99%) 
n/a 
(0.74%) 
- - 
Polydispersity 1.320 n/a n/a n/a - - 
St 53 EPS (Without 
dextranase treatment ) 
Mw & Dist. 
3.6x10
5
 
(15.53%) 
3.0x10
6
 
(45.35%) 
8.5x10
5
 
(39.12%) 
 -  - -  
Polydispersity 1.593 1.222 1.187  -  -  - 
St 3 EPS  
(Dextranase treatment ) 
Mw & Dist. 
2.7x105 
(87.98%) 
6.2x105 
(6.69%) 
n/a 
(5.53%) 
 -  -  - 
Polydispersity 1.040 1.009 n/a  -  -  - 
C. freundii EPS (Without 
dextranase treatment ) 
Mw & Dist. 
2.3x106 
(30.10%) 
2.2x106 
(21.70%) 
1.0 x106 
(48.2%) 
 -  -  - 
Polydispersity 1.198 1.028 1.029  -  -  - 
C. freundii EPS 
(Dextranase treatment ) 
Mw & Dist. 
4.7x105 
(85.35%) 
3.0x105 
(6.89%) 
8.4x105 
(7.76%) 
 -  -  - 
Polydispersity 1.153 1.009 1.640  - -   - 
^   Mw ; Molecular average molecular weight (Dalton)  Dist; Distribution of the molecule (%) 
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5.3.12 Discussion 
One of the most important aspects of the study of bacterial EPS production 
and its associated characterisation, is the selection of a media that is free of any 
interfering substances e.g. yeast extract (Alhudhud et al., 2014). In this study, 
several broth media (TSB, LB and SWF media) were ruled out due to the presence 
of these interfering substances (Figure 5.22). However TSB and LB broth have 
both been used in previous study (Subramaniam et al., 2007, Yilmaz et al., 2012, 
García et al., 2015), throwing into doubt the accuracy of currently published data. 
During the selection of a media for EPS production and characterisation, proton 
NMR analysis is not sufficient on its own to determine the presence of interfering 
substances since proton NMR analysis depends on the dissolution of the sample 
in the solvent i.e. solubility is one limiting factor in liquid state proton NMR 
analysis (de Alvarenga, 2011). For example the crude substance extracted from 
SWF medium was poorly soluble in D2O and consequently generated no spectra 
in the anomeric region during proton NMR analysis which would suggest that it 
might be a good candidate for EPS investigations. However, monomer analysis 
by HPAEC-PAD of the same sample (SWF crude substance) showed several 
sugar peaks providing evidence for the presence of polysaccharides (Figure 5.22). 
Beside proton NMR and HPAEC, the phenol sulphuric acid (Dubois et al., 1956) 
and Bradford (Bradford, 1976) tests showed the presence of sugars and significant 
amounts of protein in the SWF extract (Table 5.7). In order to avoid the problem 
associated with interfering substances, several mineral media with different 
carbon sources (MM Glc, MM Gly and MM Eth) were developed and modified. 
These media were free of interfering polysaccharides as demonstrated by proton 
NMR, the phenol sulphuric acid and Bradford tests and monomer analysis (Figure 
5.23 and Table 5.7). 
EPS production was optimised in MM Glc and MM Eth by studying the effects 
of inoculum size (104 or 107 CFU/ml), incubation temperature (30 or 37˚C) and 
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incubation time on the utilisation of the carbon source, total carbohydrate and 
polysaccharide (EPS) production during bacterial growth. According to this 
study, polysaccharide (EPS) production was optimised when a starting inoculum 
of 107 CFU/ml was employed with an incubation temperature of 30˚C and an 
incubation period of 72-80 h (≈ 80 h). This was considered optimum for 
polysaccharide (EPS) production in St 53 (Figure 5.24c and 5.25c) and Ps3 
(Figure 5.26c and 5.27c).  Lower initial inoculum sizes (104 CFU/ml) and higher 
incubation temperatures (37˚C) generated less EPS in broth culture (Figure 5.24, 
5.25, 5.26 and 5.27 a & b). These observations were confirmed in both growth 
curve experiments (Sections 5.3.3 and 5.3.4) and through the extraction and 
analysis of the EPS via proton NMR analysis (Section 5.3.6.1). During the latter 
stage an additional bacteria (C. freundii) and an additional media (MM Gly) were 
added to the study.  
Optimisation based on the extraction and characterisation of the EPS via proton 
NMR confirmed the observations made during the growth curve experiments that 
the optimum conditions were an initial inoculum size of 107 CFU/ml, an 
incubation temperature of 30˚C and an incubation period of for 72-80 h. Whilst 
this optimisation stage confirmed the growth conditions required for good EPS 
generation it also optimised the extraction methodology used in the process. This 
was focussed on the amount of TCA used in the extraction process, which is 
included for the precipitation of proteins, DNA and lipids (Bales et al., 2013). 
However the data presented here suggests that in some cases too much TCA may 
be altering the quantity and quality of the EPS extracted. When used at 14 and 10 
% TCA caused a reduction in EPS yield and the disappearance of some peaks 
from the proton NMR spectra suggesting that it may be either degrading the EPS 
or precipitating some EPS components with the proteins (Figure 5.29 and 5.31) 
(Alhudhud et al., 2014, Madhuri and Prabhakar, 2014). The impact of TCA varied 
between bacteria and in some cases between carbon sources used by the same 
bacteria (5.3.6.1 to 5.3.6.3). Several TCA concentrations have been used in 
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previous studies, ranging from 4% (Kılıç and Dönmez, 2008), 13% (Silva et al., 
2012),  14% (Leivers, 2011) to 20% (Bales et al., 2013). The data presented here 
suggests that the use of TCA should be optimised on a case by case basis to ensure 
an effective EPS extraction process.  
The three bacteria that are the focus of this section strains (Ps 3, St 53 and C. 
freundii) all produced an EPS with a significant component with a strong 
homology with dextran (Figure 5.39). The presence of this dextran like 
component was independent of the carbon source and was susceptible to digestion 
by dextranase (Sections 5.3.9). Removal of this dextran component revealed a 
second more complex EPS component that was mannose dominated with a range 
of additional sugars (See Table 5.12).  
Dextran is an extracellular homopolysaccharide characterised by a backbone of 
α- (1→6) linked D- glucose and variable amounts of α- (1→2), α- (1→3), α- 
(1→4) branching. Dextran based extracellular polysaccharides are commonly 
associated with Gram positive lactic acid bacteria such as Streptococcus, 
Leuconostoc, Lactobacillus and Weissella species (Burmølle et al., 2014, Monsan 
et al., 2001) Within a clinical setting, the ability of Streptococcus mutans to 
generate extracellular dextran to aid adherence through biofilm formation upon 
dental plaques has also been described (Bowen and Koo, 2011). Evidence of 
dextran production by Gram negative bacteria within the literature is scarce, 
however Milintawisamai and colleagues observed the production of dextran by 
Klebsiella pneumoniae and Enterobacter cloacae isolated from a sugarcane 
factory (Milintawisamai et al., 2009). More recently, the work of Jowiya et al 
showed that α-dextran containing exopolysaccharide production was stimulated 
in Campylobacter jejuni ssp when in the presence of pancreatic amylase (Jowiya 
et al., 2015).  
P. aeruginosa is associated with the generation of a range of extracellular 
polymeric substances (EPS) including three polysaccharides identified as 
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Alginate, Psl and Pel (Franklin et al., 2011, Bazaka et al., 2011, Sharma et al., 
2014). The formation of alginate is associated with mucoid growth and respiratory 
tract infection in cystic fibrosis patients (Whitfield et al., 2015). The clinical 
importance of alginate formation has resulted in this being the most studied of the 
P. aeruginosa polysaccharides. However, Ps 3 which is the focus of this 
investigation did not generate an alginate, as has been shown by the monomer 
analysis studies outlined in section 5.3.8 This is despite the fact that Ps 3 genome 
contains a full complement of alginate biosynthesis operons (PA3540-3548) 
associated with Pseudomonas aeruginosa PA01 (Sharma et al., 2014) 
(http://www.pseudomonas.com). 
The Psl polysaccharide has been characterised as a neutral, branched 
polysaccharide with repeating D-mannose, D-glucose, and L-rhamnose sub units 
(Byrd et al., 2009). The Pel polysaccharide on the other hand is associated with 
pellicle formation and remains uncharacterised, it is generally referred to as a 
glucose rich polymer (Friedman and Kolter, 2004a, Whitfield et al., 2015).  Ps 3 
contains a full complement of the pel (PA3058-PA3064) and psl (PA2231-2245) 
biosynthesis operons identified in Pseudomonas aeruginosa PA01(Sharma et al., 
2014) (http://www.pseudomonas.com). Ps 3 generated a pellicle and by inference 
the Pel polysaccharide under the conditions investigated here (See section 5.2.7). 
Analysis of the EPS generated by Ps 3 suggests that the Pel polysaccharide is a 
dextran rich polymer which is amendable to degradation by fungal dextranases. 
This analysis is consistent with the description of the Pel polysaccharide as a 
glucose rich polymer  (Ryder et al., 2007, Ma et al., 2009).  
Previous studies have suggested that the pel was cellulose-like exopolysaccharide 
and its biosynthesis is the least characterised P. aeruginosa exopolysaccharide 
(Ghafoor et al., 2013). Franklin and colleagues suggested that Pel biosynthesis is 
more similar to that of alginate and cellulose (Franklin et al., 2011). Once the 
dextran polymer has been removed the remaining EPS resembles the well 
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characterised Psl polysaccharides as indicated by the presence of mannose as a 
major component (Friedman and Kolter, 2004b, Branda et al., 2005) (Table 5.12). 
The generation of mannose rich EPS has been identified in a wide range of both 
Gram positive and negative bacteria (Bales et al., 2013). In this study mannose 
represented over 75% of the EPS once the dextran had been removed among all 
the bacterial strains (Ps 3, St 53 and C. freundii). This is similar to the results from 
a similar study where 80-90% of EPS that was extracted from  Pseudomonas 
aeruginosa and Acinetobacter baumannii was composed of mannose, while 
Klebsiella pneumoniae and Staphylococcus epidermidis strains containing 40– 
50% mannose (Bales et al., 2013). 
The EPS generated by S. maltophilia has not been as extensively researched as 
that of P. aeruginosa. The data that has been generated as part of this study does 
not align with what little data is available in the literature. For example Cescutti 
et al (2011) described the S. maltophilia EPS as a highly charged polymer due to 
the presence of three uronic acids and an ether-linked D-lactate substituent. 
Methylation analysis suggested 4-linked Glc, 4-linked GlcA and 3, 4-linked GalA 
in equal molar amounts in the native polymer (Cescutti et al., 2011). Cuzzi (Cuzzi, 
2012) also detected uronic acids (glucuronic acid (GlcA), galacturonic acid 
(GalA)) in S. maltophilia EPS alongside glucose.  
The data presented in this research suggests that S. maltophilia in common with 
P. aeruginosa is capable of synthesising more than one EPS depending on the 
environment and that pellicle formers such as Ps 3 and St 53 respond to an 
environments that favour pellicle formation by generating an EPS that is glucose 
rich.   
Biofilm formation amongst pathogenic Enterobacteriaceae such as Citrobacter 
spp. has been associated with the production of a cellulose based EPS and/or curli 
fimbre that are common in catheter-associated UTI (Zogaj et al., 2003). Other 
authors such as Jang et al (2005) have suggested that Citrobacter spp. EPS mainly 
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consists of galactose, glucose and mannose (Jang et al., 2005). While in another 
study (Rättö et al., 2006), Citrobacter spp. produced EPS that was composed 
mainly of fucose, rhamnose, and other sugars such as galactose, glucose, 
mannose, galacturonic acid, glucuronic acid and pyruvate. The compositions in 
these latter studies are closer to composition determined in this study, which once 
again underlines the fact that EPS generation can be highly varied even within 
species. 
The genome of St 53 and C. freundii showed the presence of the entire pgaABCD 
locus. This locus which is recognised to encode the synthesis of a polysaccharide 
poly-β-1,6-N-acetyl-D glucosamine (β-1,6-GlcNAc, PGA). This polysaccharide 
(PGA) is present in the extracellular matrix of biofilms generated by a wide range 
of bacteria including Escherichia coli, Actinobacillus pleuropneumoniae, 
Yersinia pestis, Bordetella spp. In these bacteria, PGA has been ascribed to 
mediating surface attachment, aggregation and adhesion for stabilizing biofilm 
formation as well as protecting against environmental stresses and antimicrobial 
resistance (Wang et al., 2004, Shanmugam et al., 2015).  
Numerous analytical techniques were used in this study for the analysis of 
bacterial EPS. One of these methods is FTIR spectroscopy that measures the 
vibrations of functional groups the mixtures (Castro et al., 2014). FTIR 
spectroscopy showed the presence of EPS with all its component like 
polysaccharide (carbohydrate), protein and may be nucleic acid also. However, 
the NMR showed very similar spectra between extracted EPS from all 3 bacteria 
(Ps 3, St 53 and C. freundii) on different carbon sources media but the fingerprint 
region 900– 1400 cm−1 showed the difference between these EPS and this due to 
the band shifts in these regions. Different EPS were characterised by FTIR in 
previous study such as EPS from acidophilic microbial biofilm (Jiao et al., 2010) 
and Bacillus subtilis (Omoike and Chorover, 2004). 
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5.3.12 Key finding 
 TSB, LB and SWF were not suitable media for the investigation of EPS 
production and characterisation due to the presence of interfering substances.  
 A range of modified mineral media with different carbon source (MM 
Glucose, MM Glycerol and MM Ethanol) were developed that were suitable 
for the study EPS production and characterisation due to the absence of 
interfering substances.  
 107 CFU/ml of bacteria as initial inoculum, and incubation at 30˚C for 
approximately 80h with 0-5% TCA for protein treatment, represent the 
optimum conditions for EPS production and extraction for Ps3, St 53 and C. 
freundii.  
 During growth and biofilm formation on MM Glucose, MM Glycerol and MM 
Ethanol, Ps3, St 53 and C. freundii produced a complex EPS that was 
composed of at least two polysaccharides in which one of them is a dextran 
like polymer. 
 EPS sugar components from Ps3, St 53 and C. freundii were very similar and 
differed in only 1 or 2 sugars.  
 The Pel polysaccharide of Ps 3 is composed of dextran and the Psl 
polysaccharide has a mannoses rich composition.  
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5.4.Pathogenicity of biofilm forming Pseudomonas aeruginosa 
strains  
This chapter discusses the pathogenicity and virulence factors of 
Pseudomonas aeruginosa (Ps 3 and Ps 10421). The pathogenicity of these strain 
is discussed in terms of their OMV and their impact on the wax worms’ G. 
mellonela infection model. Also studying bacterial survival in water.  
5.4.1 Production and extraction of OMV 
OMV were extracted as described in (Section 4.11). After overnight 
incubation, Ps 10421 (lab strain) failed to produce OMV on both MM Glc and 
MM Eth while Ps 3 (hospital strain) produced OMV on both media. The absence 
of bacterial growth on TSA after incubation with 100 µl of extracted OMV 
(suspended in 3 ml HEPES) demonstrated the purity (no contaminant) of the Ps 3 
OMV. Protein determination via the Bradford test showed the concentration of 
OMV extracted to be 346 and 538 µg/ml on MM Glc and MM Eth respectively. 
Ps 3 OMV were also visualised via SEM as a pure extract and during biofilm 
formation (Figure 5.49).  
 
   
a 
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Figure 5.49 SEM of Ps 3 of Biofilm and extracted OMV a) OMV MM Glc, b) OMV MM 
Eth and c) Biofilm and OMV on coupon MM Eth. 
 
 
5.4.2 Bacterial growth and biofilm formation  
Bacterial growth on both MM Glc and MM Eth at different interval 24, 
40, and 80 h showed different colour formation due to carbon sources, the age of 
the culture and the extent of biofilm formation  (Figure 5.50). 
b 
c 
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 Ps 3 MM Glc Ps 3 MM Eth 
Ps 10421  
MM Glc 
 
Ps 10421  
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Media before 
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0 h 
  
Culture after 
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40 h 
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Figure 5.50 Bacterial growth and biofilm formation of Ps 3 and Ps 10421 on different 
carbon sources for 80 h incubation at 30˚C. 
 
5.4.3 Preliminary pathogenicity investigations  
Preliminary pathogenicity investigations focussed on proving the method 
and developing the necessary controls. Initially worms were infected with 10 µl 
of a 40 h culture of the lab strain (Ps 10421) grown on either MM Eth or MM Glc 
and diluted to 107 CFU/ml in MRD (100000 cells per larvae). Under these 
conditions no worms survived 8 h after exposure to MM Eth grown bacteria but 
survived up to 11 h when exposed to MM Glc grown bacteria. Compared to 107 
CFU/ml, the worms demonstrated a greater survival when exposed to the same 
185 
 
volume of cell free culture supernatants, under these conditions there was 86% 
survival after 12, but 100% mortality after 24 h, (Figure 5.51a). This indicates that 
the bacteria were responsible for the mortality rather than any toxins that the 
bacteria may produce or the OMV.  
When this investigation was repeated with Ps 3 the worms had a better 
survival rate suggesting that Ps 3 was less pathogenic than the lab strain. When 
grown on MM Eth, Ps 3 generated a 0% survival within 8-11 h, however when 
grown on  MM Glc there was a 43% survival at 11 h and a total kill at 12 h post 
infection. The cell free supernatant taken from Ps 3 grown on MM Eth and MM 
Glc required 31 and 54 h respectively to generate a complete kill (Figure 5.51b). 
This data again support the observation that the lab strain is more pathogenic than 
Ps 3. The pathogenicity of extracted OMV from Ps 3 growth on both MM Glc and 
MM Eth was also studied, with 100% survival in both cases for up to 54 h. (Figure 
5.51c). In addition to the experiments outlined above a range of controls were run 
to check the toxicity of media and diluents such as MRD, MM Glc, MM Eth and 
HEPES buffer (figure 5.51). In all cases there was 100% survival of the worms 
up to 3 days post exposure, indicating the absence of toxicity of any of these 
media.  At the same time uninoculated controls (General control) survived also 
survived for more than 3 days, these control indicated that the incubation 
conditions (temperature etc.) had no deleterious impact on the worms. 
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Figure 5.51 Pathogenicity of bacterial growth on different carbon sources using wax 
worms infection model. The symbol represents pathogenicity of bacterial culture and 
supernatant free CFU from a) 40 h old culture Ps 10421 b) 40 h old culture Ps 3 c) OMV and 
d) Control and infected worms.  
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5.4.5 Pathogenicity of Ps 3 after 24 and 80 h incubation 
Following the previous experiments, a number of additional investigations 
were carried out. In these experiments a slightly improved methodology was 
employed and the age of the cultures was aligned with the EPS generation 
observed in previous experiments (Section 5.3.4).  
The direct injection of 24 h Ps 3 cultures grown in MM Glc with 1.82x109 
CFU/ml or 1.82x107 cells per larva (no washing or dilution) generated a complete 
kill within 9h post injection, the same bacteria grown on MM Eth with (1.64x109 
CFU/ml or 1.64x107 cells per larvae) generated a complete kill after 7 h. The 
injection of cell free supernatants further illustrated the difference between the 
MM Glc and MM Eth grown cultures with the glucose supernatant being 
considerable less toxic (Figure 6.4). The data showed obvious difference between 
the pathogenicity of bacterial culture and supernatant of the Ps3 that grow on MM 
Glc and MM Eth (Figure 5.52)  
 
 
 
 
Figure 5.52 Ps 3 bacterial culture and free cells supernatant pathogenicity in wax worms 
after infection from 24 h old culture.  
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When 80 h Ps 3 cultures were employed for the same investigation, the 
direct injection of MM Glc (9.65x108 CFU/ml or 9.65x106 cells per larvae) and 
MM Eth (1.05x109 CFU/ml or 1.05x107 cells per larvae) cultures generated 
complete kills after 8 and 6 h respectively. The culture supernatant (cell free) also 
showed the same pattern as shown by the fact that the survival of worms infected 
with MM Glc supernatant was 40% after 24h while the survival worms that 
infected with MM Eth was 0% after 12 h. Worms inoculated with sterile PBS, 
MM Glc and MM Eth as controls, demonstrated 100% survival and exhibited no 
change in shape, colour or activity over the incubation period (Figure 5.53). 
 
 
 
Figure 5.53 Ps 3 bacterial culture and free cells supernatant pathogenicity in wax worms 
after infection from 80 h old culture.  
 
5.4.6 Lethal Dose (LD50) estimations for Ps 3 obtained from 24 and 80 h old 
cultures 
In order to determine LD50 values for Ps 3, cells were harvested, washed 
in PBS and then serially diluted prior to worm injection to generate a dose 
response curve. This was completed for Ps 3 grown on MM Glc and MM Eth over 
24 and 80 h incubation times. As expected the data indicated that the mortality 
rates amongst the worms were decreased with decreasing bacterial inoculum size 
on both media (Figure 5.54). The LD50 values were calculated after 12 h of 
0
10
20
30
40
50
60
70
80
90
100
0 5 10 15 20 25 30
Su
rv
iv
in
g 
w
o
rm
s 
(%
)
Times (h)
Direct Culture MMGlc Direct Culture MMEth Supernatant MMGlc Supernatant MMEth
PBS Control MMGlc Control MMEth Control General Control
189 
 
infection (Figure 5.54 c & d) and the data showed that LD50 for Ps 3 grown on 
MM Glc was 3.16x108 CFU/ml (3.16x106 CFU/larvae) whilst that for Ps 3 grown 
on MM Eth was an order of magnitude lower at 1.36x107 CFU/ml (1.36x105 
CFU/larvae).  
Direct injection of 24 h culture media containing 1.24x109 CFU/ml (MM 
Eth, 1.24x107 CFU/larvae) and 1.62x109 CFU/ml (MM Glc, 1.62x107 
CFU/larvae) (Figure 5.52) killed the worms faster than injections of PBS washed 
cells containing the same overall levels of bacteria (MM Eth 1.15x109 CFU/ml, 
1.15x107 CFU/larvae and MM Glc 1.63x109 CFU/ml, 1.63x107 CFU/larvae).   
LD50 determinations using 80 h cultures (Figure 5.55) again 
demonstrated the greater pathogenicity of ethanol grown Ps 3 (Figure 5.55 a & b) 
with the LD50 for glucose grown bacteria being 1.0x107 CFU/ml (1.0x105 
CFU/larvae) and the LD50 for ethanol grown Ps 3 being once again an order of 
magnitude lower 1.73x106 CFU/ml (1.73x104 CFU/larvae). These LD50’s are 
also an order of magnitude lower than those obtained from 24 h culture grown on 
the same media (Figure 5.56).  
Direct injection of 80 h MM Eth culture media containing 1.05x109 
CFU/ml (1.05x107 CFU/larvae) and MM Glc media containing 9.65x108 CFU/ml 
(9.65x106 CFU/larvae) (Figure 5.53) killed the worms faster than the injections 
of PBS washed cells containing approximately the same overall levels of bacteria 
(MM Eth 9.5x108 CFU/ml, 9.5x106 CFU/larvae and MM Glc 1.25x109 CFU/ml,  
1.25x107 CFU/larvae) respectively (Figure 5.55).  
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Figure 5.54 Pathogenicity of different inoculum size and LD50 curve from (24 h Ps 3 old culture) in wax worms.  a)  MM Glc b) MM Eth c) 
LD50 curve on MM Glc d) LD50 curve on MM Eth.
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Figure 5.55 Pathogenicity of different inoculum size and LD50 curve from (80 h Ps 3 old culture) in wax worms.  a)  MM Glc b) MM Eth c) 
LD50 curve on MM Glc d) LD50 curve on MM Eth.
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Figure 5.56 Comparison between the pathogenicity of different inoculum size taken from 
(24 and 80 h Ps 3 old culture) on MM Glc and MM Eth using wax worms models. 
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5.4.7 Gene expression (Transcriptomic studies) 
In order to gain a more detailed understanding of the difference 
in pathogenicity observed between glucose grown and ethanol grown Ps 
3 a transcriptomic study was performed. In order to do this the mRNA 
derived from 24 h incubations of Ps 3 grown on both MM Glc and MM 
Eth were sequenced and the relative expression quantified.  
In terms of the biofilm genes, all psl genes present were 
expressed on both carbon sources (Figure 5.57), only psl N was slightly 
more expressed (1.2 fold) on MM Eth than MM Glc. All the other psl 
genes demonstrated greater expression on MM Glc (1.6-3.0 fold) with 
the exception of psl M which had a 18 fold increased expression when 
comparing to expression on MM Eth (Figure 5.57).  
Of the other biofilm gene, the pel genes demonstrated low levels of 
expression when compared to the psl genes, a surprising observation since Ps 3 is 
a pellicle forming bacteria. The expression of all pel genes except pel D and F 
was greater on MM Eth than MM Glc (Figure 5.57). The sequence data also 
showed that all alginate genes present in the genome were expressed but not 
extensively (1-5 fold) on both media. Some alg genes were expressed more on 
MM Eth while the others expressed more MM Glc. A range of other genes 
demonstrated greater expression on MM Eth than MM Glc (Table 5.14, 5.15). 
Although a number of gene demonstrated high levels of over expression when 
grown on ethanol (Table 5.14) many of these did not have a direct link to increased 
pathogenicity with the possible exception of the hypothetical proteins and tonb-
dependent receptors. A number of other genes that were more closely related to 
pathogenicity showed lower but significant levels of increased expression (all 
genes showed significant difference-gene expression between MM Eth and MM 
Glc P < 0.01)  (Table 5.15) including Exotoxin A, T3SS, protease, LPS, 
lipoprotein, OMV and pyocyanin (Ramsey and Wozniak, 2005). Other genes that 
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expressed very high such as  peptidase which is also called protease (Barrett and 
McDONALD, 1986) and Acyl-homoserine lactone acylase subunit beta is a QS 
system that control the virulence of P. aeruginosa PA01 (Table 5.15). 
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Figure   5.57 Ps 3 biofilm gene expression and fold change on both MM Glc and MM Eth.   a) pel genes expression b) Fold change expression in 
pel genes c) psl genes expression d) Fold change expression in psl genes e) alg genes expression f) Fold change expression in alg genes. 
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Table 5.14 Expression of some genes with high fold change on both MM Glc and MM Eth.  
Fold 
change 
Glucose 
Expression 
Ethanol 
Expression 
Product 
100.7679 2.515006 253.4318 Hypothetical protein 
95.08242 3.087868 293.602 Thiamine pyrophosphate-binding protein 
94.53701 3.303803 312.3317 Hypothetical protein 
93.69668 1.061799 99.48703 Zinc abc transporter permease 
90.70073 1.546175 140.2392 Abc transporter substrate-binding protein 
83.11379 1.357305 112.8107 Manganese abc transporter atp-binding protein 
67.75152 0.116182 7.871531 Atpase 
60.45531 20.1512 1218.247 
5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase 
50.16423 2.871032 144.0231 Cyclic peptide transporter 
47.66241 1.198741 57.13489 Class v aminotransferase 
43.61641 44.83348 1955.475 Transporter 
42.22653 1.875224 79.1842 Chromophore maturation protein pvdo 
40.96604 4.5713 187.2681 Biopolymer transporter exbd 
33.04537 7.2566 239.797 Hypothetical protein 
31.99378 29.25349 935.9296 Rna 3'-terminal-phosphate cyclase 
30.9771 22.67754 702.4842 Ornithine monooxygenase 
29.91421 4.890289 146.2892 Metal abc transporter substrate-binding protein 
27.08849 2.179672 59.04402 Thioesterase 
26.26187 69.72777 1831.182 Rna ligase 
24.84973 4.427303 110.0173 Acetyltransferase 
24.53562 5.895424 144.6479 Tonb-dependent receptor 
24.21095 7.536326 182.4616 Hypothetical protein 
24.01025 6.600788 158.4866 Membrane protein 
Fold change: Fold (times) change is calculated as the ratio of the difference between expression value on MM Eth and  
the expression value on MM Glc i.e. fold change = expression value on MM Eth / expression value on MM Glc. 
 
 
Table 5.15 Expression of some genes and fold change on both MM Glc and MM Eth that 
related to virulence.  
Fold 
Change 
Glucose 
Expression 
Ethanol 
Expression 
Products 
2.61 271.67 710.32 (2Fe-2S) ferredoxin 
23.11 3.50 80.96 Acyl-homoserine lactone acylase subunit beta 
2.61 271.67 710.32 (2Fe-2S) ferredoxin 
3.69 146.13 539.43 Anthranilate synthase component 2, Pyocyanine specific 
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2.12 19.77 41.99 Exoenzyme S synthesis protein C 
10.79 2.14 23.06 Exotoxin A regulatory protein 
14.89 9.84 146.49 Lipoprotein 
1.55 45.34 70.12 Lipoprotein 
1.38 147.01 202.32 LPS biosynthetic protein lpxo 
2.43 29.40 71.37 LPS core heptose(I) kinase rfap 
5.75 219.02 1260.23 Outer membrane protein 
1.40 7.84 10.99 Outer membrane protein 
1.89 153.91 291.03 Outer membrane protein assembly factor bamb 
1.43 139.58 199.83 Outer membrane protein assembly factor bamd 
2.48 2.55 6.31 Outer membrane receptor fepa 
25.90 7.63 197.366 Peptide synthase 
78.50 5.45 427.7052 Peptidase 
26.40 3.67 96.7725 Peptidase m19 
1.86 39.62 73.62 Protease 
1.63 246.79 401.70 Protease lasa 
1.49 673.51 1003.19 Protease pfpi 
2.21 427.44 944.63 Protease subunit hflk 
2.19 401.16 877.50 Protease subunit hflk 
3.22 249.65 802.68 Type II secretion system protein F 
1.92 4.85 9.32 Type III export apparatus protein 
1.37 7.38 10.13 Type III export protein psci 
1.13 3.40 3.85 Type III secretion outer membrane protein popn 
1.83 9.76 17.82 Type III secretion system chaperone yscw 
1.36 3.31 4.51 Type III secretion system protein 
1.70 18.14 30.89 Type III secretion system regulator exsd 
 
Fold change: Fold (times) change is calculated as the ratio of the difference between expression value on MM Eth and  
the expression value on MM Glc i.e. fold change = expression value on MM Eth / expression value on MM Glc. 
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5.4.8 Discussion 
As previously mentioned, P. aeruginosa causes a wide range of disease in 
humans and is an opportunistic pathogen in a range of different hosts, including 
mammals, insects, nematodes and plants (Jander et al., 2000). The application of 
infection models to pathogen is an important step in the understanding of the 
pathogenesis of the associated diseases and infections. Recently, insects have 
become commonly used infection models due to the similarity of their immune 
system to that of mammals (Insua et al., 2013). A variety of P. aeruginosa strains 
are extremely pathogenic to insects, including the wax worms or G. mellonella 
(Miyata et al., 2003). Previous reports have shown that non-pathogenic microbes 
such as E coli OP50, Saccharomyces cerevisiae and some strains of Aspergillus 
fumigatus were unable to kill the worms with up to 107 CFU per larvae. This data 
shows the viability of wax worms as an infection model to study the pathogenicity 
of Pseudomonas aeruginosa (Peleg et al., 2009). In the current study, wax worms 
were used to study the pathogenicity of P. aeruginosa, with a particular focus on 
Ps 3.  
Initial work focussed on the OMV of P. aeruginosa since these have been 
implicated in virulence and disease generation (MacDonald and Kuehn, 2013). 
However in this case the lab strain P. aeruginosa (NCIMB 10421) failed to 
produce OMV on both MM Glc and MM Eth, however in contrast Ps 3 produced 
OMV on both carbon sources (Figure 5.49). It is generally thought that both 
pathogenic and non-pathogenic Pseudomonas species, release OMV during 
normal growth (Eddy et al., 2014, Avila-Calderón et al., 2011) so the lack of OMV 
from the lab strain is contrary to accepted thinking. However, a major controlling 
factor for the production of OMV is the presence of stress such as antibiotics 
(Chatterjee and Chaudhuri, 2012). OMV production is also regulated by other 
factors including growth conditions, media type, temperature and nutrient levels 
(Kulp and Kuehn, 2010). Chatterjee and Chaudhuri (2012) indicated that 
pathogenic bacteria produce more OMV than non pathogenic bacteria and that 
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bacteria under stress produce more OMV. Proteomic analysis of OMV produced 
by Xanthomonas campestris on two different culture media indicated that the 
culture conditions have an intensive effect on the protein composition (Sidhu et 
al., 2008b). It is possible that the culture conditions and media used did not 
generate sufficient stress on the lab strain to initiate OMV production. However, 
this particular strain of Pseudomonas aeruginosa (Ps 10421) is considered to be 
none pathogenic (Wang et al., 2014)  being neither invasive or cytotoxic 
(Aristoteli and Willcox, 2003) and lacking in siderophore and pyocyanin 
production genes (Wang et al., 2014). Consequently, it may be that it is not an 
OMV producer in the absence of external stress factors such as antibiotics.  
The current study demonstrated that Ps 3 generated more OMV and was 
more pathogenic when grown on ethanol rather than glucose as sole carbon source 
(Figure 6.3 c). However, when cell free extracts were injected into the worms the 
mortality of the worms significantly decreased indicating that the OMV are not in 
themselves especially pathogenic since they would have remained in the 
supernatant after the bacterial cells had been removed. The P. aeruginosa strain 
employed in this study (Ps 3) appears to continuously generate OMV, with 
structures appears to be OMV visible in SEM images of Ps 3 biofilms (Figure 
5.49 c). OMV are produced by a wide variety of Gram-negative bacteria during 
all stages of bacterial growth as well as in a variety of growth environments 
including  liquid culture, solid culture, and in biofilms as a survival strategies and 
damage the host cells  (Kuehn and Kesty, 2005, Ellis and Kuehn, 2010). Multiple 
virulence factors are packaged in P. aeruginosa OMV including alkaline 
phosphatase, β-lactamase and haemolytic phospholipase C. These secreted 
virulence factors are important because they play important roles in host 
colonization, for example alkaline phosphatase promotes biofilm formation, β-
lactamase degrades host antimicrobial peptides, haemolytic phospholipase C is 
cytotoxic and promotes P. aeruginosa virulence  (Bomberger et al., 2009). 
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Although Ps 10421 is not considered pathogenic (Wang et al., 2014) when 
cultured on both glucose and ethanol mineral media for 40 h it was more 
pathogenic than Ps 3 (Figure 5.51 a & b). This suggests that the injection process 
has assisted Ps 10421 in overcoming its lack of invasion mechanisms. Preliminary 
studies on P. aeruginosa pathogenicity successfully demonstrated the value of the 
wax worm as a pathogenicity model.  
Wax worms have been used by several authors for the study of pathogenicity of 
P. aeruginosa. These studies have focussed on the role of Type III Secretion 
System (Miyata et al., 2003), the effects of LPS O Antigens on Type III Secretion 
(Augustin et al., 2007). Jander et al. (2000) indicated that larvae of wax worms 
are quite sensitive to P. aeruginosa. After infection of wax worms with inoculum 
size up to 10000 of P. aeruginosa strains PA14, larvae survived until 48 h and 
then died within 2 h after rapid melanisation. Both Ps 10421 and Ps 3 strains were 
more virulent during growth on MM Eth than MM Glc than published research 
on PA14. 
One of the more striking aspects of this section of the work is the enhanced 
pathogenicity associated with growth on ethanol as sole carbon source. Both Ps 
10421 and Ps 3 were more pathogenic when fed on ethanol as the sole carbon 
source suggesting that ethanol is enhancing the expression of bacterial virulence 
factors that is promoting the death of the worms. Alternatively, the bacteria may 
be responding to the presence of ethanol by altering their physiology (Smith et al., 
2004) which in turn is having a deleterious impact on the survival of the worms. 
Control experiments have indicated that the ethanol in the media is not harmful to 
the worms. In addition cell free extracts of ethanol fed broth cultures were 
considerable less toxic to the worms than washed and re-suspended ethanol grown 
cells. This data indicates that growth on ethanol has sustained impact on the 
pathogenicity of the bacterial cells. The mechanism of carbon source preference 
by P. aeruginosa is  poorly understood, despite the fact that the carbon source has 
202 
 
intensive effects on bacterial virulence, including toxin production, antibiotic 
resistant and biofilm formation (Palmer et al., 2007).  In a study on several clinical 
P. aeruginosa strains, environmental factors such as the carbon and nitrogen 
sources were shown to influence in vitro biofilm formation and quorum sensing 
(Palmer et al., 2007). In another study of growing P. aeruginosa and the yeast C. 
albicans , Chen et al. (2014) found that ethanol produced by C. albicans it 
influence biofilm formation and phenazine production in P. aeruginosa. Smith et 
al. (2004) Reported that low doses of ethanol acts as a signalling molecule that 
affects bacterial physiology and survival. In Acinetobacter species, ethanol 
stimulated growth, pathogenicity, as wells increase the survival against toxic salts 
(Smith et al., 2004).  
Extended incubation times (80 h) of bacterial culture promoted EPS production, 
the cultures became even more pathogenic when compared to the 24 h old cultures 
(Figure 5.52 and 5.53). The LD50 of the 80 h old culture was approximately 1 log 
lower than the equivalent 24 h LD50. The same observation was also seen 
between MM Eth and MM Glc grown cultures (Figure 5.54 and 5.55). 
Consequently there was a 2 log difference between the least pathogenic cultures 
i.e. MM Glc cultures grown over 24 h, and the most pathogenic cultures i.e. MM 
Eth cultures grown over 80 h.  
The direct injection of bacterial cultures were more virulent than PBS washed 
bacteria (24 and 80 h old culture) adjusted to the same inoculum size. This 
indicates that the broth contained additional toxic compounds which enhanced the 
toxic impact. However, although the supernatant did have a toxic impact on the 
worms, in isolation this impact was considerably lower than that generated by the 
bacterial cells. This data suggests that EPS production and by inference biofilm 
formation increases virulence over and above that associated with ethanol as a 
sole carbon source and that the pathogenicity of the bacteria is associated with 
cellular processes rather than the excretion of toxins.  
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In several studies, the soluble virulence factors released by bacteria during growth 
have been investigated. These soluble factors include:  LPS or endotoxin  in the 
culture supernatant of E. coil (Zhang et al., 1998); serine protease in S. maltophilia 
liquor as a nematocide (Huang et al., 2009); putative virulence factors (lipase, 
protease and phospholipase) in S. maltophilia culture supernatants with 
haemolytic, enzymatic activities and cytotoxic impacts (Figueiredo et al., 2006); 
the generation of a variety of extracellular enzymes by S. maltophilia, including 
DNase, RNase, protease, fibrinolysin, lipases, and elastase (Denton and Kerr, 
1998); quorum sensing signals, such as acyl homoserine lactones (AHLs) in P. 
aeruginosa (Gupta et al., 2011b); elastase and pyocyanin generation by P. 
aeruginosa (Frank, 2012); rhamnolipid secretion by P. aeruginosa (Zulianello et 
al., 2006). P. aeruginosa secretes a wide range of virulence factors that contribute 
to its pathogenicity  such as LPS, alginate, alkaline protease, exotoxin A, DNase, 
and phospholipase C (Kadurugamuwa and Beveridge, 1995). The accumulation 
of these toxin in the bacteria and the culture supernatant at 80 h incubation may 
be more than 24 h and this was another reason that for more virulence.  
In the current study, biofilm formation and EPS generation has been investigate 
as a virulence factor, however the transcriptome analysis of gene expression after 
24 h incubation showed quite varied expression of EPS associated genes, some of 
which are more expressed on MM Glc while others are more expressed during 
growth on MM Eth (Figure 5.57). However, the transcriptome provides no clear 
evidence that biofilm/EPS generation is the factor that enhances the pathogenicity 
of Ps 3 when grown on ethanol.  
A large number of genes appeared to be enhanced in terms of their 
expression when Ps3 was fed on ethanol. The genes in (Table 5.14) do not appear 
to be directly relevant to virulence with the exception of hypothetical protein and 
tonb-dependent receptor. Many of these gene products are related to membrane 
transport and include Thiamine pyrophosphate-binding protein , Zinc abc 
transporter permease, Abc transporter substrate-binding protein, and Manganese 
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abc transporter atp-binding protein transport (Hawkins et al., 1989, Maret, 2001, 
Berntsson et al., 2010, Garmory and Titball, 2004).  Other transport related genes 
include 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 
(zinc transporter) (Mládková et al., 2014), Class V aminotransferase (transfer of 
amino groups) (Yoshikane et al., 2008), Other genes highly expressed included 
the genes for the Chromophore maturation protein pvdo which is related to 
pyoverdine (pvdMNOP) production (Ye et al., 2014).  
A number of highly expressed genes were referred to as hypothetical 
proteins. These genes are  predicted to be expressed from an open reading frame  
which have not been experimentally characterised (no experimental evidence of 
translation) and whose functions cannot be presumed from simple sequence 
comparisons alone (no identifiable function) (Kolker et al., 2004, Desler et al., 
2009).   
The TonB-dependent receptors which is found in Gram-negative bacteria 
functions as an iron chelator (siderophores) transporting iron into the periplasm. 
Bacteria use (siderophores) to establish commensal and pathogenic relationships 
with hosts and to survive as free-living organisms (Ferguson and Deisenhofer, 
2002), so this gene may be related to increased virulence.   
 The genes in outline in Table 5.15 are more easily associated with 
increased pathogenesis. These includes genes associated with redox processes and 
electron transport such as the (2Fe-2S) ferredoxin which is a bacterial thioredoxin 
(Meyer, 2001). These ferredoxin indicated in the secretion of cytotoxic 
necrotizing factor 1 in E. coli k1 (Yu and Kim, 2010).  
Several other genes that have a relation to pathogenicity include Exotoxin 
A, Type III secretion, Protease, LPS, lipoprotein, OMV and pyocyanin. Exotoxin 
A or Pseudomonas Exotoxin (PE) is considered one of the major virulence factor 
of Pseudomonas aeruginosa. This toxin has the ability to binds to a specific 
receptor on animal cells, and entering the cells then blocks protein synthesis 
causing cell death (Morlon-Guyot et al., 2009). Some Gram-negative bacteria 
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such as P. aeruginosa and Neisseria meningitidis secrete lipoproteins that have a 
significant role in the pathogenesis of infection (Godlewska et al., 2009).  
Type III secretion (T3SS) is a complex apparatus that is used by P. 
aeruginosa to inject proteins (effector proteins) into the host cells extracellular 
environment. T3SS have been associated with an increase in disease severity 
during acute pneumonia, bacteremia, burn infections and sepsis (Hauser, 2009). 
Protease is another virulence factor secreted by P. aeruginosa that directly attack 
host tissues through  hydrolysing peptide bonds (Hoge et al., 2010). P. aeruginosa 
biofilms are also able to secrete proteases to the environment surrounding the 
biofilms (Ołdak and Trafny, 2005). Another factor in P. aeruginosa that mediates 
both bacterial virulence and host responses and consequently contributes to 
pathogenesis in burn patients and immunocompromised hosts such as those with 
cyctic fibrosis is lipopolysaccharide (LPS)  (Pier, 2007).   
Most strains of P. aeruginosa produce pyocyanin complexes which are 
redox-active phenazine compounds which have a range of functions such as the 
suppression and damaging of mammalian cells. Phenazines can also benefit P. 
aeruginosa by serving as signalling molecules, regulating persister cell formation, 
influencing colony morphology, promoting iron acquisition and biofilm 
development (Glasser et al., 2014, Mavrodi et al., 2001). The presence of high 
concentrations of pyocyanin in the sputum of patients with CF indicated that this 
complex plays a role in pulmonary tissue damage. In some model pathogenesis 
systems, pyocyanin synthesis by P. aeruginosa is necessary for causing disease 
symptoms in plants and for effective killing of the nematode and the insect (G. 
mellonella) (Mavrodi et al., 2001).  Glasser et al. (2014) Indicated that 
endogenous phenazines (such as pyocyanin) support the anaerobic survival of P. 
aeruginosa, however the physiological mechanism behind survival was unknown. 
Glasser et al. (2014) Also suggest that phenazines can increase the metabolic 
adaptability of microorganisms by facilitating energy generation ATP synthesis. 
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8.4 Key finding  
 The Ps 3 strain of P. aeruginosa was able to produce OMV in the absence of 
any external stressors on both glucose and ethanol as sole carbon source.  
 The Ps 10421 strain of P. aeruginosa was unable to produce OMV in the 
absence of any external stressors on both glucose and ethanol as sole carbon 
source. 
 When grown on ethanol Ps 3 generated a greater quantity of OMV than 
generated when grown on glucose. 
 Both Ps 3 and Ps 10421 were more virulent when grown on ethanol than when 
grown on glucose. 
 Regardless of carbon source, 80 h cultures were more virulent than 24 h old 
culture of Ps 3. 
 The LD50 of both 24 and 80 h old culture were approximately 1 Log lower 
when grown on ethanol rather than when grown on glucose.  
 PBS washed bacteria were less virulent than bacterial culture with same 
inoculum size. 
 Biofilm genes (psl, pel and alg) genes were expressed on both carbon source 
media but it’s not clear if it is related to the virulence of the Ps3.  
 
5.5 Survival of Gram negative bacteria under low nutrient 
conditions  
After inoculation of sterilised ultra-pure water (UPW) with 105 CFU/ml 
(final inoculum size), all bacterial strains were able to survive for more than 40 
days except St 18 and Ps 5 (Figure 5.58). As a general observation all bacteria 
multiplied during first 2 days, this continued at a reduced rate up to 9 days after 
which a reduction in cell numbers occurred. Increasing the inoculum size to 107 
CFU/ml for St 53, St 9203, Ps 3, Ps 10421 and C. freundii, resulted in survival for 
more than one year. The only exception being C. freundii, in this case the number 
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of cells was 4.02 x102 and 0.00 CFU/ml after 52 and 119 days respectively. 
Colony morphology and Gram stains showed that all strains remained pure during 
whole years except Ps 3 that was pure up to 277 days but was seen to be 
contaminated at 365 days. 
 
 
Figure 5.58 Bacterial survival in sterilised UPW with different inoculum size a) 105 
CFU/ml b) 107 CFU/ml. 
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5.5.1 Discussion  
In our study. Ps 3, 10421, St 53, 9203 and C. freundii survived for 
extended periods in sterilised UPW with no obvious carbon source. In a previous 
study by Brooke (2012) it was reported that P. aeruginosa was able to survive for 
months on dry surfaces and even able to persist and grow in contaminated 
antimicrobial hand soap containing triclosan. S. maltophilia also prefers wet 
surfaces and aqueous solutions. S. maltophilia has the ability to survive in 
drinking water, UPW, and treated water with filtration, UV exposure, or 
deionization. Brooke (2012) also indicated that in response to starvation such as 
in tap water, mineral water or reverse osmosis water, these bacteria produce ultra-
micro cells (UMC) 0.1 to 0.2 μm in size that can pass through a 0.2 μm filter. This 
adaption is thought to reduce the energy costs of chemotaxis. These UMC have 
been recovered from chlorinated drinking water samples and were capable to 
cultivation and biofilm formation on PVC pipe walls (Brooke, 2012).  P. 
aeruginosa was able to survive in DW with 5.45-6.15 Log for about 128-145 days 
(Farber and Todd, 2000). In another study, to understand the survival and 
multiplication P.  solanacearum in pure water, (Sunaina et al., 1998) indicated 
that the bacteria was able to multiply for the first day of incubation at 10 and 20˚C 
then bacterial number remained stable for the rest of the period but at 30˚C, all 
strains multiplied for 2 days and bacterial number decreased gradually reaching 
non detectable level by the tenth day of incubation. While in the present study, all 
strains were able to multiply at the beginning of incubation and remains detectable 
for long period except St 18 and Ps 5 (Figure 5.58). Liao and Shollenberger (2003) 
reported that P. fluorescens was able to survive for 16 years in DW while P. 
aeruginosa PA01 with approximately 9 Log inoculum size, was able to survive in 
DW for about 30 weeks (2.67 Log) (Liao and Shollenberger, 2003). 
5.5.2 Key finding  
 The bacterial strains Ps3, Ps 10421, St 53, St 9203 and C. freundii were able 
to survive for extended time periods in sterile UPW.  
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6. General Discussion  
Gram-negative bacterial pathogens have a significant impact on human 
health and wellbeing particularly since they have developed resistance to a range 
of antibiotics. The increase in infections caused by MDRO bacteria has resulted 
in efforts to examine the survival strategies and explain the mechanisms used by 
these pathogens during infection and disease. These pathogens investigated in this 
study, P. aeruginosa, S. maltophilia and C. freundii are all identified as MDRO 
(Rosenberger et al., 2011, Brooke, 2012) and this study has focused on their 
ability to form biofilms since biofilm formation is a key characteristic of 
pathogenic organisms in healthcare settings.  
This investigation focussed on a range of clinical isolates and a smaller 
number of laboratory strains obtained from culture collections. All clinical strains 
of S. maltophilia that were kindly provided by Dr Jane Turton, Laboratory of 
Health Care Associated Infection, Health Protection Agency, London, UK. The 
clinical P. aeruginosa strains had been previously isolated from discarded wound 
dressings provided anonymously from a local skin integrity practitioner.  The 
strain of C. freundii investigated in this study also originated from these discarded 
wound dressings and was found to be a contaminant of one of the original P. 
aeruginosa isolates. Initially the identity of all the strains employed was 
confirmed by 16s rRNA gene sequencing along with established culture based 
biochemical tests.  
All three candidates species (P. aeruginosa, S. maltophilia and C. freunii) 
were known to produce biofilms on polystyrene surfaces (Pompilio et al., 2015, 
Allan et al., 2002, O'Toole, 2011). This was confirmed in the present study using 
96 well plates (polystyrene). However, in this study biofilm formation was found 
to be variable and media dependent (Figure 5.11). All bacterial strains of  
Stenotrophomonas, Pseuodomonas and Citrobacter genera formed different 
biofilms ranged from no biofilm formation to strong biofilm formation on 
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different media, which agrees with a range of previous studies (Di Bonaventura 
et al., 2004, Pompilio et al., 2008, Müsken et al., 2010, Pereira et al., 2010).  
Davey and O'toole (2000) reported that the microbial adherence and biofilm 
formation is effected by a number of variables including species of bacteria and 
nutrient availability.  
The optimum inoculum size for biofilm formation was in the region of 1-
5x107 CFU/ml (Figure 5.6). It was shown that the size of inoculum significantly 
influence the amount of biofilm formation, i.e. biofilm density increased with the 
increasing of inoculum size, thus standardised inoculums should be used. In most 
studies dealing with biofilm quantification, the exact size of the inoculums has 
not been determined (Stepanovic et al., 2007). In some studies the initial inoculum 
is specified as a 1:100 dilution of an overnight culture, this approach has been 
used for the quantification of biofilm production in Gram negative bacteria 
(Zubair et al., 2011), S. maltophilia (Huang et al., 2006), P. aeruginosa (Head and 
Yu, 2004, Rogan et al., 2004, Abidi et al., 2013) E. coli O157:H7 (Ryu and 
Beuchat, 2005). However, this does not reflect the fact that different bacteria will 
generate different cell densities when grown over night. In other studies several 
inoculum size were used for biofilm formation for example in S. maltophilia, 
5x105-1x106 CFU/ml (Di Bonaventura et al., 2004), 1x108 CFU/ml (Di 
Bonaventura et al., 2007), 107 CFU/ml (Pompilio et al., 2011) 5x107-1x108 
CFU/ml (De Rossi et al., 2007), 1x106 CFU/ml  (de Rossi et al., 2009, Roscetto 
et al., 2015), in P. aeruginosa 107 CFU/ml (Cady et al., 2012) 106 CFU/ml 
(Tavernier and Coenye, 2015) 1.5x108 CFU/ml (Kazemian et al., 2015), 
Burkholderia cenocepacia 1x106-1x107 CFU/ml (Caraher et al., 2007), 
Acinetobacter spp.,  Burkholderia spp., Mycobacterium spp. 1x108 CFU/ml 
(Simões and Simões, 2013), Staphylococcus pseudintermedius 105 CFU/ml (Field 
et al., 2015). This wide range of initial inoculum sizes prevents the cross 
comparison of biofilm formation data between publications. The data generated 
here suggests that a range of inoculum sizes should be used to determine the 
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optimum for the conditions investigated before the strength of biofilm formation 
for a particular strain is reported. This will prevent to study variation in the 
reported strength of biofilm formation.  
In P. aeruginosa stains, increasing casein led to decrease biofilm 
production while increasing glucose up to 2% led to increase biofilm formation. 
This suggests that the carbon to nitrogen ratio influences biofilm formation and 
when excess carbon is present the bacteria divert this to the formation of 
extracellular polysaccharides. In S. maltophilia strains, increasing casein 
concentration showed no effects while glucose 1% was the optimum for biofilm 
formation (Figure 5.7 and 5.8). However in a study by Zgair and Chhibber (2011), 
0.2% glucose generated the maximum adhesion to polystyrene when a range of 
glucose concentrations (0, 1, 2, 4, 8, 16 g/l) in LB broth was used (Zgair and 
Chhibber, 2011). Generally, the ratio of carbon source (glucose, glycerol and 
ethanol) to nitrogen source (casein) in our study was approximately 10:1 for all 
strains, however in the case of the P. aeruginosa strains 20:1 (glucose:casein) 
showed the maximum biofilm production.  However 10:1 was used in EPS 
production investigations to avoid the glucose interfering with EPS analysis. This 
observation is in agreement with the previous study of (Sutherland, 2001) which 
indicated that the promotion of biofilm formation and associated EPS production 
was mainly affected by the nutrient content of the growth medium. EPS synthesis 
depends on the availability of carbon substrates and its balance with other limiting 
nutrients. The presence of excess carbon substrate and the limitation of other 
nutrients nitrogen, phosphate and potassium stimulate EPS production 
(Sutherland, 2001). In another study, Karatan and Watnick (2009) indicated that 
an increase in nutrients concentration of various carbon and/or nitrogen sources 
such as glucose, glutamate, citrate and ammonium chloride in the media leads to 
termination of biofilm formation in the P. aeruginosa (Karatan and Watnick, 
2009) as was seen in this study when the casein concentration was increased.  
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 In the present study, the strength of biofilm formation differed between 
bacterial strains of the same species, and this is  confirming the fact that different 
strains have different biofilm potentials (Hancock et al., 2011). All bacterial 
strains except St 18 were able to produce a pellicle (an air-liquid biofilm) on at 
least one media at room temperature (Figure 5.14), similar result were found in 
previous study (Zogaj et al., 2003, Colvin et al., 2011b). Drip flow biofilm 
reactors (DFR) are designed for the study of biofilms grown under low shear 
conditions. DFR are considered an ideal method for general biofilm studies, 
evaluating and testing of  medical material and indwelling medical device 
(Schwartz et al., 2010). DFR represent biofilm formation as seen in nature, for 
example DFR were successfully used for the study of Actinobacillus 
pleuropneumoniae biofilm formation which is associated with respiratory 
infections. This is because the DFR creates an environment with an air-liquid 
interface that closely resembles the lung environment (Tremblay et al., 2013). In 
this study, St 53, 9203, Ps 3, 10421 and C. freundii were able to produce biofilm 
on both hydrophilic (glass slides) and hydrophobic (plastic slides) surfaces 
(McQueary and Actis, 2011, Machado et al., 2011). No obvious differences were 
seen when either glucose or ethanol were used as the carbon source during biofilm 
formation on either glass or plastic under low shear conditions. Previous studies 
have demonstrated the ability of P. aeruginosa, S. maltophilia and C. freundii to 
form biofilms under flow environment (Habimana et al., 2010, Hunt et al., 2004, 
Stoodley et al., 1999) and on biotic and abiotic surfaces in hospitals devices used 
for patient care (catheters and respiratory therapy equipment) (Shirtliff and Leid, 
2009, Brooke, 2012, O'Toole and Kolter, 1998, Soto, 2014).  
The ability of P. aeruginosa, S. maltophilia and C. freundii to form 
biofilms using ethanol as a sole carbon source may be considered one of the 
strategies the results in the persistence of these bacteria in hospitals. These 
bacteria may be degrading antiseptic and detergent residues, which contain traces 
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of ethanol and that have contaminated the hospital environment as a carbon 
source.  
Sequencing of the genomes of the three of the strains investigated in this 
study (Ps 3, St 53 and C. freundii) showed the presence of set of genes associated 
with biofilm formation such as the pgaABCD locus in both St 53 and C. freundii 
and a full complement of pel (PA3058-PA3064), psl (PA2231-2245) and alginate 
biosynthesis operons (PA3540-3548) in Ps 3.  
Cell surface properties are recognized as the key factors that influence 
bacterial adhesion and colonization on biotic and abiotic surfaces (Zita and 
Hermansson, 1997, Di Bonaventura et al., 2008, Guimarães et al., 2006). The 
differences between strains and the effect of carbon source on biofilm formation 
was revealed by the hydrophobicity test data. Clear differences were observed 
between strains and the use of ethanol as carbon sources (MM Eth) generated 
greater hydrophobicity than MM Glc, SWF or TSB (except in SAT test). This 
correlation between biofilm formation and hydrophobicity is to be expected,  
since plastic surfaces are hydrophobic in nature (McQueary and Actis, 2011). 
Machado et al. (2011) also studied the cell surface hydrophobicity (MATH) to 
monitor P. aeruginosa growing in the presence of benzalkonium chloride and 
found that the hydrophobicity were increase as the cells grew in resistance to the 
disinfectant. Another study by (Norman et al., 2002) indicated that P. aeruginosa 
cells grown on glucose, produced both high molecular weight negatively charged 
B band LPS and low molecular weight neutral A band LPS  that demonstrate low 
surface hydrophobicity (Norman et al., 2002). Ethanol promoted bacterial 
adherence may be species specific. For example Streptococcus spp. increased 
adherence to human cells after exposure to 1% ethanol (Vasiliou et al., 2015).  
In the present study, different hydrophobicity result recorded according to 
using different Hydrocarbons (Section 5.2.9) a result that agrees with previous 
studies (Saini, 2010).The variability seen in the hydrophobicity results makes it 
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difficult to make any correlation with biofilm formation, however, it is noticeable 
that bacterial biofilms on (MM Eth and MM Glc) and SAT test on (MM Eth and 
MM Glc) showed a good correlation between biofilm formation and 
hydrophobicity (Table 5.6). After testing 40 clinical isolates of S. maltophilia 
strains to investigate the correlation between the adherence and the biofilm 
formation on polystyrene and cell surface hydrophobicity; Pompilio et al. (2008) 
found that most strains were able to adhere and form biofilms and that there was 
a positive correlation between hydrophobicity and biofilm formation, although 
some strong biofilm formers were hydrophilic (Pompilio et al., 2008).  
Extracellular Polymeric Substance (EPS) are high molecular weight 
polymers secreted by microorganisms which contain polysaccharides, proteins, 
phospholipid, nucleic acids (DNA and RNA) and humic substance (Czaczyk and 
Myszka, 2007, Hall-Stoodley et al., 2004, Vu et al., 2009). The production of 
these polymeric substances has a wide variety of roles includes adhesion to 
surfaces, bacterial cell aggregation, protection from engulfment by predatory 
protozoa and (phagocytes), protection from desiccation and antimicrobial agents 
(Nwodo et al., 2012). In this study the focus was on the generation and analysis 
of EPS. Selection of a media is one of the most important aspects in the study of 
bacterial EPS production and characterisation since the media should be free of 
any interfering substances e.g. yeast extract (Alhudhud et al., 2014). In this study, 
several broth media (TSB, LB and SWF media) were ruled out due to the presence 
of these interfering substances (Figure 5.22). However TSB and LB broth have 
both been used in previous studies (Subramaniam et al., 2007, Yilmaz et al., 2012, 
García et al., 2015, Ngwai et al., 2006), throwing into doubt the accuracy of 
currently published data. During the selection of a media for EPS production and 
characterisation, proton NMR analysis is not sufficient on its own to determine 
the presence of interfering substances since proton NMR analysis depends on the 
dissolution of the sample in the solvent (de Alvarenga, 2011). Beside proton NMR 
HPAEC, phenol sulphuric acid carbohydrate test, Bradford protein test and uronic 
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acid test are all good parameters to determine the suitability of any media. In order 
to avoid the problems associated with interfering substances, several 
polysaccharides free mineral media such as MM Glc, MM Gly and MM Eth were 
developed and modified (Alhudhud et al., 2014, Shoukat, 2014).  
The optimum conditions for the generation and extraction of EPS 
generated by Ps3, St 53 and C. freundii on mineral media was an initial inoculum 
of 107 CFU/ml, incubation at 30˚C for approximately 80h with 0-5 % TCA for the 
removal of proteins from the crude extract. For many bacteria the optimum 
condition for EPS production are different from their optimum growth. EPS 
production is effected by several factors such as temperature, pH and medium 
composition, and even the strain. It is also known that some bacterial EPS degrade 
after synthesis. For example some EPS by Leuconostoc mesenteroides 
and Streptococcus thermophilus showed a loss of EPS during the later stages of 
the growth cycle (Yang, 2011).  
EPS produced by Ps3, St 53 and C. freundii on all carbon sources was a 
complex polymer that was composed of at least two polysaccharides one of which 
was a dextran like polymer. The production of this dextran like component was 
independent on the carbon source. Removal of this dextran component by 
dextranase treatment revealed a second more complex EPS that was mannose 
dominated with a range of additional sugars. Some researcher are convinced that 
the type of carbon sources cannot effect on EPS composition, while the other 
found that carbon source can have an effect on molecular weight, EPS yield and 
even chemical composition. Excess of carbon and limiting nitrogen will enhance 
EPS production, however in different bacteria, carbon source has different effect 
on EPS production and sugar composition (Yang, 2011).  In some bacteria such 
as Acidithiobacillus ferrooxidans, the EPS composition varies and depends on the 
type of substrate or growth media on which the cells are grown. Different 
substrates show different mode of attachment and this leads to different EPS gene 
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expressions (Vu et al., 2009).  In the current study the chemical composition of 
each bacterial EPS generated on different carbon sources was the same but with 
different quantities i.e. different proportions of the individual monosaccharide 
sugar. This result agrees with Petry et al. (2000) who reported that the chemical 
composition of EPS generated by Lactobacillus delbrueckii subsp. bulgaricus 
growth on different carbon sources was the same but with different relative 
proportions of the individual monosaccharides (Petry et al., 2000). 
Dextran is a high molecular weight, extracellular homopolysaccharide of 
glucose that is produced by bacteria such as Streptococcus, Leuconostoc, 
Lactobacillus Weissella and Campylobacter species (Monsan et al., 2001, 
Burmølle et al., 2014, Sadiq, 2015). Streptococcus mutans produce extracellular 
dextran to adhere to teeth and form dental plaques (Bowen and Koo, 2011). The 
production of dextran by bacteria is linked to a range of hydrolytic glucansucrases 
(glucosyltransferase) (Monsan et al., 2001). Whole genome sequencing showed 
the presence of glucosyltransferases in all bacterial strains Ps 3, St 53 and C. 
freundii) (http://rast.nmpdr.org/ ) (Overbeek et al., 2014).  
EPS sugar components from Ps3, St 53 and C. freundii were very similar 
differing in only 1-2 sugars (Figure 5.34 and Table 5.11). (Bales et al., 2013) 
analysed the EPS composition of several bacteria, like Klebsiella pneumoniae, P. 
aeruginosa, and A. baumannii, among all the sugars present, they only differed in 
1-3 sugar.  According to Liu (2012), the EPS in many Gram-negative bacteria are 
relatively simple, and the monomeric composition of Gram-negative bacterial 
EPS were either homopolysaccharides (polymers composed of D-glucose), or 
heteropolysaccharides, which compose of 2-4 types of monosaccharide residues. 
Several sugars including D-glucose, D-mannose,  D-galactose, L-fucose and L-
rhamnose are frequently found in microbial EPS (Liu, 2012).  
Some of the polysaccharides in Gram-negative bacteria polyanionic due 
to the presence of uronic acid sugars or pyruvates, this leads to an increase in the 
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anionic properties of the EPS. This results in the EPS having an affinity for  
divalent cations such as calcium and magnesium which act to increase the binding 
force in a developing biofilm (Vu et al., 2009). The most common sugars in Gram 
negative EPS are glucose, galactose, ribose, fructose, xylose, and arabinose while 
the rarer sugars are fucose, rhamnose and uronic acid. The presence of rarer sugars 
in the EPS, make it more favorable for different fields of applications, such as 
anti-inflammatory substances, antiviral agents and antioxidant. An example of 
bacteria that produce rare sugars are the marine bacterium Enterobacter cloacae 
and  Streptococcus spp. (Roca et al., 2015a).  
P. aeruginosa is able to produce range of EPS such as Alginate, Psl and 
Pel (Franklin et al., 2011, Bazaka et al., 2011, Sharma et al., 2014). The Psl 
polysaccharide has been characterised as a neutral, branched polysaccharide with 
repeating D-mannose, D-glucose,and L-rhamnose sub units (Byrd et al., 2009) 
while the Pel polysaccharide that produce pellicle remains uncharacterised, but it 
is generally referred to as a glucose rich polymer (Friedman and Kolter, 2004a, 
Whitfield et al., 2015).  
WGS showed that Ps 3 contained a full complement of alginate (PA3540-
3548), pel (PA3058-PA3064) and psl (PA2231-2245) biosynthesis operons that 
also identified in P. aeruginosa PA01 (Sharma et al., 2014) 
(http://www.pseudomonas.com). One of the most significant outcomes of the 
project is the indication that the pel polysaccharide of P. aeruginosa is a dextran 
like polymer. The presence of a dextran being demonstrated by dextranase 
treatment and the removal of peaks associated with dextran from NMR spectra. 
This analysis is consistent with the description of the Pel polysaccharide as a 
glucose rich polymer  (Ryder et al., 2007, Ma et al., 2009). When the pel EPS is 
removed by the dextranase the remaining EPS is a mannoses rich polysaccharide 
consistent with a Psl polysaccharide. Ps 3 failed to produce an alginate in the 
current study, even though it had the required alginate biosynthesis operons 
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(PA3540-3548) (Sharma et al., 2014) (http://www.pseudomonas.com).  However, 
in this study the Ps 3 was grown in culture conditions ideal for pellicle formation 
rather than the cell surface biofilm environments consistent with mucoid growth 
and alginate generation. The current study suggests that the Psl and Pel 
polysaccharides may be synthesized at the same time by Ps 3 when grown under 
pellicle forming conditions. In a study by Karatan and Watnick (2009), sugar 
analysis of the EPS isolated from biofilms of non-mucoid strains of P. aeruginosa 
PA01, showed the presence of large amounts of both glucose (Pel) and mannose 
(Psl), while the absence of uronic acid indicating the lack of an alginate (Karatan 
and Watnick, 2009). This observation is highly consistent with the data generated 
here but with presence of some unknown uronic acid peaks.  
In the present study both S. maltophilia St 53 and C. freundii produced 
complex polysaccharides. One of them being dextran like and the other one 
composed of Fucose, Galactosamine, Glucosamine, Galactose, Glucose, Mannose 
and some unknown uronic sugars in case of St 53. In the case of C. freundii, it 
was composed of Galactosamine, Glucosamine, Galactose, Glucose, Mannose 
and some unknown uronic sugars. Cescutti et al (2011) mentioned that the S. 
maltophilia EPS is composed of Glucose, Glucuronic acid, Galacturonic acid 
(Cescutti et al., 2011) while Citrobacter spp. has been associated with the 
production of a cellulose based EPS (Zogaj et al., 2003). Other authors such as 
(Rättö et al., 2006) have suggested that Citrobacter spp. EPS mainly consists of 
Fucose, Rhamnose, and other sugars such as Galactose, Glucose, Mannose, 
Galacturonic acid, Glucuronic acid and pyruvate. The compositions in these latter 
studies are closer to the composition determined in this study, which once again 
underlines the fact that EPS generation can be highly varied even within species. 
The genome of St 53 and C. freundii showed the presence of the entire pgaABCD 
locus that encodes the synthesis of a polysaccharide.  
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Gram-negative bacteria are able to produce OMV during normal bacterial 
growth or as a stress response (MacDonald and Kuehn, 2013). In this study The 
Ps 3 strain of P. aeruginosa was able to produce OMV in the absence of any 
external stressors when grown on both glucose and ethanol as sole carbon sources 
while Ps 10421 failed to produce OMV on both carbon sources. Sidhu et al. 
(2008a) were able to purified OMV from Pseudomonas aeruginosa PA01 on TSB 
(Sidhu et al., 2008a). When Ps 3 was grown on ethanol it generated a greater 
quantity of OMV than when grown on glucose. Both Ps 3 and Ps 10421 were 
more virulent when grown on ethanol than when grown on glucose. Sidhu et al. 
(2008a) investigated OMV purification on two different culture media and 
reported that culture conditions have an effect on the protein composition of the 
OMV (Sidhu et al., 2008a). Kulp and Kuehn (2010) also indicated that OMV 
production is affected by growth conditions such as media type, temperature and 
nutrient levels (Kulp and Kuehn, 2010).  In a previous study, Sidhu et al. (2008a) 
reported that during growth of  Xanthomonas campestris , this bacteria was able 
to release OMV into the culture supernatant that contained 31 proteins of which 
half are virulence-associated. Another reason for the pathogenicity of OMV are 
the presence of virulence factors found within the parent bacterium. For example 
P. aeruoginosa OMV are composed of alkaline phosphatase, phospholipase C, 
protease, and peptidoglycan hydrolase (Li et al., 1998) and these OMV play a role 
in nutrient transformation, biofilm formation and resistance to antimicrobial 
agents (Lim and Yoon, 2015). OMV also play a role in communication between 
cells, the lysing and killing of competing bacteria and the modulation of host 
immune response, and as such they contribute to bacterial survival and virulence. 
For example OMV of Pseudomonas aeruoginosa PA01 are capable of lysing 
Staphylococcus aureus and Escherichia coli, while those generated by 
Citrobacter strains can lyse Mycobacterium strains (Li et al., 1998, Lee, 2012, 
Kulp and Kuehn, 2010). OMV help P. aeruoginosa in pathogenesis due to their 
association with other virulence factors such as peptidoglycan hydrolase, 
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hemolysin, phospholipase C and alkaline phosphatase. These OMV effect host 
cells by disrupting the electron transport chains and trafficking pathways of the 
cells. Due to these factors P. aeruginosa OMVs can kill both Gram-negative and 
Gram-positive competing bacteria in co-culture or in the environment especially 
during infection (MacDonald and Kuehn, 2013).  
In the current study P. aeruginosa Ps 3 grown on ethanol was more 
pathogenic than when grown on glucose. This suggests ethanol induced virulence 
gene expression more than glucose. This difference may be due to carbon sources 
that induce virulence genes to excrete toxins. Differences in virulence due to 
different grown media has been reported in Listeria monocytogenes (Park et al., 
1992). These authors reported that expression of virulence genes was greater on 
Brain heart infusion than Tryptone soya broth and this may be due to either the 
presence of unknown inducers of gene expression (virulence) in BHI and their 
absence from other (Park et al., 1992). In another study on invasion of HeLa cells 
by Streptococcus pyogenes media composition was shown to have a significant 
impact on invasion (Edwards and Massey, 2011).  
In order to gain a better insight into the impact of ethanol vs glucose, the 
associated transcriptomes were constructed. The Ps 3 transcriptome showed that 
biofilm (psl, pel and alg) genes were expressed on both carbon source media but 
it’s not clear if it is related to the virulence of the Ps 3.  To determine how ethanol 
affects psl and pel genes, Tashiro et al. (2014) studied the transcription of pslA 
and pelA in the presence and absence of ethanol. Surprisingly the results showed 
that there are no difference between the expression in both genes during presence 
and absence of ethanol however the 96 well plate showed induction of biofilm 
and pellicle formation. They reported that pslA and pelA expression is not 
effected by ethanol at the transcriptional level, rather ethanol increased Psl and 
Pel at the translational level, or increased biofilm and pellicle formation without 
affecting the synthesis processes (Tashiro et al., 2014). 
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Finally, bacterial strains Ps 3, 10421, St 53, 9203 and C. freundii were 
able to survive for long periods in sterilised ultrapure water (UPW). Kramer et al. 
(2006) indicated that Pseudomonas can survive for months on dry surfaces and 
non-living objects, they also noted that humidity can improve persistence (Kramer 
et al., 2006). Another author reported that Pseudomonas was able to growth and 
survive for months in distilled water (Leung et al., 2001) while  Liao and 
Shollenberger (2003) reported that both P. fluorescens and  P. aeruginosa PA01 
were able to survive in distilled water for 16 years and 30 weeks respectively 
(Liao and Shollenberger, 2003). S. maltophilia were also studied by some author, 
Brooke (2012) mentioned that this bacteria prefers wet surfaces and aqueous 
solution and also it that it has the ability to survive in drinking water and ultrapure 
water (Brooke, 2012).   
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7. Future works  
 
 Further studies on the production of Extracellular Polymeric Substances 
(EPS) and dextran by S. maltophilia (St 53) and C. freundii on a range of 
carbon sources. 
 
 2D NMR and Linkage analysis of the sugar monomers present in the EPS 
produced by P. aeruginosa (Ps 3) S. maltophilia (St 53) and C. freundii in 
order to determine the structure of the EPS produced by these bacteria.  
 
 
 Proteomic analysis of Ps 3 cultures grown on glucose and ethanol in order 
to identify the basis of the enhanced pathogenicity observed in ethanol 
grown cultures.  
 
 Study the links or relations between bacterial number (inoculum size), 
Quorum Sensing (QS), biofilm and pathogenicity. 
 
 
 Determine the pathogenic characteristics of the Outer Membrane Vesicle 
(OMV) produced by St 53 and C. freundii grown on a range of carbon 
sources using the wax worm infection model.  
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Statistics analysis  
 
Anova: Two-Factor Without Replication     
SUMMARY Count Sum Average Variance 
(2Fe-2S) ferredoxin 2 981.99 491.00 96206.9 
Acyl-homoserine lactone acylase subunit beta 2 84.46 42.23 3000.0 
(2Fe-2S) ferredoxin 2 981.99 491.00 96206.9 
Anthranilate synthase component 2, Pyocyanine specific 2 685.56 342.78 77342.4 
Exoenzyme S synthesis protein C 2 61.76 30.88 246.9 
Exotoxin A regulatory protein 2 25.2 12.60 218.8 
Lipoprotein 2 156.33 78.17 9336.6 
Lipoprotein 2 115.46 57.73 307.0 
LPS biosynthetic protein lpxo 2 349.33 174.67 1529.6 
LPS core heptose(I) kinase rfap 2 100.77 50.39 880.7 
Outer membrane protein 2 1479.25 739.63 542059.1 
Outer membrane protein 2 18.83 9.42 5.0 
Outer membrane protein assembly factor bamb 2 444.94 222.47 9400.9 
Outer membrane protein assembly factor bamd 2 339.41 169.71 1815.0 
Outer membrane receptor fepa 2 8.86 4.43 7.1 
Peptide synthase 2 204.996 102.50 17999.9 
Peptidase 2 433.1552 216.58 89149.7 
Peptidase m19 2 100.4425 50.22 4334.0 
Protease 2 113.24 56.62 578.0 
Protease lasa 2 648.49 324.25 11998.6 
Protease pfpi 2 1676.7 838.35 54344.5 
Protease subunit hflk 2 1372.07 686.04 133742.7 
Protease subunit hflk 2 1278.66 639.33 113449.9 
Type II secretion system protein F 2 1052.33 526.17 152921.1 
Type III export apparatus protein 2 14.17 7.09 10.0 
Type III export protein psci 2 17.51 8.76 3.8 
Type III secretion outer membrane protein popn 2 7.25 3.63 0.1 
Type III secretion system chaperone yscw 2 27.58 13.79 32.5 
Type III secretion system protein 2 7.82 3.91 0.7 
Type III secretion system regulator exsd 2 49.03 24.52 81.3 
     
Glucose Expression 30 3571.13 119.04 26992.6 
Ethanol Expression 30 9266.4537 308.88 136021.5 
 
ANOVA       
Source of Variation SS df MS F P-value F crit 
Rows 3,850,812.64 29 132,786.64 4.3929 0.0001 1.8608 
Columns 540,611.87 1 540,611.87 17.8848 0.0002 4.1830 
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Error 876,597.96 29 30,227.52    
Total 5,268,022.48 59     
 
 
Anova: Two-Factor Without Replication  
SUMMARY Count Sum Average Variance 
Hypothetical protein 2 255.95 127.97 31479.62 
Thiamine pyrophosphate-binding protein 2 296.69 148.34 42199.23 
Hypothetical protein 2 315.64 157.82 47749.12 
Zinc abc transporter permease 2 100.55 50.27 4843.76 
Abc transporter substrate-binding protein 2 141.79 70.89 9617.88 
Manganese abc transporter atp-binding protein 2 114.17 57.08 6210.93 
Atpase 2 7.99 3.99 30.07 
5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase 2 1238.40 619.20 717716.77 
Cyclic peptide transporter 2 146.89 73.45 9961.95 
Class v aminotransferase 2 58.33 29.17 1564.43 
Transporter 2 2000.31 1000.15 1825275.51 
Chromophore maturation protein pvdo 2 81.06 40.53 2988.34 
Biopolymer transporter exbd 2 191.84 95.92 16689.06 
Hypothetical protein 2 247.05 123.53 27037.52 
Rna 3'-terminal-phosphate cyclase 2 965.18 482.59 411030.78 
Ornithine monooxygenase 2 725.16 362.58 231068.55 
Metal abc transporter substrate-binding protein 2 151.18 75.59 9996.83 
Thioesterase 2 61.22 30.61 1616.78 
Rna ligase 2 1900.91 950.45 1551360.50 
Acetyltransferase 2 114.44 57.22 5574.62 
Tonb-dependent receptor 2 150.54 75.27 9626.12 
Hypothetical protein 2 190.00 95.00 15299.43 
Membrane protein 2 165.09 82.54 11534.65 
     
Glucose Expression 23 248.93 10.82 284.37 
Ethanol Expression 23 9371.45 407.45 306443.46 
 
ANOVA       
Source of Variation SS df MS F P-value F crit 
Rows 3566675 22 162121.59 1.1211 0.395 2.0478 
Columns 1809135 1 1809135.07 12.5108 0.001 4.3009 
Error 3181337 22 144606.24    
       
Total 8557147 45     
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Appendix 
  
5.1 All sequences used in the current study  
 
>STENO18_premix -- 22..960 of sequence 
CACATGCAGTCGAACGGCAGCACAGGAGAGCTTGCTCTCTGGGT
GGCGAGTGGCGGACGGGTGAGGAATACATCGGAATCTACTTTTT
CGTGGGGGATAACGTAGGGAAACTTACGCTAATACCGCATACG
ACCTACGGGTGAAAGCAGGGGATCTTCGGACCTTGCGCGATTGA
ATGAGCCGATGTCGGATTAGCTAGTTGGCGGGGTAAAGGCCCA
CCAAGGCGACGATCCGTAGCTGGTCTGAGAGGATGATCAGCCA
CACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCA
GTGGGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCCATA
CCGCGTGGGTGAAGAAGGCCTTCGGGTTGTAAAGCCCTTTTGTT
GGGAAAGAAATCCAGCTGGCTAATACCCGGTTGGGATGACGGT
ACCCAAAGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCG
GTAATACGAAGGGTGCAAGCGTTACTCGGAATTACTGGGCGTA
AAGCGTGCGTAGGTGGTCGTTTAAGTCCGTTGTGAAAGCCCTGG
GCTCAACCTGGGAACTGCAGTGGATACTGGGCGACTAGAGTGT
GGTAGAGGGTAGCGGAATTCCTGGTGTAGCAGTGAAATGCGTA
GAGATCAGGAGGAACATCCATGGCGAAGGCAGCTACCTGGACC
AACACTGACACTGAGGCACGAAAGCGTGGGGAGCAAACAGGAT
TAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATG
TTGGGTGCAATTTGGCACGCAGTATCGAAGCTAACGCGTTAAGT
TCGCCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGA
ATTGACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTA 
 
>STENO51_premix -- 26..961 of sequence 
GCAGTCGAACGGCAGCACAGGAGAGCTTGCTCTCTGGGTGGCG
AGTGGCGGACGGGTGAGGAATACATCGGAATCTACTCTGTCGTG
GGGGATAACGTAGGGAAACTTACGCTAATACCGCATACGACCT
ACGGGTGAAAGCAGGGGACCTTCGGGCCTTGCGCGATTGAATG
AGCCGATGTCGGATTAGCTAGTTGGCGGGGTAAAGGCCCACCA
AGGCGACGATCCGTAGCTGGTCTGAGAGGATGATCAGCCACAC
TGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTG
GGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCCATACCG
CGTGGGTGAAGAAGGCCTTCGGGTTGTAAAGCCCTTTTGTTGGG
AAAGAAATCCAGCTGGCTAATACCCGGTTGGGATGACGGTACC
CAAAGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTA
ATACGAAGGGTGCAAGCGTTACTCGGAATTACTGGGCGTAAAG
CGTGCGTAGGTGGTCGTTTAAGTCCGTTGTGAAAGCCCTGGGCT
CAACCTGGGAACTGCAGTGGATACTGGGCGACTAGAGTGTGGT
AGAGGGTAGCGGAATTCCTGGTGTAGCAGTGAAATGCGTAGAG
ATCAGGAGAACATCCATGGCGAAGGCAGCTACCTGGACCAACA
CTGACACTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAGA
TACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGG
GTGCAATTTGGCACGCAGTATCGAAGCTAACGCGTTAAGTTCGC
CGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATTG
ACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCG 
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>STENO53_premix -- 25..991 of sequence 
GCAGTCGAACGGCAGCACAGGAGAGCTTGCTCTCTGGGTGGCG
AGTGGCGGACGGGTGAGGAATACATCGGAATCTACTCTGTCGTG
GGGGATAACGTAGGGAAACTTACGCTAATACCGCATACGACCT
ACGGGTGAAAGCAGGGGATCTTCGGACCTTGCGCGATTGAATG
AGCCGATGTCGGATTAGCTAGTTGGCGGGGTAAAGGCCCACCA
AGGCGACGATCCGTAGCTGGTCTGAGAGGATGATCAGCCACAC
TGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTG
GGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCCATACCG
CGTGGGTGAAGAAGGCCTTCGGGTTGTAAAGCCCTTTTGTTGGG
AAAGAAATCCAGCTGGCTAATACCCGGTTGGGATGACGGTACC
CAAAGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTA
ATACGAAGGGTGCAAGCGTTACTCGGAATTACTGGGCGTAAAG
CGTGCGTAGGTGGTCGTTTAAGTCCGTTGTGAAAGCCCTGGGCT
CAACCTGGGAACTGCAGTGGATACTGGGCGACTAGAGTGTGGT
AGAGGGTAGCGGAATTCCTGGTGTAGCAGTGAAATGCGTAGAG
ATCAGGAGGAACATCCATGGCGAAGGCAGCTACCTGGACCAAC
ACTGACACTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAG
ATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTG
GGTGCAATTTGGCACGCAGTATCGAAGCTAACGCGTTAAGTTCG
CCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATT
GACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGAT
GCAACGCGAAGAACCTTACCTGGGCCTTGACATGTCGAGAACTT
TCCAGAGATGGATT 
 
>Stenotrophomonas maltophilia 9203 (ATCC 13637T) 
AGTGAACGCTGGCGGTAGGCCTAACACATGCAAGTCGAACGGC
AGCACAGGAGAGCTTGCTCTCTGGGTGGCGAGTGGCGGACGGG
TGAGGAATACATCGGAATCTACTTTTTCGTGGGGGATAACGTAG
GGAAACTTACGCTAATACCGCATACGACCTACGGGTGAAAGCA
GGGGATCTTCGGACCTTGCGCGATTGAATGAGCCGATGTCGGAT
TAGCTAGTTGGCGGGGTAAAGGCCCACCAAGGCGACGATCCGT
AGCTGGTCTGAGAGGATGATCAGCCACACTGGAACTGAGACAC
GGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGGACA
ATGGGCGCAAGCCTGATCCAGCCATACCGCGTGGGTGAAGAAG
GCCTTCGGGTTGTAAAGCCCTTTTGTTGGGAAAGAAATCCAGCT
GGTTAATACCCGGTTGGGATGACGGTACCCAAAGAATAAGCAC
CGGCTAACTTCGTGCCAGCAGCCGCGGTAATACGAAGGGTGCA
AGCGTTACTCGGAATTACTGGGCGTAAAGCGTGCGTAGGTGGTC
GTTTAAGTCCGTTGTGAAAGCCCTGGGCTCAACCTGGGAACTGC
AGTGGATACTGGACGACTAGAGTGTGGTAGAGGGTAGCGGAAT
TCCTGGTGTAGCAGTGAAATGCGTAGAGATCAGGAGGAACATC
CATGGCGAAGGCAGCTACCTGGACCAACACTGACACTGAGGCA
CGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCC
ACGCCCTAAACGATGCGAACTGGATGTTGGGTGCAATTTGGCAC
GCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGGAGTAC
247 
 
GGTCGCAAGACTGAAACTCAAAGGAATTGACGGGGGCCCGCAC
AAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGAAGAAC
CTTACCTGGCCTTGACATGTCGAGAACTTTCCAGAGATGGATTG
GTGCCTTCGGGAACTCGAACACAGGTGCTGCATGGCTGTCGTCA
GCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAA
CCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGGAACTCTAAGG
AGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAA
GTCATCATGGCCCTTACGGCCAGGGCTACACACGTACTACAATG
GTAGGGACAGAGGGCTGCAAGCCGGCGACGGTAAGCCAATCCC
AGAAACCCTATCTCAGTCCGGATTGGAGTCTGCAACTCGACTCC
ATGAAGTCGGAATCGCTAGTAATCGCA 
 
 
>Pseudo1F_premix -- 21..982 of sequence 
ATGCAGATCGAGCGAGATGAAGGGAGCTTGTCATCCTGGATTCA
GCGGCGGACGGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTG
GGGGATAACGTCCGGAAACGGGCGCTAATACCGCATACGTCCT
GAGGGAGAAAGTGGGGGATCTTCGGACCTCACGCTATCAGATG
AGCCTAGGTCGGATTAGCTAGTTGGTGGGGTAAAGGCCTACCAA
GGCGACGATCCGTAACTGGTCTGAGAGGATGATCAGTCACACTG
GAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGG
GAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCG
TGTGTGAAGAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAG
GAAGGGCAGTAAGTTAATACCTTGCTGTTTTGACGTTACCAACA
GAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTAATAC
GAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCG
CGTAGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAAC
CTGGGAACTGCATCCAAAACTACTGAGCTAGAGTACGGTAGAG
GGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAGG
AAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGA
CACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACC
CTGGTAGTCCACGCCGTAAACGATGTCGACTAGCCGTTGGGATC
CTTGAGATCTTAGTGGCGCAGCTAACGCGATAAGTCGACCGCCT
GGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGG
GGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAAC
GCGAAGAACCTTACCTGGGCCTTGACATGCTGAGAACTTTCCAG
AGATG 
 
 
>Pseudo3F_premix -- 22..961 of sequence 
ACATGCAAGTCGAGCGGATGAAGGGAGCTTGCTCCTGGATTCA
GCGGCGGACGGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTG
GGGGATAACGTCCGGAAACGGGCGCTAATACCGCATACGTCCT
GAGGGAGAAAGTGGGGGATCTTCGGACCTCACGCTATCAGATG
AGCCTAGGTCGGATTAGCTAGTTGGTGGGGTAAAGGCCTACCAA
GGCGACGATCCGTAACTGGTCTGAGAGGATGATCAGTCACACTG
GAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGG
GAATATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCG
TGTGTGAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGA
GGAAGGGCAGTAAGTTAATACCTTGCTGTTTTGACGTTACCAAC
248 
 
AGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTAATA
CGAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC
GCGTAGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAA
CCTGGGAACTGCATCCAAAACTACTGAGCTAGAGTACGGTAGA
GGGTGGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAG
GAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTG
ACACTGAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATAC
CCTGGTAGTCCACGCCGTAAACGATGTCGACTAGCCGTTGGGAT
CCTTGAGATCTTAGTGGCGCAGCTAACGCGATAAGTCGACCGCC
TGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGG
GGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAA
CGCGAAGAACCTTACCTGGGCCTTGACAT 
 
 
>Pseudo5F_premix -- 199..672 of sequence 
TAGGTCGAATTACCTAGTTGGTGGGGTAAAGGCCTACCAAGGCG
ACGATCCGTAACTGGTCTGAGAGGATGATCAGTCACACTGGAAC
TGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAAT
ATTGGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGT
GAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAA
GGGCAGTAAGTTAATACCTTGCTGTTTTGACGTTACCAACAGAA
TAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTAATACGAA
GGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCGCGT
AGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAACCTG
GGAACTGCATCCAAAACTACTGAGCTAGAGTACGGTAGAGGGT
GGTGGAATTTCCTGTGTAGCGGTGAAATGCGTAGATATA 
 
 
>Pseudomonas aeruginosa strain 10421 (ATCC 15442) 
ATCATGGCTCAGATTGAACGCTGGCGGCAGGCCTAACACATGCA
AGTCGAGCGGATGAAGGGAGCTTGCTCCTGGATTCAGCGGCGG
ACGGGTGAGTAATGCCTAGGAATCTGCCTGGTAGTGGGGGATA
ACGTCCGGAAACGGGCGCTAATACCGCATACGTCCTGAGGGAG
AAAGTGGGGGATCTTCGGACCTCACGCTATCAGATGAGCCTAGG
TCGGATTAGCTAGTTGGTGGGGTAAAGGCCTACCAAGGCGACG
ATCCGTAACTGGTCTGAGAGGATGATCAGTCACACTGGAACTGA
GACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATT
GGACAATGGGCGAAAGCCTGATCCAGCCATGCCGCGTGTGTGA
AGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGG
GCAGTAAGTTAATACCTTGCTGTTTTGACGTTACCAACAGAATA
AGCACCGGCAACTTCGTGCCAGCAGCCGCGGTAATACGAAGGG
TGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGCGCGTAGGT
GGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAA
CTGCATCCAAAACTACTGAGCTAGAGTACGGTAGAGGGTGGTG
GAATTTCCTGTGTAGCGGTGAAATGCGTAGATATAGGAAGGAA
CACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTGA
GGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTA
GTCCACGCCGTAAACGATGTCGACTAGCCGTTGGGATCCTTGAG
ATCTTAGTGGCGCAGCTAACGCGATAAGTCGACCGCCTGGGGA
GTACGGCCGCAAGGTTAAAACTCAAATGAATTGACGGGGGCCC
249 
 
GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAA
GAACCTTACCTGGCCTTGACATGCTGAGAACTTTCCAGAGATGG
ATTGGTGCCTTCGGGAACTCAGACACAGGTGCTGCATGGCTGTC
GTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGTAACGAGC
GCAACCCTTGTCCTTAGTTACCAGCACCTCGGGTGGGCACTCTA
AGGAGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGT
CAAGTCATCATGGCCCTTACGGCAGGGCTACACACGTGCTACAA
TGGTCGGTACAAAGGGTTGCCAAGCCGCGAGGTGGAGCTAATC
CCATAAAACCGATCGTAGTCCGGATCGCAGTCTGCAACTCGACT
GCGTGAAGTCGGAATCGCTAGTAATCGTGAATCAGAATGTCACG
GTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCAT
GGGAGTGGGTTGCTCCAGAAGTAGCTAGTCTAACCGCAAGGGG
GACGGTTACCACGGAGTGATTCATGACTGGGGTG 
 
 
>CitroF_premix -- 23..1001 of sequence 
TGCAGTCGAACGGTAGCACAGAGGAGCTTGCTCCTTGGGTGACG
AGTGGCGGACGGGTGAGTAATGTCTGGTAAAACTGCCCGATGG
AGGGGGATAACTACTGGAAACGGTAGCTAATACCGCATAACGT
CGCAAGACCAAAGAGGGGGACCTTCGGGCCTCTTGCCATCGGA
TGTGCCCAGATGGGATTAGCTAGTAGGTGGGGTAACGGCTCACC
TAGGCGACGATCCCTAGCTGGTCTGAGAGGATGACCAGCCACA
CTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGT
GGGGAATATTGCACAATGGGCGCAAGCCTGATGCAGCCATGCC
GCGTGTATGAAGAAGGCCTTCGGGTTGTAAAGTACTTTCAGCGA
GGAGGAAGGCGTTGTGGTTAATAACCGCAGCGATTGACGTTACT
CGCAGAAGAAGCACCGGCTAACTCCGTGCCAGCAGCCGCGGTA
ATACGGAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAG
CGCACGCAGGCGGTCTGTCAAGTCGGATGTGAAATCCCCGGGCT
CAACCTGGGAACTGCATCCGAAACTGGCAGGCTAGAGTCTTGTA
GAGGGGGGTAGAATTCCAGGTGTAGCGGTGAAATGCGTAGAGA
TCTGGAGGAATACCGGTGGCGAAGGCGGCCCCCTGGACAAAGA
CTGACGCTCAGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGA
TACCCTGGTGTCCACGCCGTAAACGATGTCGACTTGGAGGTTGT
GCCCTTGAGGCGTGGCTTCCGGACTAACGCGTTAAGTCGACCGC
CTGGGGAGTACGGCCGCAAGGTTAAAACTCAAATGAATTGACG
GGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCA
ACGCGAAGAACCTTACCTACTCTTGACATCCAGAGAACTTAGCA
GAGATGCTTTGGTGCCTTCGGG 
 
 
>gi|636559546|ref|NR_115606.1| Staphylococcus aureus strain ATCC 12600  
16S ribosomal RNA gene, partial sequence 
AGGATGAACGCTGGCGGCGTGCCTAATACATGCAAGTCGAGCG
AACGGACGAGAAGCTTGCTTCTCTGATGTTAGCGGCGGACGGGT
GAGTAACACGTGGATAACCTACCTATAAGACTGGGATAACTTCG
GGAAACCGGAGCTAATACCGGATAATATTTTGAACCGCATGGTT
CAAAAGTGAAAGACGGTCTTGCTGTCACTTATAGATGGATCCGC
GCTGCATTAGCTAGTTGGTAAGGTAACGGCTTACCAAGGCAACG
ATGCATAGCCGACCTGAGAGGGTGATCGGCCACACTGGAACTG
250 
 
AGACACGGTCCAGACTCCTACGGGAGGCAGAGTAGGGAATCTT
CCGCAATGGGCGAAAGCCTGACGGAGCAACGCCGCGTGAGTGA
TGAAGGTCTTCGGATCGTAAAACTCTGTTATTAGGGAAGAACAT
ATGTGTAAGTAACTGTGCACATCTTGACGGTACCTAATCAGAAA
GCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGT
GGCAAGCGTTATCCGGAATTATTGGGCGTAAAGCGCGCGTAGG
CGGTTTTTTAAGTCTGATGTGAAAGCCCACGGCTCAACCGTGGA
GGGTCATTGGAAACTGGAAAACTTGAGTGCAGAAGAGGAAAGT
GGAATTCCATGTGTAGCGGTGAAATGCGCAGAGATATGGAGGA
ACACCAGTGGCGAAGGCGACTTTCTGGTCTGTAACTGACGCTGA
TGTGCGAAAGCGTGGGGATCAAACAGGATTAGATACCCTGGTA
GTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCG
CCCCTTAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGA
GTACGACCGCAAGGTTGAAACTCAAAGGAATTGACGGGGACCC
GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAA
GAACCTTACCAAATCTTGACATCCTTTGACAACTCTAGAGATAG
AGCCTTCCCCTTCGGGGGACAAAGTGACAGGTGGTGCATGGTTG
TCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGA
GCGCAACCCTTAAGCTTAGTTGCCATCATTAAGTTGGGCACTCT
AAGTTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACG
TCAAATCATCATGCCCCTTATGATTTGGGCTACACACGTGCTAC
AATGGACAATACAAAGGGCAGCGAAACCGCGAGGTCAAGCAAA
TCCCATAAAGTTGTTCTCAGTTCGGATTGTAGTCTGCAACTCGAC
TACATGAAGCTGGAATCGCTAGTAATCGTAGATCAGCATGCTAC
GGTGAATACGTTCCCGGGTCTTGTACACACCGCCCGTCACACCA
CGAGAGTTTGTAACACCCGAAGCCGGTGGAGTAACCTTTTAGGA
GCTAGCCGTCGAAGGTGGGACAAATGATTGGGGTG 
 
 
 
 
 
 
 
 
5.3 Growth curve  
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Figure 5.3A Growth curves of different bacteria St 53, St 9203, Ps 3, Ps 10421, C. freundii 
and control on different media at 30ºC from time 0 until 72 h in an automated Bioscreen 
C system (O.D. wideband). Error bars represent standard error of the mean of five replicates. 
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Figure 5.3B Growth curves of different bacteria St 53, St 9203, Ps 3, Ps 10421 C. freundii  
and control on different media at 37ºC from time 0 until 72 h in an automated Bioscreen 
C system (OD: wideband). Error bars represent standard error of the mean of five replicates. 
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Figure 5.3 C Carbon utilisation and polysaccharide formation during growth of St 9203 
on different carbon sources after inoculation with 107 CFU/ml at 30°C for 4 days a) MM 
Glc (10g/l) b) MM Eth (10.57 g/l).  
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Figure 5.3 D Carbon utilisation and polysaccharide formation during growth of Ps 10421 
on different carbon sources after inoculation with 107 CFU/ml at 30°C for 4 days a) MM 
Glc (10g/l) b) MM Eth (10.57 g/l). 
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Figure 5.3 E Bacterial biofilm formation during growth on mineral media containing 
different carbon source (Glucose, Glycerol and Ethanol) a) St 53 and b) Ps 3. 
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Figure 5.3 F FTIR analysis of dextran polysaccharide and some interfering crude 
substance in TSB and SWF medium without any bacterial cultivation showing different 
functional group and band assignment. 
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Figure 5.3 G FTIR analysis of EPS produced by Ps 3 on I) MM Eth and II) MM Glc.  
a and c) prior dextranase treatment b and d) post dextranase treatment .
I 
II 
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Figure 5.3 H FTIR analysis of EPS produced by different bacteria on MM Eth prior  I) 
St 53 and II) C. freundii. a and c) prior dextranase treatment b and d) post dextranase 
treatment
I 
II 
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5.4 Bacterial pathogenicity 
 
Table 5.4 Determination of biofilm genes (psl, pel and alginate) in Ps 3 comparing to 
PA01 
 
Ps3 Genbank 
accession 
Locus tag Gene Name % similarity to PA01 Mismatches 
LH31_26130 PA2231 pslA 100.00 0 
LH31_26125 PA2232 pslB 99.59 2 
LH31_26115 PA2233 pslC 99.67 1 
LH31_26110 PA2234 pslD 99.61 1 
LH31_26120 PA2235 pslE 99.70 2 
LH31_26105 PA2236 pslF 99.75 1 
LH31_26100 PA2237 pslG 100.00 0 
LH31_26095 PA2238 pslH 98.51 6 
LH31_16460 PA2239 pslI 98.94 3 
LH31_16455 PA2240 pslJ 99.79 1 
LH31_16450 PA2241 pslK 98.93 5 
LH31_16445 PA2242 pslL 98.87 4 
LH31_16440 PA2243 pslM 98.27 10 
LH31_16435 PA2244 pslN 99.40 2 
Absent PA2245 pslO - - 
 
 
Ps3 Genbank 
accession 
Locus tag Gene Name % similarity to PA01 Mismatches 
LH31_17590 PA3064 pelA 99.05 1 
LH31_17595 PA3063 pelB 99.05 9 
LH31_17600 PA3062 pelC 100.00 0 
LH31_17605 PA3061 pelD 99.12 4 
LH31_17610 PA3060 pelE 99.09 3 
LH31_17615 PA3059 pelF 99.41 3 
LH31_17620 PA3058 pelG 100.00 0 
 
 
Ps3 Genbank 
accession 
Locus tag Gene Name % similarity to PA01 Mismatches 
LH31_22495 PA3542 alg44 100.00 0 
LH31_22490 PA3541 alg8 100.00 0 
LH31_22540 PA3551 algA 99.79 1 
LH31_19975 PA5483 algb 99.33 3 
LH31_13805 PA5322 algC 99.78 1 
LH31_22485 PA3540 algD 100.00 0 
LH31_22505 PA3544 algE 
 
100.00 0 
262 
 
LH31_22535 PA3550 algF 99.54 1 
LH31_22510 PA3545 algG 99.63 2 
LH31_08110 PA0405 algH 99.47 1 
LH31_22525 PA3548 algI 99.23 4 
LH31_22530 PA3549 algJ 100.00 0 
LH31_22500 PA3543 algK 99.79 1 
LH31_22530 PA3547 algL 100.00 0 
LH31_15795 PA3257 algO 100.00 0 
LH31_30390 PA5253 algP 100.00 0 
LH31_30380 PA5255 algQ 100.00 0 
LH31_30350 PA5261 algR 100.00 0 
LH31_22015 PA0762 algU 99.37 2 
LH31_06145 PA4446 algW 99.23 3 
LH31_22515 PA3546 algX 99.58 2 
LH31_23600 PA3385 AmrZ 100.00 0 
LH31_22020 PA0763 mucA 100.00 0 
LH31_22025 PA0764 mucB 100.00 0 
LH31_22030 PA0765 mucC 99.81 1 
LH31_22035 PA0766 mucD 99.37 3 
 
 
 
 
 
 
 
